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Abstract 
During infection, pathogenic bacteria are exposed to hostile conditions such as acidic 
pH, increase of temperature, starvation or oxidative stress leading to an accumulation of 
aggregated, unfolded or denatured proteins, which are toxic for the cell. By degrading or 
refolding the damaged proteins, the Clp protein family allows the maintainance of protein 
homeostasis in bacterial cells. Moreover, previous studies showed that the Clp proteins are 
involved in the virulence of Gram-positive bacteria such as Staphylococcus aureus, Listeria 
monocytogenes and Streptococcus pneumoniae but the mechanisms by which this class of 
proteins regulates virulence factor expression remain unclear. Our study focused on the 
impact of the Clp-mediated proteolysis in the severe human pathogen Streptococcus 
pyogenes. To investigate Clp protein functions, in-frame deletion mutants of the protease 
encoding gene clpP and the Clp ATPase encoding genes clpC, clpE and clpX were generated 
and compared to the wild-type strain in a broad phenotypic analysis. We show that ∆clpX and 
∆clpP mutants display aberrant phenotypes including a delay of growth, increased biofilm and 
aggregate formation, altered chain formation and cell morphology, deficiency in 
transformation and increased adhesion to epithelial cells. Additionally, a lack of clpX or clpP 
expression resulted in increased tolerance to heat and antibiotic stress while the sensitivity to 
oxidative and osmotic stress was elevated. At the molecular level, we demonstrate that ClpX 
and ClpP but not ClpE influence the expression of exoproteins, some of which were identified 
by mass spectrometry. Both ClpX and ClpP positively regulate the expression of cysteine 
protease SpeB whereas they negatively control the expression of M protein, the streptococcal 
inhibitor of complement (Sic) and streptokinase (Ska). Transcription of the virulence gene 
regulators, RopB, CovR, FasA and fasX RNA, was also affected in the ∆clpX and ∆clpP 
mutants. We propose a model where the ClpXP-mediated proteolysis is required for the 
transcriptional regulation of RopB, the main regulator for the entry into stationary phase, 
thereby altering the physiology, adaptation and virulence of S. pyogenes.  
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Zusammenfassung 
Während einer Infektion sind pathogene Bakterien unterschiedlichen lebensfeindlichen 
Einflüssen wie saurem pH, erhöhter Temperatur, Nährstoffknappheit oder oxidativem Stress 
ausgesetzt, was zur Anhäufung von defekten, entfalteten oder denaturierten Proteinen führt, 
die für die Zellen toxisch sind. Die Familie der Clp Proteine ist für den Abbau von diesen 
aggregierten Proteinen und damit die Aufrechterhaltung des Protein Gleichgewichts 
verantwortlich. Frühere Studien haben gezeigt, dass Clp Proteine auch an der Virulenz von 
gram positiven Bakterien wie Staphylococcus areus, Listeria monocytogenes und 
Streptococcus pneumoniae beteiligt sind, wobei der dafür verantworliche Mechanismus 
bislang unbekannt ist. Unsere Untersuchungen beschäftigen sich besonders mit dem Einfluss 
der Clp vermittelten Proteolyse auf das human pathogene Bakterium Streptococcus pyogenes. 
Zu diesem Zweck wurden „in-frame“ Deletionsmutanten der Gene ClpP, kodierend für eine 
Protease sowie der Gene für die Clp ATPasen ClpC, ClpX und ClpE hergestellt und in 
unterschiedlichen phänotypischen Untersuchungen mit einem wildtyp Stamm verglichen.  
Wir konnten zeigen, dass diese ∆clpX und ∆clpP Mutanten phänotypische Veränderungen 
aufweisen hinsichtlich einer zeitlichen Wachstumsverzögerung, einer verstärkten Bildung von 
Biofilmen und Aggregaten, einer veränderten Kolonieform und Morphologie, einer 
reduzierten Transformierbarkeit als auch einer erhöhten Adhesion an Epithelzellen. Weiters 
führt das Fehlen von ClpX und ClpP zu einer höheren Toleranz gegenüber 
Temperaturveränderung und antibiotischen Substanzen wohingegen die Sensitivität in Bezug 
auf oxidativen oder osmotischen Stress zunimmt. Zudem konnten wir feststellen, dass ClpX, 
ClpP aber nicht ClpE die Expression von Exoproteinen beeinflussen, die zum Teil mittels 
Massenspektrometrie identifiziert wurden. Zusätzlich verstärken ClpX und ClpP die 
Expression der Zystein Protease SpeB, während die Expression des M Proteins, des 
Komplement-Inhibitors (Sic) sowie der Streptokinase (Ska) reduziert wird. Ausserdem 
beeinflussen ClpX und ClpP auch die Virulenz Regulatoren RopB, CovR, FasA und fasX 
RNA. Daher postulieren wir ein Model bei dem die ClpXP vermittelte Proteolyse von 
entscheidender Bedeutung für die transkriptionelle Regulierung von RopB, einem wichtigen 
Regulator für den Eintritt in die stationäre Phase, ist und dadurch die Physiologie, Adaption 
und Virulenz von S. pyogenes beeinflusst wird.  
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9 
 
 Introduction 
1. Proteolysis generalities  
Proteolysis was originally thought to be a processus only involved in the metabolism of 
the cells, to recycle proteins and generate amino acids and energy [1]. Later on, proteolysis 
was found to be a key component in stress response by degrading biologically inactive 
aggregates, which interfere with vital cell functions. Furthermore, proteolysis is involved in 
the regulation of various biological processes including cell division, physiology and 
pathogenicity by controlling the stability of key regulators and thus promoting a rapid 
response to environmental changes. Proteolysis is required as a regulatory mechanism of 
protein expression either by generating specific cleavage of domains or motifs of proteins, 
changing their conformation or by complete degradation of proteins [2]. Active and regulated 
protein degradation is essential in all living cells and is conserved from bacteria to eukaryotic 
organisms. However, the energy cost necessary to make and degrade proteins is massive, so is 
proteolysis really beneficial for the cell? Indeed, this regulation allows extremely fast kinetics 
required to adapt quickly to new environments [2-4].  
In eukaryotes, ATP-dependent proteolysis is carried out by the 26S proteasome whereas in 
bacterial cells degradation is performed by several ATP-dependent proteases such as FtsH, 
Lon and caseinolytic protease (Clp). These proteases, including the eukaryotic 26S, do not 
show a high sequence identity but share common properties [5]. They are located in the 
cytoplasm, depend on ATP and degrade proteins into 10-15 amino acids peptides. Their 
ATPase and protease activities are carried out by separated domains where the ATPase 
domain blocks the entrance to the proteolytic site. The substrate degradation begins with the 
binding of the substrate to the ATPase domain which unfolds the protein and translocates it 
into the proteolytic domain for degradation. FtsH and Lon exhibit both domains on the same 
protein whereas the Clp proteolytic complex is a two-component protease where protease and 
ATPase activities are carried out by two distinct proteins. In addition, FtsH possesses two 
trans-membrane domains which also enable the degradation of membrane-associated proteins 
[6]. All these ATP-dependent proteases are located in the cytoplasm. Substrate recognition is 
the most important step of proteolysis. It needs to be tightly regulated to avoid every cytosolic 
protein to be degraded at all time. Hydrophobic motifs and degradation tags exhibited by the 
substrate have been identified to specically direct proteins for degradation [7].  
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2. Clp proteolysis 
The Clp proteolytic complex is composed of a two-component cylindrical architecture 
with a chaperone adenosine triphosphatase (ATPase: ClpA, ClpC, ClpE, ClpX and ClpY) 
responsible for the specific recognition and unfolding of substrates and a protease (ClpP and 
ClpQ) involved in the degradation of polypeptides. To avoid unintentional degradation of 
proteins, the proteolytic site of the protease is located deep inside the barrel structure and can 
only be reached through a really narrow pore. For this purpose, the substrate needs to be 
unfolded to access the protease and be degraded. The Clp ATPase use the energy produced by 
the hydrolysis of ATP to unfold the substrate and translocate it into the protease barrel [8-9]. 
Clp proteins are ubiquitous in prokaryotes but also present in mitochondria and chloroplasts 
of eukaryotic cells. The various combinations of Clp proteases and Clp ATPases result in an 
inventory of several Clp proteolytic complexes. The protease ClpP interacts with ClpA, ClpC, 
ClpE and ClpX whereas ClpQ interacts exclusively with ClpY. ATPases interact as well with 
adaptor proteins to enhance the recognition specificity of the substrate and its delivery into the 
protease barrel. The proteolytic activity of the protease is not sequence specific therefore the 
specific recognition of the substrate is carried out by Clp ATPases and adaptor proteins. This 
section of the manuscript will focus on the particular characteristics of the different Clp 
protease components. 
2.1. 
Clp ATPases or HSP100 are members of the AAA
Clp ATPases 
+ family (ATPases associated with 
various cellular activities) that is present in all kingdoms and known to harbor a highly 
conserved AAA+ domain involved in the hydrolysis of ATP. The main role of AAA+ 
proteins is to induce conformational changes into target proteins thus promoting their 
unfolding. Thus, AAA+ proteins are involved in proteolysis, disassembly of protein 
aggregates, activation of transcription, maintenance of organelle functions or chromosome 
replication [10]. The AAA+ domain (200-250 amino acids) contains several motifs that 
distinguish AAA+ proteins from other classical ATPases. First, the classic P-loop NTPase, 
containing the Walker A and Walker B motifs is involved in the interaction and hydrolysis of 
nucleotides (Fig. 1). The Walker A motif participates in the binding to the phosphate of ATP 
molecules. Mutations in the Walker A domain inhibit nucleotide binding therefore 
inactivating AAA+ proteins. On the other hand, the Walker B motif also participates in the 
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binding of the nucleotide but is in addition responsible for the hydrolysis of ATP. Mutations 
in the Walker B domain allow the binding but not the hydrolysis of ATP. As ATP is required 
for the interaction with AAA+ substrates, these Walker B mutant proteins bind the substrates 
without releasing them and thus can be used as substrate traps [11]. The Sensor 1 and 2 
domains interact with the Walker B to hydrolyze ATP [12-13]. The arginine finger domain is 
involved in the oligomerisation of AAA+ proteins into hexameric rings (Fig. 1) [14].  
 
 
Fig. 1: Organisation of the AAA+ domain.  (A) Linear diagram of the key elements of the AAA+ domain. The 
letters on top of the elements represent the amino acids required for binding and hydrolysis of ATP. (B) 
Structure of the AAA+ domain showing the approximate position of the various motifs. The position of the 
nucleotide is represented by a stick AMP molecule. Adapted from [15]. 
 
Based on their number of AAA+ domains, Clp ATPases are divided in two classes: the 
class I, composed of ClpA, ClpB, ClpC, ClpE and ClpL, contains two consecutive AAA+ 
domains separated by a linker region of variable length whereas the class II, composed of 
ClpX and ClpY, exhibits only one AAA+ domain (Fig. 2). The functional significance of 
having one versus two AAA+ domains remains unknown. In addition to the AAA+ domain, 
Clp ATPases possess an amino-terminal region involved in chaperone oligomerisation, 
formation of the proteolytic machine and in the binding of adaptors and substrates [16-18]. 
This N-terminal region differs between the Clp proteins. For example, for ClpA, ClpB, and 
ClpC it consists of two homologous repeats of 75 amino acids while ClpX and ClpE exhibit a 
Zn-binding domain. Morever, ClpA, ClpC, ClpE and ClpX can interact with ClpP thanks to 
the presence of a ClpP recognition domain at their C-terminal end known as the P-loop, 
exhibiting a conserved isoleucine-guanine-phenylalanine (IGF) motif [19]. However, ClpB 
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and ClpL lack this P-loop and can only act as chaperones. Interestingly, when the P-loop from 
ClpA or ClpX is added to ClpB, the substrate can be delivered to ClpP for degration [20]. 
 
 
Fig. 2: Domain organisation of Clp ATPases. The AAA+ domain is pictured in blue, the amino-terminal 
domain is in green and the zinc binding finger is in yellow. The P-loop required for the binding to ClpP is 
represented in purple. 
 
ClpA and ClpC are orthologues and bacteria exhibit one or the other. ClpA is found in 
Gram-negative bacteria whereas ClpC is present in Gram-positive bacteria and cyanobacteria. 
ClpY and its associated protease ClpQ are most often present alongside ClpA in Gram-
negative bacteria but can be found as well in some Gram-positive bacteria such as S. aureus. 
ClpX is the most ubiquitous Clp ATPase and is present in almost all bacteria (Table 1). 
To be active, Clp ATPases as the other AAA+ proteins, assemble into homohexameric 
rings with ATP binding sites located at the interface between monomers and a central pore 
necessary for the translocation of substrates (Fig. 3A). The binding of ATP promotes 
conformational changes within the hexamer enabling the binding of the substrate to the 
amino-terminal domain and stabilization of the complex [21-23]. Clp ATPases can bind the 
protease via their surface exposed P-loop only when bound to the substrate, in a hexameric 
ring conformation and activated [24-25]. In the case of ClpC in Bacillus subtilis, it was shown 
that its oligomerisation requires the interaction with an adaptor protein such as MecA [18]. 
Thus, the activity of ClpC depends on the presence of this adaptor proteins acting as regulator 
of ClpC-mediated proteolysis. 
Besides acting with proteases, Clp ATPases or Hsp100 act as chaperones to eliminate 
stress induced protein aggregates (Fig. 3B). The mechanism of disaggregation is based on the 
same principle: forcing the unfolding by translocation of the substrate peptide through the 
central pore of the chaperone. In this case, ClpB unfolds single peptides from aggregates and 
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cooperates with other chaperones such as the Hsp70 system to properly refold proteins [20]. 
Furthermore, Clp chaperones can also unfold stable proteins to disassemble protein 
complexes. For example, ClpX was found to unfold MuA subunits via their C-terminal end 
leading to the destabilization of MuA tetramers, a bacterial virus inhibiting DNA replication 
[26]. Another example is ClpA, which converts the plasmid replication initiator RepA from an 
inactive dimer to an active monomer [27]. 
 E. coli B. subtilis L. monocytogenes S.  aureus S. pneumoniae S. mutans S. pyogenes 
ATPases 
ClpA ClpC ClpC ClpC ClpC ClpC ClpC ClpX ClpX ClpX ClpX ClpX ClpX ClpX  ClpE ClpE  ClpE ClpE ClpE ClpY ClpY  ClpY     ClpB  ClpB ClpB  ClpB ClpB       ClpL ClpL ClpL ClpL 
Proteases 
ClpP ClpP ClpP1/ClpP2 ClpP ClpP ClpP ClpP ClpQ ClpQ  ClpQ     FtsH FtsH FtsH FtsH FtsH FtsH FtsH LonA        LonB             
Regulation 
  CtsR CtsR CtsR CtsR CtsR CtsR  McsA McsA McsA     McsB McsB McsB       MecA MecA MecA  MecA MecA MecA 
     
 Table 1: Clp proteins present in E. coli and Gram-positive bacteria. 
2.2. 
ClpP is a serine protease, exhibiting a conserved catalytic triad (serine-histidine-
aspartic acid), that assembles into a double heptameric ring structure forming a barrel with a 
1-2 nm pore where the proteolytic active sites are protected (Fig. 3A) [28]. The ClpP protease 
pore is narrow and only peptides smaller than 5 amino acids can enter the pore without the 
need for a chaperone. In fact, the entry of larger peptides is blocked by a loop present at the 
amino-terminal region of ClpP. In order to degrade larger peptides, the ClpP complex binds 
on both sides of the barrel to a Clp ATPase hexameric ring which unfolds and translocates the 
substrate into the protease barrel for degradation. ClpP interacts via a surface hydrophobic 
patch leading to hydrophobic interaction with residues of the P loop of the ATPase [29-30]. In 
addition, the N-terminal domain of ClpP is essential for the binding of the chaperone to the 
protease [31]. The conformational changes triggered upon interaction with the ATPase ring 
open the pore for larger substrates [30, 32]. ClpP degrades proteins in a processive manner, 
producing smaller peptides of approximately 15 amino acids. 
Clp protease 
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 Several studies using fluorescently labelled proteins investigated the localization of 
ClpCP, ClpEP and ClpXP proteolytic complexes in B. subtilis [33-35]. They revealed that 
these complexes gather at the vicinity of the cell poles. Additional reports described that 
adaptor proteins including MecA and McsB also gather with the proteolytic complexes at the 
poles [33]. This suggests that in B. subtilis, Clp-mediated proteolysis is localized at the poles 
where most of the protein synthesis and protein quality control take place [36-37]. 
 
 
Fig. 3: Clp proteolytic complex. (A) Structure of ClpX hexameric ring and ClpP heptameric barrel [38]. (B) 
Pathways involving Clp proteins: refolding or degradation. Clp ATPase is in blue and Clp protease is in orange. 
(C) Electron microscopy picture of the ClpXP proteolytic complex [39]. 
2.3. 
In order to enhance and diversify their substrate spectrum, the Clp proteolytic 
complexes interact with specific recognition factors also called adaptor proteins [40]. These 
adaptors can be specific for one protein or a whole group of substrates. In some cases, they 
are essential for the recruitment of the substrate whereas in other cases they only promote the 
substrate recognition and/or activate the chaperone. First discovered in B. subtilis, adaptor 
proteins have been identified to interact and modulate the activity of ClpA, ClpC and ClpX in 
B. subtilis and E. coli (Table 2). However, no adaptor proteins have been found for ClpE so 
far. Unfortunately, these adaptor proteins are unrelated in sequence as well as in structure, 
which makes difficult the identification of new adaptors by bioinformatic predictions. 
Adaptor proteins 
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Most importantly, adaptor proteins provide an additional control level in the tightly 
regulated process of proteolysis. Regulation by adaptors is an efficient strategy to quickly and 
specifically respond to environmental changes. For instance, their affinity for the substrate 
can be controlled by modifications as demonstrated by RssB, an adaptor which only transfers 
the substrate σS
2.4. 
 to ClpXP when phosphorylated. Alternatively, other proteins can compete 
with the substrate to bind the adaptor therefore inhibiting the interaction between the substrate 
and the protease. This is illustrated by the binding of ComS to the adaptor MecA releasing the 
substrate ComK, a regulator of competence in B. subtilis. The role and regulation of adaptor 
proteins in combination with their substrates will be discussed below (Table 2). 
2.4.1. SsrA-tagged proteins 
Substrates 
The SsrA tag consists of 11 amino acids added to the carboxy-terminal end of nascent 
peptide chains blocked in the ribosome [41]. ssrA is a small RNA acting as tRNA and mRNA, 
that enters in the A-site of the ribosome stalled at the 3’ end of a truncated mRNA. When 
stalled, the ribosome switches template to the ssrA RNA thus adding 11 amino acids to the 
carboxy-terminal end of the peptide. This tag targets these truncated proteins to degradation 
by proteases such as the ClpAP and ClpXP complexes. In the case of the ClpXP proteolytic 
complex, the mediated degradation can proceed without the help of an adaptor. However, 
interaction with SspB increases the concentration of the substrate in the vicinity of the 
protease therefore stimulating its degradation [42-45]. Indeed, SspB forms a dimer that binds 
the SsrA tag via its N-terminal domain and docks to ClpX through a C-terminal binding 
motif. In E. coli, the SsrA tagged protein can also be degraded by the ClpAP complex [42]. In 
vivo, the ClpAP complex interacts with the adaptor ClpS, which inhibits the degradation of 
the SsrA tagged proteins but enhances degradation of other ClpAP substrates [46-47]. 
Nevertheless, when the ClpXP complex is overwhelmed, the ClpAP protease can degrade in 
vivo SsrA tagged substrates. 
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ATPase Adaptor Substrate Reference 
ClpA 
ClpS Misfolded and aggregated proteins [40] N-end rule protein [47] no adaptor SsrA tag  [40] 
ClpX 
SspB SsrA tag [42-43, 45]  RseA [45] RssB Sigma S [48]  UmuD UmuD' [49] no adaptor RsiW [50] LexA fragments [51] unknown Dps [52-53] unknown Sda [54] YjbH Spx [55-56] 
ClpC 
MecA 
ComK [57] ComS [57-58] DegU [59] Spx [60] Misfolded and aggregated proteins [61] YpbH Misfolded and aggregated proteins [61] Spx (in vitro) [60] McsB CtsR [18] unknown SpoIIAB [62] unknown MurAA [63] 
 
Table 2: Adaptor proteins and substrates identified for Clp proteins in E. coli (white) and B. subtilis 
(green).  
2.4.2. Sigma S 
RpoS or σS is the main regulator of stress response in E. coli. Its expression is 
activated under various stress conditions including starvation, pH shift or heat-shock [64]. σS 
is specifically degraded by the ClpXP complex in association with the adaptor protein RssB 
[65]. The phosphorylated RssB, which exhibits higher affinity to σS than its unphosphorylated 
form, targets σS to degradation via the ClpXP complex. Following degradation, RssB is 
released from the proteolytic complex in its dephosphorylated form. Therefore, the stability of 
σS depends on the phosphorylation of RssB, which belongs to a two-component system where 
ArcB, the sensor kinase is responsible for its phosphorylation. Upon stress, the activation of 
ArcB is reduced, leading to a decreased phosphorylation of RssB and thus to stabilization of 
σS [66]. Furthermore, Ira proteins have been identified to interfere with RssB adaptor function 
therefore stabilizing σS during specific stress conditions. In response to phosphate starvation, 
IraP binds to RssB thus releasing σS [67]. On the other hand, upon Mg2+ or Ca2+ starvation 
IraM binds RssB, whereas IraD binds RssB following DNA damages [68-69]. Although the 
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Ira proteins bind RssB, no specific binding motif or sequence similarities have been 
identified. Therefore it is difficult to identify other proteins involved in RpoS regulation [68]. 
2.4.3. Spx 
In B. subtilis, Spx was first identified as a suppressor locus of clpP and clpX 
mutations. Spx is a global transcriptional regulator that exerts both positive and negative 
control on the expression of multiple genes during oxidative stress [70-71]. Disulfide stress 
leads to induction of the Spx regulon, which includes trxA encoding for a thioredoxin, trxB 
coding for a thioredoxin reductase and other genes involved in the oxidative stress response 
[72]. Spx-dependent regulation of gene expression requires interaction with RNA polymerase 
holoenzyme [73-74]. Spx exhibits a motif similar to the SsrA tag on its C-terminal end, which 
promotes its degradation by the ClpXP complex. Later on, YjbH was identified to be the first 
adaptor protein of the ClpXP complex in B. subtilis and exhibits as ClpX a zinc binding 
domain. YjbH interacts specifically with Spx inducing a conformational change that leads to 
the exposure of the C-terminal motif of Spx therefore promoting its degradation by ClpXP 
[55]. Upon oxidative stress, the zinc atoms dissociate from ClpX and YjbH resulting in the 
loss of ATPase activity of ClpX, the release of Spx from YjbD and the activation of Spx-
mediated oxidative stress response [55, 75]. 
2.4.4. ComK / ComS: regulation of competence  
ComK, the main regulator of competence in B. subtilis, activates the expression of 
DNA-uptake components [76-77]. In non-competent cells, inactivation of ComK involves its 
degradation by ClpCP after binding to the adaptor protein MecA [57]. The binding of MecA 
to the ClpC monomers is required to promote the oligomerisation of ClpC and activates the 
ClpCP-MecA complex [18]. During stationary phase, competence is activated by quorum 
sensing signals, leading to the expression of ComS [78]. ComS and ComK share a motif 
required for the binding to MecA and therefore compete for MecA-dependent degradation by 
the ClpCP protease [58]. Consequently, under conditions where ComS is expressed, it is 
degraded by ClpCP-MecA instead of ComK, which escapes its degradation and can thus 
activate its expression as well as the expression of genes required for competence [57]. 
Unfortunately, the MecA-binding motif in ComK and ComS was not found in any other 
proteins of B. subtilis thus suggesting that this motif is specific for the regulation of 
competence by ClpCP-MecA. However, in contrast to ComK, MecA orthologues are found in 
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most Gram-positive bacteria expressing ClpC, thus suggesting that MecA could be involved 
in other processes in Gram-positive bacteria [58, 61]. 
YpbH, a paralogue of MecA in B. subtilis, acts as well as an adaptor for ClpC but is 
not involved in the regulation of ComK [61]. MecA and YpbH promote the degradation of 
misfolded and aggregated proteins by the ClpCP complex [61]. Interestingly, ClpX is also 
involved in the regulation of competence in B. subtilis. In fact, ClpX and ClpP are required 
for the expression of comS probably by degrading a repressor of comS transcription [79]. 
2.4.5. CtsR: heat-shock induced regulation of Clp proteins 
In the Gram-positive model organism B. subtilis, expression of heat-shock genes 
involves at least four different regulatory mechanisms [80-81]. Class I heat-shock genes 
encode classical chaperones, such as GroES, GroEL and DnaK, and are controlled by the 
HrcA repressor. Class II genes encode general stress proteins whose transcription is 
dependent on the alternative sigma factor σB [81]. Class III heat-shock genes encoding ClpP 
and two Hsp100 Clp ATPases, ClpC and ClpE, form part of the CtsR stress response regulon. 
Finally, class IV includes stress response genes whose expression is independent of HrcA, σB 
or CtsR (such as FtsH, LonA, ClpX) and whose regulatory mechanisms remain to be 
identified [80-82]. Expression of the class III genes is dependent on the negative regulator of 
transcription, CtsR. The ctsR gene is the first gene of the clpC operon, which comprises the 
kinase activator encoding gene mcsA, an arginine kinase encoding gene mcsB and the ATPase 
encoding gene, clpC [83-85]. CtsR binds as a dimer to a tandem heptanucleotide repeat 
A/GGTCAAA/T located in the promoter region of the clpP and clpE genes and of the clpC 
operon,  indicating that CtsR inhibits as well its own expression [80, 82, 86-87]. Morever, in 
B. subtilis, clpE appears to be the gene the most tightly repressed by CtsR as five binding sites 
are located in its promoter region [82]. Interestingly, the binding motif recognized by CtsR 
was found intact in the promoter regions of clpP, clpE and the clpC operon of other Gram-
positive bacteria including S. pneumoniae and S. pyogenes, which also possess a ctsR 
homologue. This indicates that the heat-shock regulation mediated by CtsR is highly 
conserved in Gram-positive bacteria [80]. Surprisingly, the CtsR binding motifs were also 
found in promoters of chaperone GroESL and DnaK encoding genes in S. pneumoniae, 
S. mutans, S. aureus, S. pyogenes and L. monocytogenes, indicating that in these organisms, 
these chaperones can be regulated by both HcrA and CtsR [88-91]. Notably, the promoter 
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region of clpX does not exhibit any CtsR binding motif in any organism examined so far, thus 
suggesting that clpX is not a member of the CtsR regulon [92].  
Regulation of the negative regulator CtsR is a key component of the heat-shock 
response. ClpC and the arginine kinase McsB are activators of this regulation by promoting 
the degradation of CtsR by the ClpP protease [93-94]. Under normal growth conditions, MscB 
is inhibited by its interaction with ClpC. Upon stress conditions, ClpC interacts preferentially 
with MecA to degrade stress induced misfolded proteins, while releasing MscB. Free McsB, 
activated by McsA, inhibits CtsR by phosphorylating arginine residues located close to its 
DNA binding site therefore inhibiting its dimerisation [94-95]. Phosphorylated monomers of 
CtsR are unable to interact with promoters therefore inducing expression of the class III heat-
shock genes. Moreover, the phosphorylated McsB acts as an adaptor protein of ClpC that 
targets CtsR for degradation by the ClpCP complex [96]. In this context, the ClpC-MecA 
complex acts as a sensor of misfolded proteins resulting from stress which leads to lifting the 
inhibition on heat-shock genes. Finally, the phosphatase YwlE was shown to dephoshoprylate 
McsB and CtsR in vitro, suggesting a putative switch-off mechanism of the class III heat-
shock response [95].  
2.5. 
In non stressed cells, an increase in global protein degradation is observed when cells 
reach stationary phase. ClpP appears to be the major determinant of this protein turn-over as 
cells lacking ClpP show an increase in protein aggregates and do not exhibit a growth phase-
dependent regulation of degradation [63]. ClpP was shown to be important during stress 
response as most clpP-deficient strains are restricted in growth upon various stress conditions 
in Gram-positive bacteria [91, 97-101]. Studies using deficient stains showed that the 
associated Clp ATPase ClpC, ClpE and ClpX are taking part in the stress induced ClpP-
mediated proteolysis in Gram-positive bacteria. The entry of bacterial pathogens into host 
organisms constitutes dramatic environmental changes enhancing expression of stress 
response proteins. Their degradation may confer a selective advantage to facultative 
intracellular bacteria for survival in phagocytes, leading to their proliferation and 
dissemination throughout the host. There is growing evidence suggesting that Clp proteins 
play an important role in the survival and virulence of pathogens during host infection. Table 
3 regroups the functions of Clp proteins in cell physiology, stress response and regulation of 
Role of Clp proteins in bacterial virulence 
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virulence in the main Gram-positive pathogens L. monocytogenes, S. aureus, S. pneumoniae 
and S. mutans. Some of these functions will be discussed in more detail. 
2.5.1. Physiology 
ClpP is required to remove misfolded proteins and aggregates from the cytosol. 
Interestingly the various clpP-deficient strains studied so far in S. aureus, L. monocytogenes, 
S. pneumoniae and S. mutans exhibit a delay of growth when cultivated at normal 
temperature, most likely due to an accumulation of non-native proteins [87, 99, 101-102]. 
Therefore, the proteolytic activity of ClpP is necessary for the physiological growth of Gram-
positive bacteria. In addition, Clp proteins have been linked to cell division. In fact, in S. 
pneumoniae, clpC-deficient strains grow in longer chains compared to wild-type whereas in 
L. monocytogenes, clpC and clpE mutants show no phenotype concerning cell division [103-
104]. However, in the double mutant clpE-clpC, cells were elongated and no septum was 
observed indicating a failure in cell division and suggesting that ClpE acts synergistically with 
ClpC to promote cell division [104]. Similar phenotypes were observed for the clpX and clpP 
mutants in S. mutans [105]. The acquisition of foreign DNA is a crucial step in the survival 
under stress conditions. The role of Clp proteins in the regulation of competence has been 
analyzed in B. subtilis with the degradation of ComK/ComS [57]. In other naturally 
competent bacteria such as S. pneumoniae or S. mutans, deletion of clpP was associated with 
a decrease in competence [88, 91]. Furthermore, several studies have reported the impact of 
Clp proteins in biofilm formation, a well known mechanism to evade the immune response 
and antibiotic treatment. However, the impact of Clp proteins in this phenotype differs 
depending on the bacterial species. In the high biofilm producing organism S. aureus, the 
ATPases ClpC and ClpX promote biofilm formation whereas the protease ClpP represses it 
[83]. In S. mutans, biofilm formation is inhibited by ClpX and ClpP while it is enhanced by 
ClpE [105]. These results show that biofilm formation is repressed by Clp-mediated 
proteolysis and enhanced by the chaperone activity of some Clp proteins. Notably, ClpX 
appears to be an essential gene in S. pneumoniae as no clpX-deficient mutant strain was ever 
obtained [106]. Interestingly, the clpP-deficient mutant strain is viable in S. pneumoniae 
indicating that the chaperone role of ClpX might be essential in this organism. 
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Table 3: Involvement of the Clp proteins in morphology, stress responses and virulence of Gram-positive 
pathogens L. monocytogenes, S. aureus, S. pneumoniae and S. mutans. The third column indicates the regulation 
of Clp proteins by CtsR (*). 
 Protein * Functions of Clp proteins References 
L.
 m
on
oc
yt
og
en
es
 
ClpP + Growth Resistance to heat and osmolarity stress Virulence in mouse; escape of phagosome and intracellular replication in macrophages and hepatocytes; activation of Listeriolysin O (LLO); inhibition of sip and svpA; recruitment of actin [99, 107-110] 
ClpC + Cell division  Resistance to heat-shock and osmolarity stress Survival in spleen and liver; adhesion and invasion of hepatocytes by activating expression of adhesins; survival in macrophages by promoting escape from the phagosome; inhibition of sip and svpA 
[85, 104, 107-108, 110-111] 
ClpE + Cell division  Heat tolerance Survival in spleen and liver [104] ClpB + Resistance to suboptimal temperature; thermotolerance Virulence in mouse [90, 112] 
S.
 a
ur
eu
s 
ClpP + Growth at 37°C; morphology; inhibition of autolysis; inhibition of biofilm formation Tolerance to oxidative stress, osmotic stress, heat-shock, suboptimal temperature  Virulence in skin abcess model; inhibition of internalisation; intracellular replication;  haemolysin expression derived from agr activation; degradation of antitoxin [83, 101, 113-115] ClpC + Biofilm formation; long term survival; programmed cell death; TCA cycle Tolerance to heat-shock, oxidative stress Degradation of antitoxin [83, 113, 116] 
ClpX - Biofilm formation Tolerance to oxidative stress, osmotic stress, suboptimal temperature Virulence in bacteraemia  and skin abcess model; intracellular replication; haemolysin and PrtA expression derived from  agr activation; activation of spa and 
rot expression 
[83, 101, 114, 117-118] 
ClpB - Tolerance to heat-shock and thermotolerance Intracellular replication [83] ClpL - Tolerance to heat-shock and thermotolerance [83] ClpY - Tolerance to heat-shock [119] ClpQ - Tolerance to heat-shock [119] 
S.
 p
ne
um
on
ia
e 
ClpP + 
Inhibition and termination of competence; growth Resistance to heat, oxidative stress, supobtimal temperature; inhibition of σColonization of the lung and nasopharynx; virulence in septicemia and pneumonia murine models and intraperitoneal infection; proliferation in lung and blood; intracellular survival in macrophages; virulence factor expression;  
X 
Protective effect (vaccine development) 
[87-88, 106, 120-126] 
ClpC + Growth; cell division; autolysis; competence Adhesion to human lung cells; virulence in mouse pneumoniae model; proliferation in lung and blood [103, 106, 121, 127 ] ClpE + Resistance to heat Virulence in intraperitoneal infection; adherence to epithelial cells [87-88, 106, 128] ClpX - Essential gene [106] 
ClpL + Growth; autolysis;  Heat-shock response Inhibition of adherence and invasion of epithelial cells; survival in macrophages; induction of TNF-α [87, 106, 129, 130 ] 
S.
 m
ut
an
s 
ClpP + Growth; competence; chain morphology; aggregation; autolysis; inhibition of biofilm in sucrose Resistance and adaptation to heat, acid and oxidative stress; degradation of IrvR [91, 105, 131-132] ClpC + Degradation of IrvR [91, 132] ClpE + Biofilm formation in sucrose [91, 105] ClpX - Growth; aggregation; chain morphology; autolysis; inhibition of biofilm in sucrose resistance to heat and acid stress; degradation of IrvR [105, 132] ClpL - Growth; inhibition of biofilm in sucrose  Acid tolerance [105, 133] 
. 
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2.5.2. Stress response 
As mentioned above, expression of most of the Clp proteins is repressed by the heat-
shock response regulator CtsR upon heat stress, leading to CtsR degradation and subsequently 
enhanced clp gene expression. Therefore, Clp proteins are expected to be involved in 
resistance to heat-shock. So far most of the clp mutants described are more sensitive to high 
temperature exposure with the exception of the clpC mutant in S. pneumoniae where no 
striking difference in survival at higher temperature was observed. Therefore, in 
S. pneumoniae the heat-shock response seems to be mediated by the ClpEP complex instead 
of ClpCP [88, 103, 123]. The other exception is ClpX, which is not a member of the CtsR 
regulon and the transcriptional expression of which is not increased upon heat-shock. In fact, 
it was shown in S. aureus that the clpX mutant was more resistant than the wild-type strain 
during exposure at 45°C [101]. On the other hand, in S. aureus the clpC- and clpP-deficient 
strains are sensitive to heat-shock and ClpX and ClpP but not ClpC are required for tolerance 
to oxidative stress, osmotic stress and suboptimal temperature exposure. This indicates that in 
S. aureus, ClpC and ClpP mediate the response to heat-shock while ClpX is associated with 
ClpP to mediate the response to oxidative, osmotic and cold stress [83, 101]. The oxidative 
response is as well mediated by ClpXP in S. mutans [91, 105]. In L. monocytogenes, 
resistance to heat is mediated by the ClpCP and ClpEP complexes whereas the ClpB 
chaperone is involved in tolerance to suboptimal temperature. The ClpCP complex is as well 
involved in the response to high salt concentration allowing L. monocytogenes to grow in 
processed food [99, 104, 111].  
2.5.3. Infection and Virulence 
So far, no clp-deficient strains have been associated with an increase in virulence in 
Gram-positive pathogens. Moreover, immunization with ClpP was shown to elicit an immune 
response that protected mice against pneumococcal infection emphasizing the fact that Clp 
proteins are important factors in virulence [120, 122].  In L. monocytogenes, ClpC is involved 
in the adhesion and invasion of epithelial cells and in association with ClpP required for the 
escape of the phagosome and intracellular replication [85]. However in S. aureus, intracellular 
replication requires the ClpXP complex [83]. In addition, a study in S. aureus showed that 
transposon disruption of clpX reduces virulence in a bacteraemia mouse model [118]. 
Comparably, ClpX and ClpP but not ClpC are required for infection in a skin abcess model 
[101]. This could be explained partly by the decrease in intracellular replication of clpX- and 
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clpP-deficient strains in bovine cells [83]. In S. pneumoniae, a large scale mutagenesis in a 
pneumonia mouse model identified ClpC as required for virulence. Later on, ClpC and ClpE 
were shown to be involved in the adherence to human lung cells [103, 127]. Comparably, 
ClpP was shown to be required for virulence in a septicemia and pneumonia mouse model. In 
fact, the clpP-deficient strain was defective to colonize the lung and nasopharynx and to 
replicate inside the macrophages explaining the reduced virulence [122-123]. 
The effect of Clp proteins on virulence can be explained in some cases by their role in 
response to stress widely encountered during infection. For example, the fact that the 
S. pneumoniae clpP-deficient strain failed to survive in the acidic phagosome of macrophages 
can be a result of the increased sensitivity of the mutant to oxidative stress [121-122]. 
However, variation of virulence factor and transcriptional regulator expression was observed 
indicating that Clp proteins are involved in the regulation of virulence. For instance, ClpC is 
required for the transcription of major virulence factors (inlA, inlB and actA) involved in cell 
invasion in L. monocytogenes confirming its role in adhesion [85]. The same is observed in 
S. pneumoniae where ClpC is required for the transcription of adhesins and pneumolysins 
[103]. Interestingly, in L. monocytogenes, clpC is downregulated by the main transcriptional 
activator of virulence factor PrfA [134]. However, the mechanism by which the Clp proteins 
interfere with virulence is best characterized in S. aureus. Indeed, ClpXP is required for the 
transcriptional regulation of numerous virulence factors such as haemolysins, extracellular 
proteases and surface adhesins [101, 114-115]. This regulation is linked to the quorum 
sensing two-component system Agr, a major and extremely complex regulator of virulence in 
S. aureus [135]. Upon signal sensing, activation of the agr operon leads to the production of 
the effector molecule, RNAIII, a small regulatory RNA responsible for gene regulation. ClpX 
and ClpP were shown to activate the transcription of RNAIII [114]. Moreover, it was 
suggested that RNAIII may bind directly to regulatory proteins, thereby inducing 
conformational changes that destine the protein for degradation by ClpXP. Noteworthy, ClpX 
independently of ClpP is essential for transcription of spa, encoding a cell wall associated 
protein, Protein A [101, 114]. As Rot is a known activator of spa transcription, the authors 
suggested that ClpX might be required as a chaperone for expression, folding or dimerization 
of the transcriptional regulator Rot [114, 117, 136]. 
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2.6. 
The spread of antibiotic resistance impairs treatment of life threatening diseases. The 
emergence and increase of multi drug-resistant Gram-positive bacteria such as S. aureus, 
S. pneumoniae and Enterocccus causes special concerns and new antibacterial agents are 
urgently needed. Acyldepsipeptides (ADEPs), isolated from the fermentation broth of 
Streptococcus hawaiiensis, were shown to have antibacterial activity against Gram-positive 
bacteria including S. aureus, S. pneumoniae, S. pyogenes and Enterococcus faecalis [137]. 
Studies showed that ADEPs interact with ClpP abolishing the binding of Clp ATPases, 
therefore preventing the degradation of folded proteins by ClpP. Thus, cells treated with 
ADEPs exhibit typical clpP-deletion phenotypes such as inhibition of cell division [137-138]. 
The interaction of ADEPs with ClpP induces conformational changes, which enable ClpP to 
degrade unfolded proteins without the help of an ATPase. Therefore, ClpP degrades nascent 
chains exposed at the ribosome leading to the death of the bacteria [138]. Consequently, 
ADEPs are the first naturally occurring molecules activator of a proteolytic machinery 
suggesting a new mechanism by which an antibiotic can trigger bacterial death. In contrast to 
other antibiotics that inhibit essential cellular functions, ADEPs trigger bactericidal activity 
by turning a tightly regulated peptidase into an uncontrolled protease. 
Antibiotic therapy 
3. Streptococcus pyogenes 
S. pyogenes also known as group A streptococcus (GAS) is a human Gram-positive 
extracellular pathogen. GAS is a non-motile, non-spore-forming bacterium that appears as 
pairs or moderate-sized chains (2-30 cells in length). The streptococcal cell is spherical or 
ovoid and has a diameter of 0.6-1.0 µm. Colonies can be easily distinguished when cultured 
on blood agar plates, appearing white, translucent, sometimes mucoid surrounded by a 
hemolytic zone. It is a facultative anaerobic bacterium with a fermentative metabolism, 
auxotrophe for most of the amino acids. The Lancefield classification identified S. pyogenes 
as group A streptococcus based on its surface carbohydrate (N-acetyl-β-D-glucosamine link to 
a polymeric rhamnose backbone). Group A streptococci were then classified based on their 
surface M protein [139]. The M protein typing, based on the different alleles of emm, 
encoding M protein, is the most diverse up to now, with more than 150 M serological types 
identified. The T-typing, based on the diversity of tee, the T protein antigen encoding genes, 
can be used in addition to M protein, to classify strains [140].  Alternatively, GAS is also 
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subclassified with regard to the expression of the serum opacity factor (OF), an enzyme that 
causes mammalian serum to increase in opacity.  
3.1. 
S. pyogenes can colonize the throat and skin and cause a wide variety of human 
diseases. Infections due to GAS range from common clinical illnesses including pharyngitis, 
tonsillitis, cellulitis, impetigo and scarlet fever to severe life threatening invasive infections 
such as sepsis, necrotising fasciitis and streptococcal toxic shock syndrome. Moreover, GAS 
is associated with the development of post-streptococcal sequelae including acute rheumatic 
fever or acute glomerulonephretis (Table 4) [141]. These sequelae are explained by the fact 
that several streptococcal virulence factors are mimicking human molecules therefore 
inducing an autoimmune response [142]. Interestingly, M serotypes causing skin infection are 
in general different from those causing pharyngitis [143].  
Diseases and persistence 
The late 1980’s saw the resurgence in the USA and Europe of severe diseases 
involving S. pyogenes, despite the sensitivity of the pathogen to penicillin. The reemergence 
of toxic shock syndrome and “flesh eating” disease, fast progressing invasive diseases with 
high mortality rates ranging from 30% to 80%, could be linked to new or reemerging 
serotypes. Several different M types were isolated with a domination of M protein serotype 1. 
Acquisition of new genetic material through horizontal gene transfer of bacteriophages has 
led to new and more aggressive streptococcal strains. Indeed, bacteriophages count for 7.1% 
of the M1 serotype genome and carry genes coding for important virulence factors including 
superantigens SpeA and SpeC [144]. New combinations of genes or allelic variants results in 
genetic diversity that might increase the fitness of the bacterium by conferring unique 
properties [8, 145]. Interestingly, studies showed that the same strain can induce different 
symptoms in infected individuals [146-147]. This could be explained by variations of the host 
immunogenic factors conferring predisposition or protection against streptococcal infections 
[148]. Penicillin is still the drug of choice to beat GAS infections. So far no resistance to 
penicillin has developed in GAS strains. However, some strains showing tolerance to 
penicillin arised, although the relative infections can be treated with higher amounts of the 
antibiotic. The production of a safe and effective vaccine is still in progress. The most 
promising approaches are targeting the conserved region of the M protein to avoid serotype 
specificity [149-151]. Altogether, GAS causes immense human morbidity and mortality and 
remains a significant public health problem. 
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Superficial skin and soft- tissue infections Cellulitis Pharyngitis Eryipelas 
Invasive Group A streptococcal diseases Streptococcal toxic shock syndrome (STSS) Necrotizing fasciitis (NF) Bacteremia Osteomyelitis Septic arthritis Pneumonia 
Complications of GAS illness 
nonsuppurative Acute Rheumatic fever Poststreptococcal glomerulonephritis 
suppurative Cervical lymphadenitis Endocarditis Fasciitis/myositis syndrome Mastoiditis Meningitis Otitis media 
 
Table 4. Diseases caused by GAS. Adapted from [141].  
 
3.2. 
S. pyogenes is considered as an extracellular human pathogen. The most important 
step for the onset of infection is the attachment of GAS to throat or skin epithelial cells. 
Therefore, the bacterial cell must compete with the existing tissue flora and avoid clearance 
through mucous and salivary fluids. The adhesion is a combination of a first weak interaction 
with the mucosa mediated by the lipotheichoic acid followed by a strong tissue specific 
adherence involving multiple adhesins that includes M protein, fibronectin binding protein 
and hyaluronic acid capsule [152]. After adherence, GAS must maintain itself at the site of 
infection. Thus, S. pyogenes can form aggregates directly on the tissue promoting 
microcolonies and biofilm formation [153-154]. Strains with the ability to form these 
aggregates persist longer in the host [155]. For long thought to be an extracellular pathogen, 
S. pyogenes was shown to be able to invade epithelial cells at frequencies equal or greater 
than L. monocytogenes, a classical intracellular pathogen [156-157]. Internalization enables 
GAS to avoid host immune response and antibiotic mediated killing and persist in the 
organism [158]. It is possible that penetration into epithelial cells is the first step to deeper 
Infection cycle 
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tissue invasion. The next step of infection is to escape the host immune response by 
developing mechanisms against opsonization and phagocytosis. The antiphagocytosis 
behavior of S. pyogenes involves the inhibition of the complement activation via the binding 
of M protein to the factor H or the cleavage of the complement component C5a. Moreover, 
GAS exhibits at its surface proteases able to cleave specifically immunoglobulins. Finally, 
severe streptococcal diseases are linked to the spreading of GAS in the blood stream and/or 
through tissues. To achieve this goal, GAS secretes a variety of molecules involved in the 
dissolution of clots, degradation of DNA or disruption of cellular junctions leading to 
complete tissue destruction.  
3.3. 
Virulence factors are defined as factors allowing an organism to set in the host and 
maintain the bacteria after initial infection. These factors support adherence at the site of 
infection, allow internalization into epithelial cells, enable the bacteria to escape from the 
immune response and promote tissue damage. The main streptococcal virulence factors are 
listed below and grouped in two categories: factors associated to the cell wall and those that 
are released from the cell (Table 5).  
Virulence factors 
3.3.1. Cell wall-associated virulence factors 
3.3.1.1. M protein 
M protein is the best characterized streptococcal virulence factor. It is composed of 
two polypeptide chains complexed in an alpha-helical coiled-coil configuration anchored in 
the cell membrane, traversing the cell wall and appearing as fibrils on the cell surface. The C-
terminal end of the protein located in the cell wall is highly conserved among S. pyogenes 
strains whereas its hypervariable amino terminal end extends in the environment. The 
hypervariability of the N-terminal region constitutes the base of the M protein typing system 
[139].  
The main role of M protein is the inhibition of phagocytosis. Streptococcal strains 
lacking the emm gene are phagocytocized more efficiently [159]. M protein binds the factor 
H, thus impeding the binding of the C3b to the bacterial surface therefore inactivating the 
complement response and the recognition by polymorphonuclear phagocytes, PMNs [160-
161]. Futhermore, M protein acts as an adhesin by binding fibronectin and mediates 
adherence to keratinocytes via attachment to the CD46 located on their membrane [161-162]. 
 
28 
 
M protein is mainly expressed during the first stage of infection. Its expression is 
regulated by the major regulator Mga whose encoding gene is located upstream of emm, 
among other regulators [163-164]. 
 
Adherence Internalisation Lipoteichoic acid (LTA) M protein Fibronectin binding proteins Protein F1 M protein Invasion Hyaluronic acid capsule Hyaluronic acid capsule Collagen binding protein M protein Pili Spread through tissues 
Antiphagocytocic Streptokinase M protein Cysteine protease SpeB M-like protein DNase SdaI Hyaluronic acid capsule Hyaluronidase Immunoglobulin degrading enzyme IdeS Systemic toxicity C5a peptidase Streptolysin O (SLO) Streptococal inhibitor of complement (Sic) Streptolysin S (SLS) 
 
Table 5.  Streptococcal virulence factors. Adapted from [165].  
 
3.3.1.2. M-like proteins 
The genes enn, mrp, fcrA, arp and prtH are among the members of the emm-like gene 
family.  It has been proposed that a common ancestral gene underwent duplications leading to 
the diversified family of M-like proteins [166-168]. They code for proteins, which are 
structurally similar to M protein especially in the C-terminal region [169]. They bind a wide 
range of host proteins such as albumin, fibrinogen, immunoglobulin and plasminogen 
participating along with M protein to the antiphagocytic response and adhesion of GAS to the 
specific tissue at the site of infection [142, 170-171]. As for emm, expression of the emm-like 
genes is regulated by Mga [172]. 
3.3.1.3. C5a peptidase 
The C5a peptidase or ScpA is an endopeptidase that specifically cleaves the 
complement component C5a, thereby inhibiting the recruitment of PMNs and protecting the 
organism from immune detection [173]. ScpA mutant strains exhibit a decrease in 
colonization of the mouse nasopharynx [174]. The size of the scpA gene varies among the 
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different GAS serotypes due to a variation of the number of repeat units [175]. ScpA is 
mainly expressed during exponential phase and its expression is activated by Mga. 
3.3.1.4. Capsule 
The hyaluronic acid capsule promotes resistance against phagocytosis [176]. Strains 
lacking the capsule exhibit a reduced virulence in various animal models. Moreover, the 
hyaluronic capsule binds CD44 on epithelial cells indicating a role in adherence [177]. The 
binding to CD44 can induce cytoskeleton changes resulting in disruption of intercellular 
junctions thereby promoting the invasion of the epithelium [178].   
The amount of capsule varies between the different streptococcal strains, and more 
virulent strains produce higher amounts of capsule displaying a mucoid appearance when 
cultivated on agar plates [179]. The capsule is highly produced during the early-exponential 
phase. The streptococcal capsule is composed of a polymer of hyaluronic acid containing 
units of glucoronic acid and N-acetylglucosamine [180]. The three genes involved in the 
synthesis of the polymer are grouped together in the same locus and expressed as an operon 
[181]. The has operon is composed of hasA encoding a hyaluronate synthase, hasB coding for 
a UDP-glucose deshydrogenase and hasC encoding a UDP-glucose pyrophosphorylase. 
Interestingly, hasA and hasB are sufficient for a standard capsule expression indicating that an 
alternative source of UDP-glucose could be used for capsule production while hasC
3.3.1.5. Adhesins 
 is not 
necessary for hyaluronic acid synthesis [182]. The operon is expressed as a single transcript 
from the promoter located upstream of hasA and is negatively regulated by the two 
component system CovR/CovS [183-186].  
S. pyogenes expresses at least 17 different kinds of adhesins [187]. The expression of 
these adhesins can differ between strains, the site of infection or environmental factors. 
The lipoteichoic acid (LTA) binds to fibronectin using hydrophobic interactions. It has 
been postulated that LTA brings the organism into close contact with the host cell and then 
other adhesins promote higher affinity binding [152, 188]. 
The protein F1 also called SfbI binds fibronectin and is involved in the adherence to 
respiratory epithelial cells [189]. Moreover it plays a major role in the adherence to cutaneous 
Langerhans cells [162]. SfbI expression is enhanced by oxygen indicating that SfbI is 
displayed in case of cutaneous adhesion. 
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In addition, other fibronectin binding proteins have been identified to act as adhesins 
including, SfbII, FBP54, PFBP and protein F2 [190-193].  
3.3.1.6. HtrA 
HtrA is a heat-shock induced envelope associated serine protease. Its E. coli 
homologue, DegP, located in the periplasm, is responsible for the degradation of abnormal 
periplasmic proteins [194-195]. In the absence of periplasm in Gram-positive bacteria, HtrA 
is associated with the membrane. The protease is involved in the regulation of the secreted 
virulence factor SpeB by activating its maturation and in the control of hemolysin S by 
inhibiting its activity during the exponential phase [196]. 
3.3.1.7. Pili 
For long, S. pyogenes was thought to be non piliated. However, in 2005 a study 
highlighted the presence of pilus-like structures at the surface of the bacteria [197]. The GAS 
pili are encoded by a highly variable 11 kb pathogenicity island known as the fibronectin-
binding, collagen-binding, T-antigen region (FCT). This region contains genes coding for the 
pili backbone protein, ancillary proteins and sortase. The backbone protein harbors a LPXTG 
motif, commonly found in adhesins [197]. Unsurprisingly, streptococcal pili are involved in 
adhesion to epithelial cells and biofilm formation [154].  
3.3.2. Secreted virulence factors 
3.3.2.1. Streptokinase 
A common defense mechanism employed to prevent systemic dissemination of 
invasive bacteria involves occlusion and encapsulation of bacteria within fibrin networks. 
Streptokinase or Ska converts plasminogen into its active form plasmin therefore promoting 
the dissolution of clots that facilitate the spread of the bacteria in the host [198]. To improve 
the spreading of the bacteria and the bacterial toxins, the streptokinase-plasmin complex 
degrades fibrin clots as well as extracellular matrix. Streptokinase is highly specific for 
human plasminogen, exhibiting little or no activity against other mammalian species, 
including mouse [199]. 
3.3.2.2. DNases 
The Streptococcal DNases were one of the first secreted proteins to be identified 
[200]. However, their role in virulence remained vague for decades. Every serotype produces 
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at least one DNase and most strains produce several distinct enzymes [201-202]. Their 
expression is upregulated after interaction with epithelial cells and PMNs [203-204]. The 
discovery of secreted neutrophil extracellular traps (NETs), composed of chromatin and 
granulocyte components, which capture and kill bacteria, shed some light on the role of 
DNase in GAS virulence [205]. Indeed, it was shown that the bacteriophage located sdaI 
gene, encoding the main DNase in the GAS M1 serotype, was necessary to escape NETs 
therefore limiting the PMN-mediated killing [206-207].  
3.3.2.3. Streptococcal inhibitor of complement 
Along with M protein and C5a peptidase, the streptococcal inhibitor of complement 
(Sic) interferes with the complement response. Sic binds the membrane insertion site on 
complement C5b-C7 complex therefore inhibiting the complement mediated lysis [208]. In 
addition, Sic inactivates two main antibacterial peptides involved in the innate immune 
response, LL37 and alpha-defensin [209]. Two other components of the innate immune 
response, proteinase inhibitor and lysozyme can intereact with Sic leading to the inhibition of 
their activity [210]. In addition, Sic enhances bacterial survival by binding the eukaryotic 
plasma membrane protein Ezrin. This interaction alters the internalization and PMN-mediated 
killing of S. pyogenes [211]. sic is located in the vicinity of the transcriptional regulator mga 
and was identified to be part of the Mga regulon [146]. 
3.3.2.4. Cysteine protease SpeB 
The streptococcal cystein protease or pyrogenic toxin B (SpeB) is one of the best 
characterized streptococcal virulence factors. The fact that SpeB is present in all GAS strains 
and highly conserved, suggests its importance for the virulence of S. pyogenes [212-213]. As 
a result of its protease activity, SpeB is involved in the cleavage of proteins such as 
immunoglobulin, vitronectin, fibronectin and the complement component C3 [214-215] and 
induces active peptides such as interleukin-1, kinins and histamine [216-217]. Futhermore, 
SpeB cleaves and thereby inactivates the antimicrobial peptide dermatan sulphate on the 
extracellular matrix [218]. In parallel, SpeB cleaves streptococcal surface proteins either to 
release them from the surface promoting their dissemination in the host (M protein, C5a 
peptidase, protein H) or in the case of Ska, SdaI, Protein F1, to degrade them when not needed 
anymore [219-222].  
SpeB is produced as a 40 kDa zymogen and then processed to a 28 kDa mature peptide 
[77]. The maturation of SpeB is complex, involving a combination of cis- and trans-
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processing from SpeB itself leading to eight intermediates. SpeB is also regulated by other 
streptococcal proteins such as HtrA, a surface anchored streptococcal serine protease 
necessary for the maturation of SpeB, however its role remains unknown [196, 223]. In 
addition, M protein was shown to be necessary for the proper folding of SpeB [224]. 
3.3.2.5. IdeS 
IdeS or Mac is another cysteine protease, which cleaves specifically the heavy chain of 
immunoglobulin IgG [225-226]. The other classes of human immunoglobulins IgA, IgD, IgE 
and IgM are not affected by IdeS. To date no other substrate of IdeS has been identified. IdeS 
is mainly expressed during exponential phase being a better candidate than SpeB for cleaving 
opsonizing IgG as soon as they reach the GAS surface [225, 227].  
3.3.2.6. Streptolysins 
GAS secretes two streptolysins and encodes three other putative ones based on 
homology to hemolysins of other organisms [144].  
The streptolysin O (SLO) is an oxygen sensitive, thiol activated toxin produced by 
nearly all GAS isolates. SLO is binding and aggregating onto the cholesterol of the host cell 
membranes leading to the formation of pores [228]. Target cells include among others, 
erythrocytes, macrophages and leukocytes. 
Produced by most of the GAS strains, the streptolysin S (SLS) is an oxygen stable 
non-immunogenic toxin that is released from the cell upon presence of the appropriate carrier 
molecule. The mechanism of SLS mediated lysis is similar to the one of the complement: a 
lysine complex introduced into the membrane leads to the formation of pores [229-230]. SLS 
is encoded by a nine gene operon where the first gene sagA, codes for a 53 amino acid peptide 
responsible for the hemolytic activity [231-232]. The downstream genes, sagB to sagI are 
required for the proper processing and export of SLS. The pleiotropic effect locus (pel) is 
located at the sag operon. pel includes the sagA gene and codes for a regulatory RNA 
involved in the regulation of the sag operon as well as speB, emm and sic [233]. 
3.3.2.7. Streptococcal superantigens 
The streptococcal superantigens or streptococcal pyrogenic exotoxins are believed to 
be associated with the streptococcal toxic shock syndrome. The family of exotoxins includes 
the bacteriophage-encoded SpeA and SpeC, SpeG, SpeH, SpeJ, SpeK, SpeL, SpeM, SSA, 
SMEZ and SMEZ-2. The crystal structures of the superantigen are highly similar to each 
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others and to staphylococcal superantigens [234]. Exotoxins are able to simultaneously bind 
to the MHC class II molecules and the T-cell receptor leading to the secretion of excessive 
amounts of inflammatory cytokines responsible for the toxic shock syndrome.  
3.4. 
Unlike other Gram-positive bacteria such as S. aureus or L. monocytogenes, 
S. pyogenes does not appear to use alternative sigma factors to regulate virulence gene 
expression in response to stress or growth [235]. It depends instead on various transcriptional 
regulators responsive to environmental changes. 
Regulators 
3.4.1. Stand-alone regulators 
The term “stand-alone” regulator was first used in 2003 by Kreikemeyer and 
colleagues to describe transcriptional regulators controlling a multigene regulon in response to 
environmental changes [236]. Mga, RAPLs and RopB were identified as stand-alone 
regulators. GAS exhibits a growth phase-dependent profile of virulence factor expression 
controlled mainly by these regulators. The Mga regulon is mainly expressed during 
exponential phase thus likely to promote colonization of the host [237]. When encountering 
stationary phase, RAPL and then RopB inhibit the Mga regulon, thus likely to promote the 
transition from colonization to persistence and spread in the organism [238-239]. 
3.4.1.1. Mga 
The multigene regulator Mga, previously called VirR, is encoded upstream of emm 
and was identified as the positive regulator of M protein expression [163, 240]. Mga is 
ubiquitous in GAS and has been found in all strains examined up to now [241]. Mga is growth 
phase dependently regulated. Its expression is maximal during exponential phase and is 
environmentally regulated by aeration conditions [237]. Indeed, carbon dioxide is stimulating 
the expression of mga [242]. Furthermore, Mga is necessary during the first stage of infection 
enabling colonization and escape from the immune response by activating the expression of 
genes involved in adherence, internalization into non phagocytic cells and evasion of the host 
immune response. 
Various studies show that Mga positively regulates the expression of several virulence 
factors mainly surface-associated factors such as C5a-peptidase, serum opacity factor, 
glycoprotein binding protein, fibronectin binding protein (Fba, Sfb), collagen binding protein 
(SclA) and the secreted inhibitor of complement (Sic) [172, 243-247]. In addition to virulence 
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factors, Mga positively regulates the opp and dpp operons, involved in nutrition by 
transporting small peptides into the cell [248-249]. Interestingly, opp and dpp operons 
upregulate the expression of speB, establishing that Mga is indirectly involved in the 
regulation of the cysteine protease SpeB. Moreover, microarray analysis of the Mga regulon 
showed that Mga additionally regulates operons involved in the transport and utilization of 
carbohydrates and iron [247]. Thus, Mga has a major impact not only in the regulation of 
virulence but also in metabolism. 
 Mga directly binds DNA in the promoter region of the genes it regulates. Mapping of 
the binding sites of Mga in the promoter region of emm, emm-like genes and scpA led to the 
identification of a 45 bp consensus Mga-binding site overlapping the -35 region and allowing 
the interaction with the α-subunit of the RNA polymerase [250-251]. Mga also regulates its 
own transcription via binding to its promoter via a distinct activation mechanism [164]. mga 
is expressed via two promoters a distal promoter P1 and a proximal promoter P2. The binding 
of mga is required for the activation of transcription via the major promoter P2 as well as for 
the inhibition of expression via the distal promotor P1. The expression via the distal promoter 
is activated early in growth by CcpA, the catabolite repression regulator initiating the Mga 
response [252]. On the other hand, RopB and RofA, two transcriptional regulators were 
identified as negative regulators of mga expression [238-239]. Ribardo and colleagues 
showed that AmrA, a membrane protein involved in cell wall synthesis, is required for the 
maximal expression of the Mga regulon during exponential phase, thus linking mga 
expression to the cell wall turn-over [253].  
3.4.1.2. RAPLs 
RofA-like proteins (RAPL) are a family of transcriptional factors that possess a high 
homology to each other. The genome of S. pyogenes counts 4 RAPLs: RofA, Nra, RALP-3 
and RivR. 
• RofA 
RofA for regulator of the fibronectin binding protein (Protein F) was identified in a 
strain where Protein F was constitutively expressed [254]. Further studies showed that RofA 
is involved in the positive regulation of protein F1 but is negatively regulating the expression 
of speA, sagA and the transcriptional regulator mga [238, 255]. A rofA knock-out strain 
exhibits reduced attachment and internalization to epithelial cells and decreased host cell 
viability. The gene coding for the protein F, prtF and rofA are adjacent on the chromosome 
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but divergently oriented. RofA is autoregulated and binds to a consensus sequence of 17 bp 
(TTTTCACCAAAAANCAT) present in the promoter of its gene as well as the one of prtF 
[256]. This sequence was also identified in the promoter of the pilus associated protein coding 
gene cpa. However, the RofA binding site is absent in the promoter region of speA, sagA or 
mga indicating that the effect of RofA on these genes might be indirect. Moreover, whereas 
mga is activated by carbone dioxide, RofA responds to increased oxygen level [257].  
• Nra 
Nra, a negative regulator in GAS, possesses 62% sequence homology to RofA. Unlike 
RofA, Nra expression is not affected by the level of oxygen. Nra negatively regulates the 
expression of the fibronectin binding protein F2, the collagen binding protein Cpa, SpeB, 
SpeA, SLS, Mga and its own expression [258-259]. Transcriptome and proteome analysis 
increased the Nra regulon by adding genes coding for pilus biogenesis and capsule synthesis, 
along with other stand alone regulators such as RopB and other RAPL members, RAPL3 and 
RivR [260]. Nra inactivated strains exhibit an increase in adherence and internalization and 
escape more efficiently the phagosome [259]. 
• RAPL3 
RAPL3 has been identified in some specific serotypes, such as M1 and M49. RAPL3 
is located upstream and divergently transcribed from lsp encoding a fibrinogen binding 
protein and in the vicinity of sagA [261].  RAPL3 represses the expression of lsp, the has 
operon and speB. 
• RivR 
Finally, RivR, the last RAPL was shown to activate the expression of mga and the 
Mga regulon [262]. Interestingly, RivR is directly repressed by CovR/CovS linking the two 
component system and the Mga regulon. RivR is associated with a small RNA, rivX, involved 
in the regulation of mga [263]. 
 
Despite the high homology within the RAPL family, each member contributes to the 
regulation of bacteria-host attachment, internalization and intracellular persistence throughout 
different stages of bacterial growth. 
3.4.1.3. RopB 
Members of the Rgg family of transcriptional regulators can be found in many Gram-
positive bacteria including S. gordonii, S. oralis, Lactococcus lactis or S. pyogenes [264-266]. 
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A common feature of these orthologues is the transcriptional regulation of neighboring genes 
by binding to their promoter region [267-268].  
The Rgg orthologue in GAS, ropB, is located adjacent to and divergently transcribed 
from speB [269]. Nevertheless, RopB positively regulates the expression of SpeB. Indeed, in 
the absence of ropB, the expression of speB is completely abolished [265]. Several 
transcriptome and proteome studies clarified the RopB regulon [239, 270-273]. In addition to 
speB, RopB activates the transcription of grab, the superantigen speG, autolysin and 
lysozyme. On the other hand, RopB represses the expression of SLO, SLS, Nga, secreted 
DNases MF, HtrA protease and the Mga regulon (sic, sclA, scpA, emm, ska). However, RopB 
does not only interfere with virulence factor expression, it is also involved in the control of 
streptococcal regulators. As previously mentioned, RopB inhibits the expression of Mga 
leading to complete blockage of its regulon expression at stationary phase and activates the 
expression of several two-component systems, including CovRS, FasBCA and Irk/Irr. 
RopB is additionally involved in the repression of amino acid catabolism operons 
including arginine, histidine and serine [271-272], while it is essential for the growth in non 
glucose sugar conditions [274]. During infection, the concentration of glucose in the host (i.e. 
nasopharynx) is too low for GAS to survive, which results in the use of an alternative carbon 
source mediated by RopB, highlighting its major impact for survival. Thus, RopB is essential 
for the proliferation of GAS in the host. In addition, RopB interferes in the heat-shock and 
oxidative response by repressing the expression of several genes important for thermal (clpE, 
clpL) and oxidative stress (ahpCF) [272]. Another study shows that ropB deficient strains are 
more resistant to penicillin, thus emphasizing the role of RopB in response to antibiotic 
treatment [275]. 
RopB exhibits a helix turn helix domain and was shown to bind to the intergenic 
region of speB and ropB leading to the transcriptional regulation of both genes. This indicates 
that speB and ropB share the same promoter region [269]. So far, no other binding site has 
been identified and no consensus binding sequence has been proposed. 
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Table 6: S. pyogenes regulators. UP: up-regulated; DW: down-regulated. Updated from M. Siller’s Ph.D thesis 
manuscript 2008 
   
CodY 
Stand-alone regulators 
UP: pel/sagA, nga-slo, mga, grab, scl, prtS, scpA, speH, ideS, hasA  
DW: covRS, ropB, opp, ska, sda 
[280-281] 
LacD.1 UP: manL, slo, sagH, ntpK 
DW: speB, salA, scrA 
[282] 
MalR DW: transcripts of polysaccharide utilization proteins. [283] 
Mga UP: arp, emm, enn, scpA, fcrA, nra, mga, ska, speB, scnA/salA, opp, fbA, sic, lbp, 
scl1/scl-A, sof, mrp 
DW: genes for sugar utilization 
[164, 236, 284-285] 
MsmR UP: prtF2, cpa, nra, spy0128, nga, spy0166, slo, spy0170, spy2006,  sof, sfbx, hasA [286-287] 
MtsR UP: htsA, mga, ska, emm, SpeB 
DW: sia operon, mtsA, PrsA 
[288-291] 
RALP3 DW: hasA, spn, sdal, lsap, speB, mga, slo, covR, sic, sagA, grab, emm, eno (at logarithmic 
phase), ska, scpC     
UP: scpA, cpa, eno (at stationary phase), sic 
[260-261] 
RALP4 
(RivR) 
UP: mga, emm, scpA, fba, sic, scl, grm speB, 
spy1508/NT01sp1245,5005_spy0190/NT01sp0244 and NT01sp1815 (hypot. proteins) 
[263] 
Nra DW: cpa, mga, nra, prtF2, operon orf5-nifR3L-kinL, operon cpa-lepAL-egfflSL-orf2 
(pilus gene), sof/sfbII, sagA, speA, speB, ralp3 
[236, 258-260] 
RofA UP: prtF, rofA, rpsL, hasB, emm2 
DW: emm6, mga, sagA, speA, speB, ska 
[236, 238, 254] 
Rgg/RopB UP: speB, autolysin, clpB, lysozyme, covR, covS, fasBCA, isp1, isp2, ihk, irr 
DW: mf, DNA entry nuclease (orf226), orf953, emm, grab, hasAB, orfX, sagA, scl1, 
scpA, ska, slo, speH, mac, mga, cpsX, yufM, lytR, spy0875, ClpE, ClpL, HtrA, AphCF 
[239, 265, 269, 272-273, 
292-293] 
PerR UP: csp, sod, czcD, Dpr 
DW: mtsA, mrgA, pmtA, phtY, phtD, lsp, lrpsN2 
[294-296] 
P-Ser-HPr UP: mga [284] 
Srv UP: sir, spy0044 (zinc containing dehyDWogenase), spy0285 (ATP binding protein), 
spy0714 (zinc binding protein), spy2007, sic, speB 
[278-279] 
CovRS 
Two-component systems 
UP: spy0138, spy1062, spy1680, spy1755, spy533 
DW: covR, grab, has-operon, dppA, ideS, ihk/irr, isp2, lmb, mac, mspA, ralp3, sagA, sda, 
ska, speB, speF, speMF, trxSR, rivR 
[184-185, 262, 297-301] 
fasBCAX UP: ska, SLS activity 
DW: fbp45, mrp, sagA 
[302] 
Ihk/Irr UP: cytokine genes, fbp, gidB, mf/mf3, mryY, sagA, spy0510, spy1035, spy1093,  
spy1205, spy1311 
[204, 303] 
SilA/B UP: silE/D/CR, spyM3-1016 (transposase), bacteriocin like peptide (blp) 
DW: silC 
[304-305] 
SptRS UP: carbyhyDWate metabolism enzymes, emm, hasA, perR, rofA, sagA, sic, spd,  
speB, spy0470 
[306] 
VicRK UP: putative cell wall hyDWolase gene pcsB, putative phosphotransferase system enzyme 
II for carbohyDWate transport. 
DW: spy0183, spy0184 (osmoprotectant transporter OpuA 
[307] 
fasX 
Regulatory RNAs 
UP: ska, SLS activity 
DW: fbp45, mrp, sagA 
[302] 
pel UP: emm, nga, sic, SpeB activity  [233] 
rivX UP: mga, emm, scpA, fba, sic, scl, grm (Mga regulated genes), speB, 
spy1508/NT01sp1245, M5005_spy0190/NT01sp0244 and NT01sp1815 (hypot. proteins) 
[263] 
 
3.4.1.1. Srv 
The streptococcal regulator of virulence (Srv) is a member of the Crp/Nfr family of 
transcriptional regulators and share 53% sequence homology with the L. monocytogenes 
positive regulator factor A (PrfA) [276]. Srv is involved in biofilm formation and therefore 
inactivation of srv results in a decrease in biofilm [277]. Moreover, it was shown in mice 
 
38 
 
infection models that Srv is necessary for the full virulence of GAS [278]. Microarray 
analysis revealed that Srv slightly represses virulence gene expression but its impact on their 
transcription is really modest [279]. 
3.4.1.2. CodY 
CodY is a pleiotropic transcriptional regulator involved in the response to nutrient 
limitation in a RelA-independent pathway [281]. It is highly conserved in low-G+C Gram-
positive bacteria and activated by branched-chain amino acids [308]. As response regulator 
for nutrient limitation, CodY directly or indirectly controls the expression of many genes 
coding for transporters and metabolic enzymes as well as virulence factors. In addition, CodY 
influences the expression of regulators of virulence factors including ropB, mga, covR and pel 
and their regulon [280-281]. 
3.4.2. Two-component systems 
A two-component system is based on two proteins: a sensor kinase that detects the 
specific signal and phosphorylates a DNA binding regulator, which in turns directly 
influences target gene expression. Bioinformatic studies revealed the presence of 13 two- 
component systems encoded in the genome of various strains of S.  pyogenes. So far not all of 
them have been functionally characterized. This part will focus on the well studied ones. 
3.4.2.1. CovR/CovS 
CovR/CovS (control of virulence genes) previously known as CsrR/CsrS (capsule 
synthesis regulator) regulates more than 15% of streptococcal chromosomal genes [186]. 
First, CovR/CovS was found to negatively regulate the expression of the streptococcal capsule 
[184]. Inactivation of covR, encoding the repressor molecule, results in an increase of 
hyaluronic acid capsule production associated with elevated virulence in animal models. 
Further studies showed that CovR downregulates the expression of several other virulence 
factors such as sagA, speMF, speB and ska [185, 299] and also represses its own transcription 
[185]. Upon ligand binding, CovR is phosphorylated by CovS resulting in the formation of a 
complex composed of multimers of CovR [309]. This complex binds to a common 16 bp 
motif [5’-T(T/A)ATTTTTAA(A/T)AAAA(C/A)-3’] conserved in the promoter region of 
hasA, speMF, ska, sagA and speB [310-311]. In S. pyogenes, CovR/CovS responds to 
environmental Mg2+ but not to Ca2+, Mn2+ and Zn2+ abundance [312]. Growth in the presence 
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of Mg2+ leads to the repression of capsule production, streptokinase and streptolysin S 
expression indicating that Mg2+
3.4.2.2. FasBCAX 
 activates CovR via phosphorylation [312]. 
The FasBCA operon was identified by its homology to the well described S. aureus 
agr and S. pneumoniae com operons. The operon codes for 2 potential histidine kinases, FasB 
and FasC and one response regulator, FasA. The significance of these two histidine kinases 
remains unclear. Either they sense different signals or they act as a heterodimer. fasX, located 
downstream of the operon, codes for a small RNA regulating the operon.  
The FasBCA system regulates fibrinogen/fibronectin binding, hemolytic activity and 
streptokinase transcription. Inactivation of the fasBCA operon results in an increased 
expression of the fibrinogen binding proteins Fbp54 and Mrp, a decrease activity of Ska and 
SLS and a reduced transcription of sod, coding for the superoxide dismutase. Nevertheless, no 
changes in expression of speB, emm, hasB, slo or mga were observed in the fasBCA deficient 
strains [302]. 
3.4.2.3. Ihk/Irr 
The Ihk/Irr two-component system encoding genes are located upstream of isp, coding 
for the immunogenic secreted protein, thus explaning their name: isp-adjacent histidine kinase 
(Ihk) and isp-adjacent response regulator (Irr). Ihk/Irr regulates the expression of genes 
involved in cell wall formation and peptidoglycan synthesis [204], and thus plays a major role 
in the evasion of GAS from PMN-mediated killing [303]. 
3.4.3. Regulatory RNAs 
In prokaryotes, regulatory RNAs act as signal transducers of environmental conditions 
to coordinate gene expression. These RNAs carry out a variety of biological functions such as 
plasmid replication, transposition, viral replication, bacterial replication, and some of them act 
as regulators of virulence gene expression [313]. In GAS, three loci have been reported to be 
involved in RNA-mediated control of gene expression. One, termed fasX RNA was described 
to be the effector molecule of the fas operon [314]. rivX, encoded within the riv operon, 
activates the expression of the Mga regulon [315]. Finally, pel located within the GAS sag 
operon (encoding SLS) was identified to exert a pleiotropic effect on the expression of a 
number of virulence factors [233]. 
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3.5. 
3.5.1. Proteases  
Proteases in S. pyogenes 
Proteolysis plays a major role in biological processes. It enables inactivation of 
proteins by degradation but also activation following cleavage of immature forms of proteins. 
Proteases in pathogenic bacteria participate in many functions essential to virulence, including 
the acquisition of nutrients, biogenesis of virulence factors, cleavage of key host proteins for 
modulation of host response, and activation of streptococcal proteins. Several proteases act as 
virulence factors (i.e. SpeB, IdeS and C5a peptidase). 
In addition to the production of several proteases, S. pyogenes can recruit human 
proteases to its surface. The main example is the plasminogen/plasmin, involved in the 
fibrinolytic system. Plasminogen is recruited to the surface via interaction with cell wall 
attached proteins and converted to plasmin by the streptococcal secreted streptokinase [316]. 
The acquisition of plasmin by GAS is important to cross biological barriers such as the 
extracellular matrix and disseminate in the host. 
Proteolysis is tightly regulated and depends on the stages of GAS infection. During 
adhesion, corresponding to the exponential phase in vitro, GAS exhibits on its surface 
proteins that are mainly involved in adhesion and antiphagocytic mechanisms. The protease 
C5a peptidase is necessary at this stage to escape the complement response. IdeS is mainly 
expressed during this phase to degrade IgGs as soon as they reach the GAS surface [225]. 
Later, when GAS colonizes the site of infection, SpeB is produced. It cleaves C5a peptidase, 
which is not required anymore and adhesins (M protein and fibronectin-binding protein), 
allowing GAS to leave the site of infection and spread [219].  
3.5.2. Clp proteins in S. pyogenes 
GAS possesses orthologues of the main clp genes. Genes coding for the protease ClpP and 
the chaperone ATPases ClpX, ClpC, ClpE, ClpB and ClpL are present in the genome. 
Surprisingly, little is known about Clp proteins in S. pyogenes. A study identified ClpP as a 
repressor of σx
  
, a secondary sigma factor involved in the regulation of competence [317-318]. 
Moreover, a microarray study showed that expression of clpC and clpE is up-regulated under 
starvation conditions [319]. Finally, as mentioned above, RopB represses the transcription of 
clpE and clpL [272]. 
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 Aims of the study 
The aim of our study is to determine the functions of Clp-mediated proteolysis in the 
human pathogen S. pyogenes. Proteolysis is required in the cell for the natural turn-over of 
cytosolic proteins as well as in the regulation of metabolic pathways. Various studies have 
also shown that Clp-mediated proteolysis plays an important role in the regulation of 
virulence in Gram-positive pathogens such as L. monocytogenes, S. aureus, S. pneumoniae 
and S. mutans. However, the impact of Clp proteolysis in the human pathogen S. pyogenes, 
agent of pharyngitis and life threatening diseases such as flesh eating disease and toxic shock 
syndrome, has not been studied so far. Using in-frame deletion mutants of the Clp ATPases 
encoding genes clpC, clpE and clpX and of the protease encoding gene clpP, we performed 
various phenotypic analyses to examine the impact of Clp-mediated proteolysis on growth, 
cell division and survival to stress conditions encountered during infection. In parallel, we 
investigated the function of Clp proteins in the pathogenicity of S. pyogenes by investigating 
the expression of virulence factors. Additionaly, we analysed the expression of transcriptional 
regulators and two-components systems in order to obtain an insight into the mechanism by 
which Clp proteins influence adaptation and virulence. 
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 Materials and methods 
1. Bacterial strains and growth conditions 
E. coli strains DH5α was used for the cloning of all constructs prior to their introduction 
into S. pyogenes SF370 (EC904). E. coli strains were grown in Luria-Bertani medium (LB) at 
37°C with shaking (160 rpm). For solid LB medium, 1.5% of agar was added. To select for 
antibiotic resistance, 25 µg/ml of kanamycin was added to the medium as required. 
S. pyogenes strains were routinely cultured in Todd Hewitt Broth (THB, BD) 
complemented with 0.2% of yeast extract (THY) at 37°C, 5% CO2
2. DNA manipulation and plasmid constructions 
 without agitation or on 
Trypticase soy agar (TSA, BD) supplemented with 3% of sheep blood. For selection, 300 
µg/ml of kanamycin and 1 mg/plate of Xgal were added. 
DNA preparation, amplification, digestion, ligation and purification were performed 
according to standard techniques. Southern blot analyses were performed following 
manufacturer instruction (NEBlot phototop kit and Phototop star detection kit, New England 
Biolab). Primers used in this study were supplied by VBC-Biotech Services GmbH. 
Sequencing reactions were performed by VBC-Biotech Services GmbH. 
3. Construction of S. pyogenes M1 SF370 clpX- and clpP-deficient 
strains 
Deletion of clpX (∆60-1161 bp), clpP (∆1-591 bp), clpE (∆1-2283 bp) and clpC (∆115-
2213 bp) were performed by temperature shift using a Gram-positive thermosensitive 
replicative plasmid pEC214. In the case of clpX, a fragment containing 955 bp upstream of 
the deleted region and a fragment containing 1069 bp downstream of the deleted region 
flanked by restriction enzyme were amplified and inserted into pEC214, leading to pEC231. 
In the case of clpP, a fragment containing 950 bp upstream of the deleted region and a 
fragment containing 1086 bp downstream of the deleted region flanked by restriction enzyme 
were amplified and inserted into pEC214, leading to pEC217. In the case of clpE, a fragment 
containing 947 bp upstream of the deleted region and a fragment containing 1054 bp 
downstream of the deleted region flanked by restriction enzyme were amplified and inserted 
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into pEC214, leading to pEC266. In the case of clpC, a fragment containing 457 bp upstream 
of the deleted region and a fragment containing 436 bp downstream of the deleted region 
flanked by restriction enzyme were amplified and inserted into pEC214, leading to pEC275. 
(Appendix Table 2 and 3). Wild-type S. pyogenes M1 SF370 electro-competent cells were 
transformed with the corresponding plasmid at 28°C selecting on kanamycin and Xgal. 
Positive clones were grown for 3 cycles at 37°C in the presence of kanamycin to induce the 
first recombination event. Clones were selected on kanamycin and Xgal. Integration of the 
plasmid was checked by PCR. Positive clones were grown for 3 cycles at 28°C without 
kanamycin to promote the second recombination event. White clones were selected and 
picked on TSA blood plates with and without kanamycin. Sensitive clones were analysed by 
PCR (Appendix Table 1). The deletion of clpX, clpP, clpE and clpC was verified by PCR, 
sequencing of the region and Southern blot analysis. The loss of the plasmid was ensured by 
temperature shift assays. 
4. Complementation plasmids 
The putative promoter region, the coding sequence and the putative terminator of clpP, 
clpX and clpE were amplified by PCR, flanked by restriction enzyme and inserted into 
pEC85, a Gram-positive replicative plasmid containing a kanamycine resistance cassette 
(Appendix Table 2). Plasmids were inserted into the corresponding competent mutants. 
pEC85 was used as transformation control. Cells were selected on kanamycin agar blood 
plate. Unfortunatly, no clone were retrieved in the case of the ∆clpX and ∆clpP with pEC85 or 
their corresponding plasmids. 
5. Growth curves 
For each strain, a THY overnight culture was diluted 1/100 into THY and grown at 37°C, 
5% CO2, 41°C, 5% CO2 or at 37°C with agitation at 120 rpm. The OD620nm was measured 
every hour. 
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6. Cfu analysis 
For each strain, a THY overnight culture was diluted 1/100 into THY and grown at 37°C, 
5% CO2
7. Survival under oxidative stress 
. Every hour, aliquots were removed and appropriate dilutions were plated in 
triplicates on TSA blood plate to determine the colony forming unit (cfu). 
For each strain, a THY overnight culture was diluted 1/100 in THY and grown at 37°C, 
5% CO2 until mid-exponential phase. An aliquot was removed and H2O2
8. Survival upon lethal temperature 
 (Sigma) was added 
to the culture to a final concentration of 4 mM. After 1 h, 2 h and 3 h aliquots were removed 
and 0.05 mg/ml final concentration of catalase (Sigma) was added to stop the reaction. 
Appropriate dilutions were plated in triplicates on TSA blood plate to determine the colony 
forming units (cfu). The percentage of survival was obtained by the ratio of cfu / ml after 
stress to the cfu / ml prior to stress.    
For each strain, a THY overnight culture was diluted 1/100 in THY and at 37°C, 5% CO2 
until mid-exponential phase. An aliquot was removed and the culture was transfered to 44°C, 
5% CO2
9. Osmotic stress 
. After 1 h, 2 h and 3 h aliquots were removed and appropriate dilutions were plated 
in triplicates on TSA blood plate to determine the cfu. The percentage of survival was 
obtained by the ratio of cfu / ml after stress to the cfu / ml prior to stress.    
For each strain, a THY overnight culture was diluted 1/100 in THY and grown at 37°C, 
5% CO2 until mid-exponential phase. 1 µl of dilutions 1 to 10-3 were spotted on a TSA blood 
plate supplemented with 0.65 M NaCl. Plate was incubated at 37°C, 5% CO2 
10. Penicilin resistance 
for 24 h and 
48 h.  
For each strain, a THY overnight culture was diluted 1/100 in THY and grown at 37°C, 
5% CO2 until stationary phase. After a dilution 1/100 into fresh THY, an aliquot was removed 
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and a final concentration of 100 µg/ml penicillin was added to the culture. After 2 h 
incubation at 37°C, 5% CO2
11. Electron microscopy 
, appropriate dilutions of the culture were plated in triplicates 
onto TSA blood plate to determine the cfu. 
For each strain, a THY overnight culture was diluted 1/100 in THY and grown at 37°C, 
5% CO2 until early-stationary phase. Final concentrations of 2.5% paraformaldehyde, 0.015% 
glutaraldehyde and 30 mM phosphate buffer pH 7.0 were added to an aliquot of the culture. 
Cells were incubated 15 min at room temperature then transfered on ice for 30 min. After 
washing, cells were resuspended in 1x PBS and an aliquot was laid on L-polylysine coated 
slides. Slides were dried 30 min at 37°C, washed in 1x PBS and dipped 10 sec in methanol. 
Samples were treated 1 h with 1% osmium in 0.1 M cacodylate buffer pH 7.4. After 3 
washings in ddH2
12. Biofilm formation 
O, samples were dehydratated in a graded series of acetone solutions and 
critical point dried with hexamethyldisilazane (Merck). Samples were then covered with a 
10 nm thick gold film and examined with a Fei XL30 scanning electron microscope. 
For each strain, a C-medium overnight culture was diluted 1/10 in C-medium and 1.5 ml 
were inoculated in a 24 well plate (3 wells per strain). The plate was incubated at 37°C, 5% 
CO2 for 24 h. The medium was removed and wells were washed gently two times with dH2O. 
Adherent bacteria were stained with a solution of 0.2% crystal violet for 10 min at room 
temperature. Wells were washed gently with dH2O. Adherent cells were retrieved with 1% 
SDS and the cell density was determined at OD540nm
13. Aggregation 
.  
Strains were grown overnight in THY under agitation (160 rpm) at 37°C. Cultures were 
kept at 37°C without agitation. The sedimentation rates were determined by the cell density of 
the upper layer of the culture measured at OD620nm.  
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14. Adhesion to epithelial cells  
HepA II cells were routinely grown in RPMI (Gibco) supplemented with 10% FCS 
(Sigma) and 1% penstrept (Sigma). Cells were regularly checked for mycoplasma infection. 
Prior to the experiment, HepA II cells were seeded in RPMI, 10% FCS without antibiotic, at 
1.5 x 105 /well in 24 well plates and incubated for 24 h at 37°C, 5% CO2. In parallel, bacterial 
strains from a THY overnight culture in were diluted 1/25 in THY and grown at 37°C, 5% 
CO2 until stationary phase. Bacteria were harvested, washed with RPMI, 10% FCS and added 
to the HepAII at a multiplicity of infection (MOI) of 5. After 30 min incubation at 37°C, 5% 
CO2, cells were washed five times with 1 x PBS to remove the non-adherent bacteria and then 
incubated 15 min in ice-cold dH2
15. Northern blot analysis 
O to retrieve adherent epithelial cells. Appropriate dilutions 
were plated to determine the colony forming units (cfu) per ml.  
For each strain, a THY overnight culture was diluted 1/100 in THY and grown at 37°C, 
5% CO2. Cells were harvested at appropriate time points corresponding to OD620nm (Lag: 
0.08; EL: 0.2; ML: 0.32; LL: 0.44; ES: 0.5). Total RNA extracts were isolated using Trizol 
reagent (Invitrogen). 25 µg of RNA were separated on a formaldehyde agarose gel and 
transferred onto a Nylon N+ Hybond membrane (Amersham). PCR generated probes, 
corresponding to an internal fragment of genes, were labelled using α-32
For the heat-shock response, 2 cultures of EC904 were grown until late-exponential phase 
at 37°C, 5% CO
P-dATP (Appendix 
Table 4).  
2. One of the cultures was transferred at 41°C, 5% CO2
16. Exoprotein purification and Western blot analysis 
. Aliquots of 10 ml of 
culture were harvested after 15, 30, 45 and 60 min. 
For each strain, a THY overnight culture was diluted 1/100 in THY and grown at 37°C, 
5% CO2. 20 ml of culture were harvested at appropriate time points corresponding to OD620nm 
(EL: 0.2; ML: 0.32; LL: 0.44; ES: 0.5). Supernatants of culture were filtered and the proteins 
were precipitated using 10% TCA.  
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Exoproteins were separated by 8-18% gradient SDS-PAGE. Gels were fixed 3 h into a 
40% ethanol, 10% acetic acid solution and transferred over night into a 0.1% coomassie G-
250 solution.  
For Western blot, proteins were transferred onto nitrocellulose membranes (Protan). 
Antibodies against SpeB (1/2000), M (1/1000), Sic (1/1000) and Ska (1/500) were diluted 
into 2% BSA, 1x TBST. Anti-rabbit (SpeB, Ska, Sic) and anti-mouse (M) HRP antibodies 
(Amersham) were diluted 1/10000 into TBST. Finally, the HRP activity was detected by 
chemoluminescent reagent (Pierce).   
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 Results 
1. Genetic organization of the Clp encoding genes 
The genomic organization of the protease coding gene clpP and genes coding for the Clp 
ATPases participating in the Clp mediated proteolysis clpX, clpE and clpC loci in S. pyogenes 
are shown in Fig. 4. The clpX gene is located directly upstream of yihA, which encodes a 
homologue of YsxC, a GTP-binding protein essential for ribosome assembly and stability in 
B. subtilis and S. aureus (Fig. 4C) [320-321]. The clpP gene is located immediately 
downstream of the upp gene encoding a homologue of uracil phosphoribosyltransferase (Fig 
4B) [322]. clpC is situated directly downstream of ctsR, encoding the negative transcriptional 
regulator of several clp genes in B. subtilis (Fig. 4E) [80]. Finally, clpE is located upstream of 
an orthologue of the mutator protein coding gene, mutT (Fig 4D) [323]. The tandem 
organization of upp-clpP, clpX-yihA, ctsR-clpC is conserved among S. pyogenes genomes and 
is also found in other streptococcal species, i.e. S. mutans and S. pneumoniae (Fig. 5) [324]. 
Interestingly in B. subtilis, L. monocytogenes and S. aureus, clpC is part of a ctsR regulated 
operon composed of ctsR itself, mcsA, mcsB and clpC (Fig. 5C) [80, 85]. In S. pyogenes, no 
homologues of mcsA or mcsB have been identified. Similar to other Gram-positive bacteria, 
the promoter regions of clpP, clpE and the clpC operon but not of clpX exhibit an 
heptanucleotide repeat motif (TTTGACC/T-N(3)
Furthermore, nucleotide sequences of clpE, clpC, clpX and clpP are 100% identical in 
all S. pyogenes genomes. S. pyogenes Clp proteins show a high percentage amino-acid 
sequence homology with the corresponding proteins in other Gram-positive species, with the 
highest score observed among streptococcal proteins (Fig. 6). S. pyogenes Clp ATPases ClpX, 
ClpC and ClpE contain the typical domains for ATPase activity, and domains involved in 
substrate and ClpP binding. The Walker A and Walker B motifs involved in the binding and 
hydrolysis of ATP, the P-loop domain required for the interaction with ClpP and the pore 
forming loop domain described in B. subtilis and other Gram-positive Clp ATPases are 
conserved (appendix Fig. S1,S3,S4) [15]. In addition, the zinc binding domain of ClpX 
involved in the binding of the substrate is also conserved in S. pyogenes. The catalytic triade 
-TTTGACC/T) corresponding to a CtsR 
binding site (Fig. 4). Thus, it appears that the co-transcription of ctsR and clpC, regulated by 
CtsR itself is conserved among Gram-positive bacteria.  
 
49 
 
(SHD) essential for ClpP activity is also present and conserved in S. pyogenes and various 
Gram-positive bacteria (appendix Fig. S2). 
 
Fig. 4. Genomic organisation of the clp loci in S. pyogenes. (A). Gene sequences surrounding clpP (green), 
clpX (pink), clpE (blue) and clpC (yellow) are depicted to scale. (B-E). Prediction of the promoter and terminator 
region of clpP (B), clpX (C), clpE (D) and clpC (E). -35 and -10 box are highlighted in green, the RBS sequence 
in purple, the CtsR binding site in orange and the Rho-independent terminator in red.  
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Fig. 5. Genomic organisation of the clp loci in Gram-positive bacteria.  Region  organisation surrounding 
clpX (A), clpP (B), clpC (C) and clpE (D). The genes are not depicted to scale. The nature of the genes stated are 
listed in the annexe.  
 
51 
 
2. Construction clp-deficient strains 
To determine the impact of the Clp proteins in S. pyogenes, each of the respective genes 
were deleted from the chromosome. Because of the genomic arrangement of clpE, clpC, clpX 
and clpP, in-frame deletion mutants with non-polar effect on the neighboring genes were 
constructed. As wild-type strain, we chose S. pyogenes SF370, a reference clinical isolate of 
M1 serotype which complete genome sequence is publicly available (accession number: 
ATCC 700294). The S. pyogenes M1 type is the most representative serotype among clinical 
isolates world-wide and is linked to minor infections including pharyngitis but also to lethal 
infections such as toxic shock syndrome. 
 
 
Fig. 6.  Homology of Clp proteins in Gram-positive bacteria.  Percentage of amino-acid sequence identity of 
Clp proteins between S. pyogenes SF370, and B. subtilis 168, L. monocytogenes EGD-e, S. aureus COL, S. 
pneumoniae TIGR4 and S. mutans UA159.  
 
For clpP and clpE, the entire coding sequences of 591 nt and 2283 nt, respectively, were 
deleted in-frame. However, in the case of clpX only an internal fragment of 1101 bp (∆60 -
1161) was deleted in-frame in order to keep the yihA ribosome binding site located at the 3’ 
end of the coding sequence of clpX in the clpX-deficient strain. Because of the tandem 
transcriptional organization of clpC and ctsR, only an internal fragment of clpC of 2098 nt 
(∆115-2213) was deleted from the chromosome. Thus, in both generated ∆clpX and ∆clpC 
mutants, expression of the downstream co-transcribed gene should be unaffected compared to 
the wild-type. 
The upstream and downstream regions surrounding the sequence to delete were cloned 
into a thermosensitive plasmid, pEC214 (Appendix Table 2). Following enzymatic restriction 
and sequence analysis, the plasmids were introduced into S. pyogenes M1 SF370. Then, 
strains underwent several temperature shifts promoting recombination events that ultimately 
led to the generation of ∆clp mutants or wild-type strains. Wild-type strains resulting from 
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this procedure are refered to as “WTts” in this study. They were kept and used in the study as 
controls in the analysis of ∆clp phenotypes (Appendix Table 1). 
After the deficient strains were obtained, complementation plasmids were constructed by 
inserting the coding sequence as well as the putative promoter region and the putative 
transcriptional terminator of each clp gene into pEC85 (Appendix Table 2). The 
complementation plasmids were successfully introduced into the wild-type strain and the 
∆clpE mutant. However, attempts to transform ∆clpX and ∆clpP mutants with the 
corresponding complementation plasmids or pEC85 failed. Therefore, no complemented 
strains for ∆clpX and ∆clpP could be obtained. Introduction of the clpC complementation 
plasmid into the ∆clpC mutant remains to be performed. 
3. Analysis of the clpX- and clpP-deficient strains 
3.1. 
Sequence analysis of the clpX-yihA region revealed the presence of a putative 
promoter located 40 bp upstream of the translational start codon (Fig. 4C). We predicted two 
putative Rho-independent transcriptional terminators, located in the clpX-yihA intergenic 
region and downstream of yihA. Accordingly, Northern blot analysis of clpX shows 
expression of two transcripts of  approximately 1300 nt and 1900 nt, that correspond in size to 
the predicted transcripts, starting from the same transcription start but stopping at two distinct 
Rho-independent terminators (Fig. 7). Expression analysis throughout the growth phase 
shows a decreased amount of both clpX transcripts when cells enter stationary phase. In 
addition, clpX expression is up-regulated in the ∆clpP mutant compared to the wild-type 
cultures from lag to late-logarithmic phase (Fig. 7). In B. subtilis, expression of clpX is not 
regulated by CtsR [92]. The absence of a CtsR binding site in the promoter region of clpX in 
S. pyogenes confirms that clpX is likely to not be directly regulated by CtsR in this organism. 
In the case of upp-clpP, we identified two putative promoters upstream of upp (P1) and in the 
upp-clpP intergenic region (P2) (Fig. 4B). Only one putative Rho-independent transcriptional 
terminator located downstream of clpP was identified. Consistent with sequence predictions, 
two distinct clpP-specific transcripts were detected by Northern blot analysis (Fig. 7). 
Transcriptional analysis of clpX and clpP mutants 
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Fig. 7. Transcriptional analysis of clpX and clpP expression. Northern blot analysis of wild-type (WT), 
∆clpX, ∆clpP and control wild-type (WTts) total RNA prepared throughout growth: LAG (lag phase), EL (early-
log), ML (mid-log), LL (late-log) and ES (early-stationary). Transcripts were detected with clpX or clpP specific 
PCR generated probes labeled with α-32
Constitutive expression of both transcripts is observed from lag- to mid-logarithmic 
phase. Stronger expression of the shorter transcript in comparison to the longer transcript is 
observed at late-logarithmic and early-stationary phase. Expression of the longer transcript is 
also decreased when cells enter stationary phase. These data indicate that at late growth phase, 
activity of the promoter located upstream of clpP is enhanced compared to that located 
upstream of upp. Interestingly, a CtsR binding is located in the intergenic region between upp 
and clpP, overlapping the promoter region P2. As Clp ATPases and proteases are qualified as 
heat-shock proteins, we analyzed the influence of heat on S. pyogenes clpX and clpP 
expression. Northern blot analysis shows that shifting S. pyogenes cultures from 37°C to 41°C 
induced an increase of expression of the shorter transcripts of clpX after 30 min and clpP after 
15 min (Fig. 8). Thus, clpX and clpP are induced by heat and both transcribed as mono- and 
bi-cistronic transcripts. Moreover, the regulation of clpX and clpP expression by heat is 
mediated via the mono-cistronic transcript. 
P-dATP. clpX and clpP are expressed both as mono- and bi-cistronic 
transcripts. The estimated sizes of the transcripts are indicated in Kilo-bases. 23S rRNA was used as a loading 
control.  
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3.2. 
Growing cells in THY medium, at 37°C, 5% CO
Growth of ∆clpX and ∆clpP mutants 
2
As a more direct read-out of cell viability of ∆clpX and ∆clpP mutants, colony 
forming units (Cfu) were determined throughout the growth curve (Fig. 9B). After 1 h of 
growth, the wild-type already started duplicating whereas at this time point the number of 
∆clpX and ∆clpP cells remained unchanged. This result may provide an explanation for the 
longer lag phase and the slight delay of growth observed in the mutants. During exponential 
phase, the generation time was similar comparing the wild-type and ∆clp mutant strains 
(Fig. 9B). Interestingly, at stationary phase, even when the density of cells was lower for 
∆clpX and ∆clpP, the number of cells was equal to the wild-type strain. To conclude, ∆clpX 
and ∆clpP mutant strains exhibit a longer lag phase explaining their delay of growth 
compared to the wild-type. However, the generation time and number of cells at stationary 
phase of ∆clpX and ∆clpP mutants is comparable to the ones of the wild-type whereas the cell 
density is decreased which could be explained by the decreased size of the ∆clpX and ∆clpP 
mutant cells. 
 revealed a slower growth 
characterized by a longer lag phase of ∆clpX and ∆clpP mutants compared to the wild-type 
parent (Fig. 9A). Moreover, both mutants failed to reach the same density of cells at 
stationary phase compared to the wild type. 
 
 
Fig. 8. Heat inducible expression of clpX- 
and clpP-deficient strains. Northern blot 
analysis of total RNA harvested from wild-
type culture after 15, 30, 45 and 60 min of 
heat shock at 41°C. Transcripts were 
detected with clpX- or clpP- specific PCR 
generated probes labeled with α-32P-dATP. 
clpP expression is induced by heat after 15 
min whereas clpX expression is induced 
after 30 min. The estimated sizes of the 
transcripts are indicated in Kilobases. 23S 
rRNA was used as a loading control.  
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Fig. 9. Growth of clpX- and clpP-deficient strains is delayed due to a longer lag phase. Wild-type (WT), 
∆clpX and ∆ clpP were cultivated in THY at 37°C, 5% CO2. (A) Culture density was measured regularly at 
OD620 nm. The results from three independent cultures are expressed as mean OD620 nm 
3.3. 
. (B) Aliquots of cultures 
were removed during growth and colony forming units (cfu) / ml were determined by plating dilution series onto 
TSA blood in triplicates. The experiment was performed three times independently. A representative result is 
shown. 
3.3.1. Biofilm formation 
 Cell morphology analysis 
 
As a defense mechanism against the host, S. pyogenes is able to grow in biofilms 
[325]. Here, the capacity of the clpX- and clpP-deficient strains to form biofilm in rich 
medium (C-medium) was evaluated. After 24 h, ∆clpX and ∆clpP showed a significant 
increase in biofilm formation on polystyrene plastic surfaces (Fig. 10). Quantifications 
revealed that ∆clpX and ∆clpP produced approximately twice more biofilm than the parent 
strain SF370. The same results were observed after 48 h incubation at 37°C, 5% CO2.  
Fig. 10. ClpP and ClpX are involved in 
biofilm formation. Wild-type (WT), ∆ clpX 
and ∆ clpP were cultivated in triplicates for 
24 h in C-medium at 37°C, 5% CO2. After 
washing with PBS, attached cells were dyed 
with 0.2% crystal violet. Cells were 
retrieved with 1% SDS solution and cell 
density was determined at OD540 nm. The 
values shown are the average of three 
inocula ± SD. The experiment was 
performed three times independently. A 
representative result is shown 
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3.3.2.  Aggregation 
During culture in rich medium (THY) at 37°C without agitation, ∆clpX and ∆clpP 
were observed to settle down earlier than the wild-type. Consequently, sedimentation was 
evaluated by measuring the OD620 nm of the upper layer of culture after growth under 
agitation. Our measurements showed that after 4 h, the wild-type strain reached the OD620 nm 
of 0.3 (Fig. 11). In the case of ∆clpX and ∆clpP, the OD620 nm
 
 of 0.3 was already reached after 
1 h and no cells were left in the upper layer after 4 h without agitation. This result shows that 
the clpX-and clpP-deficient strains are forming more aggregates than the parent strain SF370.  
 
Fig. 11. clpX and clpP deletions affect streptococcal aggregation. Wild-type (WT), ∆ clpX and ∆clpP were 
cultivated over-night in THY medium at 37°C with shaking. Culture were kept standing. Cell density of the 
upper phase of culture was determined at OD620 nm
3.3.3. Microscopy 
. The picture shows cultures standing after one hour. The 
experiment was performed three times independently. A representative result is shown. 
S. pyogenes has the characteristic to grow in pairs of cells or in chains of varying 
lengths [326]. A defect in chain formation could explain the increase in aggregation of the 
∆clpX and ∆clpP strains. Stationary phase cultures of wild-type, ∆clpX and ∆clpP were 
observed by scanning electron microscopy. Compare to wild-type, ∆clpX and ∆clpP exhibited 
longer chains of diplococci (Fig. 12 upper panel). In addition, chains of the ∆clpP mutant 
were disorganized and aggregated with cells that appeared to not properly segregate. It 
appeared as well that ∆clpP cells were slightly smaller than ∆clpX or the parent strain (Fig. 12 
lower panel). As predicted above, the decrease in cell size of the mutants could explain their 
reduced cell density at stationary phase. In conclusion, these results suggest that ClpX and 
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ClpP are involved in biofilm formation and cell aggregation. In addition, ClpP seems to affect 
cell segregation.  
 
Fig. 12. Scanning electron microscopy reveals that clpX and clpP deletion affect chain formation. Wild-
type (WT), ∆clpX and ∆clpP were cultivated until mid-log phase. Cells were fixed to poly-lysine coated 
coverslips and dried as explained in « Materials and Methods ». Samples were covered with a 10 nm thick gold 
film and examined with a Fei XL30 scanning electron microscope. Chains were observed at magnification 
x 8 000 (upper panel) and x 25 000 (lower panel).  
3.4. 
3.4.1. Growth under stress conditions 
Tolerance to stress conditions 
In several other Gram-positive bacteria, ClpX and ClpP are involved in stress 
response. First, tolerance to heat and oxygen was assessed by monitoring the growth of wild-
type, ∆clpX and ∆clpP strains in rich medium at 41°C and at 37°C under shaking, respectively 
(Fig. 13).  
 
Fig. 13. Growth of clpX- and clpP-deficient strains is not affected at 41°C or with oxygen. Wild-type (WT), 
∆clpX and ∆clpP strains were cultivated in THY medium at 41°C, 5% CO2 (A) or at 37°C under agitation (B).  
Culture density was measured regularly at OD620 nm. The experiment was performed three times independently. 
A representative result is shown. 
 
58 
 
Interestingly, ∆clpX and ∆clpP mutants exhibited a delay of growth compared to the 
wild-type. In the two stresses tested, the delay in growth was comparable to the one already 
observed at 37°C, 5% CO2
3.4.2. Survival under critical conditions 
. Consequently, ClpX and ClpP are not involved in the response to 
heat-shock or oxygen exposure. 
Additionally, we assessed the survival of ∆clpX and ∆clpP mutants under the 
following critical conditions: lethal temperature, superoxide compounds, high salt 
concentration and acidic pH.  
Surprisingly, the deletion of clpX or clpP provided an advantage for S. pyogenes to 
tolerate lethal temperature (Fig. 14A). Compared to wild-type, the ∆clpX and ∆clpP mutants 
showed an increased survival rate after shifting the cultures from 37°C to 44°C over a 3 hour 
period. 
 
 
Fig. 14. ClpX and ClpP are involved in the response to heat-shock and oxidative stress. (A) Resistance to 
lethal temperature. Wild-type (WT), ∆clpX and ∆clpP were cultivated in THY at 37°C, 5% CO2. At mid-log 
phase, culture temperature was shifted to 44°C. Aliquots were collected every hour and the ratio of colony 
forming units (cfu) / ml was determined by plating dilution series onto TSA blood in triplicates. The values 
shown are mean survival percentages ± SD. The experiment was performed three times independently. A 
representative result is shown. (B) Resistance to oxidative stress. Wild-type (WT), ∆clpX and ∆clpP were 
cultivated in THY medium at 37°C, 5% CO2. At mid-log phase, 4 mM H2O2
 
 were added to the culture. Aliquots 
were collected every hour and colony forming units (cfu) / ml were determined by plating dilution series onto 
TSA blood in triplicates. The values shown are mean survival percentages ± SD. The experiment was performed 
three times independently. A representative result is shown.  
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In contrast, clpX- and clpP-deficient strains were more sensitive to exposure to 4 mM 
H2O2 
Furthermore, resistance to high salt concentration was examined. Cells were grown on 
plate containing 0.65 M NaCl. After 24 h incubation, wild-type and ∆clpX exhibited colonies 
until the dilution 10
than the wild-type (Fig. 14B). After 1 h, only 20% of ∆clpX and ∆clpP cells survived 
compared to 70% for the parental strain. The ratio remained constant over a time period of 3 
hours.  
-4 whereas ∆clpP displayed a decrease in resistance of about 3-log with 
colonies observed until 10-1
 
 dilution (Fig. 15). 
 
 
Finally, wild-type, ∆clpX and ∆clpP strains were subjected to acidic stress. Cells were 
incubated at pH 5.0 and pH 6.0 in PBS. No significant differences were observed compared to 
the wild-type strain (data not shown). 
3.4.3. Antibiotic resistance 
Penicillin is typically used to treat infections caused by S. pyogenes such as 
pharyngitis, necrotisis fasciitis and toxic shock syndrome [141]. In order to determine the role 
of ClpX and ClpP in penicillin resistance, the deficient strains were incubated for 2 h with a 
lethal concentration of penicillin (Fig. 16). ∆clpX and ∆clpP mutants were 10 times more 
resistant than the wild-type strain.  
 
In conclusion, ClpX and ClpP are required for S. pyogenes to tolerate oxidative stress 
whereas they negatively regulate penicillin-mediated killing and resistance to heat-shock. 
Additionally, ClpP is necessary for resistance of S. pyogenes to high salt concentration. 
 
Fig. 15. ClpP but not ClpX is involved in 
the resistance to salt stress. Wild-type 
(WT), ∆clpX and ∆clpP were cultivated in 
THY medium at 37°C, 5% CO2 until 
stationary phase. Serial dilutions were 
spotted onto a 0.65 M NaCl blood plate. 
After 24 h of growth at 37°C 5% CO2 plate 
was scanned. The experiment was performed 
three times independently. A representative 
result is shown. 
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3.5. 
The enhanced aggregation observed in ∆clpX and ∆clpP mutants suggested a possible 
role of ClpX and ClpP in adhesion of S. pyogenes to epithelial cells. Interactions of wild-type, 
∆clpX and ∆clpP strains with monolayers of human pharyngeal epithelial cells were analyzed 
(Fig. 17). With the mutant strains, a 2-fold increase of bacteria adhering to epithelial cells was 
observed after 30 min incubation, when compared to wild-type.  
Adhesion to epithelial cells 
In addition, we analyzed the internalization by epithelial cells of the clpX- and clpP-
deficient strains compared to the wild-type strain. Epithelial cells were incubated with ∆clpX, 
∆clpP or wild-type strains for 1 h and treated with penicillin to kill the external remaining 
bacteria. However, as the ∆clpX and ∆clpP strains are more resistant to penicillin than the 
wild-type, our results were compromised.  
 
 
Fig. 16. clpX and clpP are involved in 
resistance to penicillin. Wild-type (WT), 
∆clpX and ∆clpP strains were cultivated in 
THY medium at 37°C, 5% CO2 until early 
stationary phase. 60 ng/ml final 
concentration of penicillin was added to the 
culture. After 2 hours incubation, cells were 
washed. Survival was determined by plating 
dilution series onto TSA blood in triplicates. 
The values shown are mean survival 
percentages ± SD. The experiment was 
performed three times independently. A 
representative result is shown.  
 
Fig. 17. Deletion of clpX and clpP 
enhances the adhesion of S. pyogenes to 
epithelial cells. Wild-type (WT), ∆clpX and 
∆clpP strains were grown until early 
stationary phase. Hep-2 II cells were 
infected with the GAS strains at a MOI of 5 
in triplicates. After 30 min of incubation, 
epithelial cells were washed with PBS and 
adherent bacteria were retrieved. Survival 
was determined by plating dilution series 
onto TSA blood in triplicates. The values 
shown are mean survival percentages ± SD. 
The experiment was performed three times 
independently. A representative result is 
shown.  
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3.6. 
The increased adhesion of ∆clpX and ∆clpP cells to epithelial cells indicated that ClpX 
and ClpP are involved in regulation of virulence factor expression. Consequently, the 
virulence factor expression pattern of ∆clpX and ∆clpP strains was analyzed. Exoproteins 
from S. pyogenes cultures at different time points during growth were prepared and analyzed 
by SDS-PAGE (Fig. 18). Striking differences in the exoprotein pattern between the wild-type 
and mutants were revealed throughout the growth. Six proteins displaying a different 
expression pattern in ∆clpX and ∆clpP mutants were extracted from the gel and analyzed by 
mass spectrometry. Five proteins were identified as M protein, streptokinase A (Ska), 
streptococcal inhibitor of complement (Sic), cysteine protease SpeB and superantigen SpeC. 
M protein, Ska and Sic amounts were enhanced in ∆clpX and ∆clpP mutants whereas SpeB 
and SpeC expression was reduced.  
Exoprotein expression 
 
 
Fig. 18. Exoprotein expression pattern of clpX- and clpP-deficient strains. Wild-type (WT), ∆clpX, ∆clpP 
and control wild-type (WTts) exoproteins were harvested during growth: EL (early-log), ML (mid-log), LL (late-
log) and ES (early-stationary). Proteins were separated on a gradient (8-18%) SDS PAGE and were detected 
with colloidal comassie staining. The black boxes represent the proteins sent for identification by mass 
spectroscopy. (1) M protein, (2) Ska, (3 & 5) SpeB, (4) Sic and (6) SpeC were identified. The sizes of the ladder 
are indicated in kDa.  
To verify the observed influence of ClpX and ClpP on virulence factor expression, 
western blot analysis using specific antibodies against M protein, Ska, Sic and SpeB were 
performed (Fig. 19). The results confirmed the mass spectrometry outcome. The expression of 
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M protein and Sic was constitutively up-regulated throughout growth. However, while Sic 
was not anymore expressed in the wild-type grown to late-log and early-stationary phase, its 
expression remained constant in the clpX- and clpP-deficient strains suggesting an increased 
stability in the mutants. In the case of SpeB, there was a total absence of expression in ∆clpP, 
whereas in ∆clpX, SpeB was expressed but not processed to its 28 kDa mature form. In 
conclusion, ClpX and ClpP are involved in the regulation of expression of SpeB, M protein, 
Ska and Sic but also in the maturation of SpeB.  
 
 
Fig. 19. Virulence factor expression analysis by Western blot. Western blot analysis of wild-type, ∆clpX, 
∆clpP and control wild-type (WTts) exoproteins harvested during growth: EL (early-log), ML (mid-log), LL 
(late-log) and ES (early-stationary). 5 µg of exoproteins were loaded on a 10% SDS-PAGE. Additionally, equal 
loading was determined by ponceau staining of the membrane. Proteins were detected with specific antibodies 
against SpeB, Ska, Sic and M protein. Sizes are indicated in kDa.  
3.7. 
In order to determine if ClpP and ClpX act at the transcriptional level, expression of 
the main streptococcal virulence genes was studied by Northern blot analysis. Interestingly 
the gene expression profile was similar to the previously observed exoprotein profile (Fig. 
20). An increased expression of the genes coding for Ska (ska), M protein (emm) and Sic (sic) 
was observed in the clpX- and clpP-deficient strains. The expression of SpeB encoding gene 
(speB), was clearly reduced in ∆clpX and abolished in ∆clpP. Morever the expression of sagA 
coding for Streptolysin S, slo coding for Steptolysin O and speC coding for Superantigen C 
was diminished in ∆clpX and ∆clpP mutants compared to the parental strain. In conclusion, 
ClpX and ClpP down-regulate the expression of emm, ska and sic and upregulate the 
Transcriptional regulation 
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expression of slo, sls, speC and speB. This result illustrates that ClpX and ClpP regulate GAS 
virulence factor expression at the transcriptional level.  
 
 
Fig. 20. Transcriptional analysis of S. pyogenes virulence factor expression. Northern blot analysis of wild-
type (WT), ∆clpX, ∆clpP and control wild-type (WTts) total RNA harvested during growth: LAG (lag-phase), 
EL (early-log), ML (mid-log), LL (late-log) and ES (early-stationary). Transcripts were detected using gene 
specific PCR generated probes labeled with α-32
3.8. 
P-dATP. speB, slo, sls and speC expression is down-regulated in 
the mutants whereas ska, sic and emm expression is up-regulated. 16S rRNA was used as a loading control.  
RopB is the main regulator of speB expression [265, 269]. rgg, the gene coding for RopB, 
is located adjacent to speB on the chromosome. As the expression of speB was diminished in 
the ∆clpX mutant and abolished in the ∆clpP mutant, the expression of rgg was examined. 
The mapping of the rgg promoter region by primer extension revealed 2 distinct promoters at 
-114 nt (P
Regulator expression 
1) and -922 nt (P2) upstream the start of translation (Fig. 21) (unpublished data). 
Accordingly, rgg was expressed as two independent transcripts of approximately 1000 nt and 
1800 nt, respectively (Fig. 22). Analyzing the expression of rgg throughout the growth, it 
appeared that during exponential phase, rgg was expressed via the promoter P2. Then, later in 
the exponential phase, a switch of expression from P2 to P1 occurred leading to an expression 
via P1 during stationary phase. In ∆clpX and ∆clpP, rgg expression from P2 continued to late 
exponential phase and an abolition of rgg expression from P1 was observed in late 
exponential and stationary phase.  
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Fig. 21. Genomic organisation of the speB-ropB intergenic region. The promoter regions of ropB (P1 and P2) 
located by primer extension are indicated in blue. The promoter regions of speB (Pa and Pb) are highlighted in 
green [269] 
 
To determine whether only rgg was affected by ClpX and ClpP, other streptococcal 
regulators were examined by Northern blot. First, the expression of genes encoding three 
other stand-alone regulators, mga, nra and rofA, did not seem to be affected by the deletion of 
clpX or clpP. Other regulators such as CodY, PerR, MtsR, MalR or SigX were studied and no 
difference in expression of the corresponding genes was observed (data not shown). However, 
ClpX and ClpP affected the expression of covR and fasA encoding the response regulators of 
the two-component systems CovRS and FasBCAX, respectively as well as the expression of 
fasX, a small non coding RNA regulating expression of the FasBCA operon (Fig. 22). In fact, 
the expression of covR, fasA and fasX was decreased in ∆clpX and ∆clpP mutants compared 
to the wild-type. To conclude, ClpX and ClpP positively regulate in vivo the expression of the 
transcriptional regulator RopB and the two-component systems, CovRS and FasBCAX.  
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Fig. 22. Transcriptional analysis of S. pyogenes virulence regulator expression. Northern blot analysis of  
wild type (WT), ∆clpX, ∆clpP and control wild type (WTts) total RNA harvested during growth: LAG (lag 
phase), EL (early-log), ML (mid-log), LL (late-log) and ES (early-stationary). Transcripts were detected using 
gene specific PCR generated probe labeled with α-32
4. Analysis of clpE-deficient strain 
P-dATP.  Expression of ropB, covR, fasA and fasX is down-
regulated in the mutants. 16S rRNA was used as a loading control. Size are indicated in nt 
4.1. 
Since clpX- and clpP-deficient strains exhibited a delay of growth most probably due 
to a longer lag-phase, it was interesting to study the growth of the clpE-deficient strain. The 
growth was monitored in rich medium at 37°C, 5% CO
Growth 
2
 
. Interestingly, ∆clpE displayed the 
same growth as the wild-type and complemented strain (Fig. 23). Therefore, we conclude that 
ClpE is not involved in the growth of S. pyogenes. 
 
Fig. 23. Growth of clpE-deficient strain. 
Strains of wild-type (WT), ∆clpE and ∆clpE 
complemented with clpE in trans were cultivated 
in THY at 37°C, 5% CO2. Culture density was 
measured regularly at OD620 nnm. The experiment 
was performed three times independently. A 
representative result is shown.  
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4.2. 
The ability of ∆clpE mutant to form biofilm in rich medium on polystyrene plastic 
plates was monitored after 24 h. Whereas ∆clpX and ∆clpP formed more biofilm than the 
wild-type strain, ∆clpE produced twice less biofilm compared to the parental or the 
complemented mutant (Fig. 24). Thus, ClpE is involved in the formation of S. pyogenes 
biofilm, however its role is reverse to that of ClpP and ClpX. 
Biofilm formation 
 
 
4.3. 
As biofilm formation linked to cell to cell aggregation, the sedimentation rate of wild-
type, ∆ clpE and ∆ clpE complemented strain was examined. ∆clpE aggregated with slightly 
slower rate compared to the wild-type (Fig. 25). 
Aggregation 
 
 
Fig. 24. ClpE is involved in biofilm formation. 
Strains of wild-type (WT), ∆clpE and ∆clpE 
complemented with clpE in trans were cultivated 
in triplicates for 24 h in C-medium at 37°C, 5% 
CO2. After washing with PBS, attached cells 
were dyed with 0.2% crystal violet. Cells were 
then retrieved with 1% SDS solution and cell 
density was determined at OD540 nm. The values 
shown are the average of three inocula ± SD. A 
representative result is shown. 
 
Fig. 25. Deletion of clpE affect 
streptococcal aggregation. Strains of 
wild-type (WT), ∆clpE and ∆clpE 
complemented with clpE in trans were 
cultivated over-night in THY medium at 
37°C with shaking. Cultures were kept 
standing. Cell density of the upper phase 
of culture was determined at OD620 nm. The 
experiment was performed three times 
independently. A representative result is 
shown. 
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4.4. 
4.4.1. Lethal temperature 
Survival under critical conditions 
In other Gram-positive bacteria, the main role of the ClpATPase ClpE was to respond 
to heat-shock [82, 104]. Here, tolerance to lethal temperature was assessed by exposure of the 
wild-type, the ∆clpE mutant and the complemented mutant at 44°C. After an hour at this 
temperature, the wild-type surprisingly grew reaching the double amount of cells. This could 
be explained by the fact that the volume of culture was bigger than for the experiment using 
∆clpX and ∆clpP therefore a longer time was needed for the media to acquire the desired 
temperature. However, after 2 h of heat-shock, 80% of the wild-type strain survived compared 
to only 50% of the ∆clpE strain (Fig. 26). A similar ratio was observed after 3 h. Thus, ClpE 
plays a positive role in the resistance to lethal temperature.  
 
 
Fig. 26. ClpE is involved in the resistance to lethal temperature. Strains of wild-type (WT), ∆clpE and ∆clpE 
complemented with clpE in trans were cultivated in THY at 37°C, 5% CO2
4.4.2. Oxidative stress 
. At mid-log phase, culture 
temperature was shifted to 44°C. Aliquots were collected every hour and colony forming units (cfu) / ml were 
determined by plating dilution series onto TSA blood in triplicates. The values shown are mean survival 
percentages ± SD. A representative result is shown.  
Knowing that ∆clpX and ∆clpP were more sensitive to oxidative stress, the survival of 
∆clpE after H2O2 exposure was examined. As shown in Fig. 27, no significant differences in 
survival between wild-type strain and ∆ clpE mutant were observed. Consequently, it appears 
that ClpX and ClpP but not ClpE are involved in the response to oxidative stress. 
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Fig. 27. ClpE is not involved in the response to oxidative stress. Strains of wild-type (WT), ∆clpE and ∆clpE 
complemented with clpE in trans were cultivated in THY medium  at 37°C, 5% CO2. At mid-log phase, 4 mM 
H2O2
4.5. 
 were added to the culture. Aliquots were collected every hour and the ratio of colony forming unit (cfu) / 
ml was determined by plating dilution series onto TSA blood in triplicates. The values shown are mean survival 
percentages ± SD. A representative result is shown.  
To assess the role of ClpE in the regulation of virulence, the exoprotein expression 
pattern of the wild type and ∆clpE strains were compared by SDS-PAGE. No obvious 
differences were observed between the respective exoprotein patterns (data not shown).  
Exoprotein expression 
To confirm the absence of differences in exoprotein expression between wild-type and 
∆clpE strain, the expression of some key virulence factors: SpeB, M protein, Sic and Ska, was 
studied by western blot analysis. Interestingly, some differences were observed. Ska was more 
expressed in the clpE-deficient strain compared to the wild-type but this increase of 
expression was lower than the one observed in ∆clpX and ∆ clpP strains. In the case of M 
protein, its expression was increased at comparable level in the three ∆clp-deficient strains 
compared to the wild-type (Fig. 28).  However, no differences were observed between ∆clpE 
and wild-type for the expression of SpeB and Sic. In conclusion, ClpE is involved in the 
regulation of expression of Ska and M protein but not of SpeB and Sic. 
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Fig. 28. Virulence factor expression. Western blot analysis of wild-type, ∆clpX, ∆clpE and ∆clpP exoproteins 
harvested during growth: EL (early-log), ML (mid-log), LL (late-log) and ES (early-stationary). 5 µg of 
exoproteins were loaded on a 10% SDS-PAGE. Additionally, equal loading was determined by ponceau staining 
of the membrane. Proteins were detected with specific antibodies against SpeB, Ska, Sic and M protein. Sizes are 
indicated in kDa.  
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 Discussion 
Proteolysis is required in the cell for the natural turn-over of cytosolic proteins as well 
as in the regulation of metabolic pathways. Various studies have also shown that proteolysis 
plays an important role in the regulation of virulence. In Gram-positive bacteria, Clp 
proteolytic complexes are involved in pathogenicity by degrading misfolded proteins 
accumulating upon stress conditions that occurr during infection. They also regulate the 
expression of key virulence factors by interfering with their regulators [99, 101, 109, 114, 
121]. The goal of our study was to determine the role of Clp-mediated proteolysis in the 
human pathogen S. pyogenes, agent of pharyngitis and life threatening diseases such as flesh 
eating disease and toxic shock syndrome. To assess this question, we performed in-frame 
deletion mutants of each clp gene involved in proteolysis, the Clp ATPase encoding genes 
clpX, clpE and clpC and the protease encoding gene clpP. Following extensive phenotypic 
analysis we were able to show that in S. pyogenes, Clp-mediated proteolysis is involved in 
cell morphology, biofilm formation, response to various stresses encountered during infection 
such as heat-shock, oxidative stress and osmotic stress, resistance to penicillin and adhesion to 
epithelial cells. Moreover, we showed that Clp proteins are involved in the transcriptional 
regulation of key streptococcal virulence factors interfering with the expression of the 
transcriptional regulator RopB, the regulator fasX RNA and regulators CovR and FasA. 
1. Clp gene organization 
In order to perform in-frame clp gene deletion in S. pyogenes, we analyzed the genetic 
organization of the clpX clpE, clpC and clpP loci in this pathogen’s genome, predicting the 
promoter region, the terminator and various transcriptional regulator binding motifs. We 
could predict the presence of two distinct promoters P1 and P2 located upstream of clpP, 
respectively at -921 nt and -119 nt from the start of translation, suggesting that clpP can be 
transcribed as a mono-cistronic transcript as well as a bi-cistronic transcript including upp, a 
gene coding for an uracil phosphoribosyltransferase, located downstream of clpP (Fig. 4B). 
This genetic organization is similar to that observed in S. mutans [324]. Northern blot 
analyses confirmed that clpP is constitutively expressed as both mono- and bi-cistronic 
transcripts, however, an increase of mono-cistronic expression during late-exponential phase 
was observed (Fig. 6). Interestingly, during heat-shock, we observed an induction of 
expression of clpP after 15 min from the promoter P2 suggesting that the regulation of clpP 
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expression occurs at the level of the mono-cistronic transcript (Fig. 7). Upstream of the 
promoter P2, we located a CtsR-binding site consistent with the fact that in other Gram-
positive organisms, clpP is regulated by the transcriptional repressor CtsR. However, no CtsR 
binding sites were identified upstream of the promoter P1 (Fig. 4B). Together our data 
indicate that the induced expression of the clpP mono-cistronic transcript observed upon heat-
shock or at the entry to stationary phase is regulated by CtsR. Thus, clpP but not upp is part of 
the CtsR regulon. In addition, the presence of a weak transcriptional terminator downstream 
of upp suggests that upp can as well be expressed on its own. Nevertheless, it is surprising to 
see, that co-transcription of clpP with upp, encoding an uracil phosphoribosyl transferase, an 
enzyme involved in S. mutans in the microbial pyrimidine salvage pathway, is observed in all 
streptococci. This enzyme catalyzes the conversion of uracil and 5-phosphoribosyl-α-1-
pyrophosphate to UMP and pyrophosphate. Co-transcription of clpP and upp suggests a link 
between ClpP-mediated proteolysis and nucleotide biosynthesis pathway which might be 
important during infection where nucleotide starvation can occur. Further experiments are 
required to determine the link between ClpP proteolysis and upp.  
In the case of clpX, our predictions led to the identification of one promoter region 
upstream of clpX and a weak terminator downstream of the clpX transcript (Fig. 4C). 
However, the ribosome binding site of yihA, gene coding for a GTP binding protein 
orthologue of engB or ysxC, located downstream of clpX is overlapping the 3’end of the clpX 
transcript, suggesting that these two genes are expressed in an operon. Northern blot analysis 
revealed the presence of 2 distinct transcripts matching with the 2 different terminators of 
transcription: downstream of clpX and downstream of yihA indicating that clpX is expressed 
both as mono- and bi-cistronic transcripts (Fig. 7). The co-organization of clpX and yihA is 
conserved in S. aureus, S. pneumoniae, S. mutans and S. pyogenes and it was already shown 
that clpX and ysxC are expressed in an operon in S. aureus (Fig. 5)[83]. YihA or YsxB, which 
have been reported to be essential in B. subtilis, E. coli, S. pneumoniae and S. aureus, are 
involved in bacterial growth and cell division. It is required for the biogenesis of the large 
ribosomal subunit 50S [320-321, 327-329]. Noteworthly, our efforts to generate a yihA 
deficient strain in S. pyogenes remained unsuccessful most likely indicating that YihA is also 
essential in S. pyogenes. Interestingly in E. coli, YihA is expressed in an operon with Lon, 
another cytosolic protease related to Clp proteins [330]. This would suggest that proteolysis is 
involved in YihA regulation and that ClpX mediates this function in S. pyogenes.  
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2. Heat regulation of clp genes 
Our results show that upon exposure to high temperature, clpP was overexpressed already 
after 15 min whereas an increased expression of clpX was only observed after 30 min. 
Consequently, clpX cannot be characterized as a classical heat-shock gene due to the delayed 
response upon heat-shock. Moreover, we indentified a CtsR-binding site in the promoter of 
clpP, clpE and clpC operon suggesting that in S. pyogenes as in all the Gram-positive studied 
so far, ClpP, ClpE, ClpC and CtsR expression is under the control of the negative 
transcriptional regulator CtsR. However, no CtsR-binding site was found in the vicinity of the 
clpX promoter consistent with the observation made in other Gram-positive organisms that 
ClpX is not part of the CtsR regulon and therefore its expression is not influenced by heat. In 
the model organism B. subtilis, CtsR has been shown to be regulated by ClpCP-mediated 
proteolysis with the help of the adaptor protein MscB, which gene is part of the clpC operon 
[96]. However in S. pyogenes, like in S. pneumoniae and S. mutans, the clpC operon is only 
composed of ctsR and clpC and neither mscB nor mcsA homologues could be identified in the 
genome. This indicates that in Streptococci, the regulation of CtsR is still probably involving 
the ClpCP complex, but with a different adaptor protein, which remains to be identified. 
Alternatively, CtsR could be regulated by a completely different mechanism.  
3. Clp proteins are required for cell division 
To study the role of Clp proteins in the pathogenicity of S. pyogenes, we engineered 
clp-deficient mutants in the M1 serotype clinical isolate, SF370, the complete genome of 
which is publicly avalaible. Interestingly, the clpX- and clpP-deficient strains exhibited a 
slight delay of growth of approximately 1 h and 2 h, respectively and they reached a lower 
cell density at stationary phase compared to the wild-type strain. This observation was already 
made for clpP-deficient strains in the Gram-positive bacteria B. subtilis, L. monocytogenes, S. 
aureus, S. pneumonia and S. mutans and for the clpX-deficient strain in S. mutans, where 
another protease, the Lon protease is missing [91, 99, 101, 105, 115, 123]. However, in Gram-
negative bacteria such as E. coli and S. typhimurium, where the Lon protease is present, no clp 
mutants exhibited a delay in growth [331-332]. Thus, in the absence of Lon and Clp-mediated 
proteolysis, the accumulation of misfolded proteins and aggregates may be too significant for 
the cells to replicate at their native pace [102]. In our case, the amount of bacteria showed that 
the generation times of the mutants were not reduced, however they started replicating 1 h 
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after transferring the cells to the new medium. This prolonged lag phase could be explained 
by a delayed adaptation to the new medium after inoculation. Moreover, at stationary phase 
we observed a lower density of cells but the bacterial count was similar comparing mutant and 
wild-type stains, thus suggesting a reduction in cell size of the mutants. In fact, electron 
microscopy studies of clpP and clpX mutant strains revealed that both strains exhibited 
smaller cells than the wild-type (Fig. 12). This result is consistent with the finding that in S. 
aureus, the clpP-deficient strain is 0.8 times smaller than the wild-type [115]. Furthermore, 
microscopic studies revealed that the streptococcal chain morphology was affected in the 
mutants. Indeed, the clpP mutant chains showed a defect in cell division whereas the clpX 
mutant chains were longer compared to the wild-type with an increased aggregation of these 
chains. In the case of the clpX mutant, this phenotype is consistent with phenotypes observed 
in B. subtilis clpP mutant and S. pneumoniae clpC mutant, which exhibit longer chains due to 
a defect in cell dissociation explained by a decreased level of autolysin [97, 103, 121]. 
Morever, clpX- and clpP-deficient strains displayed a reduced expression of ropB, which 
positively regulates autolysin expression [273]. Therefore, ClpX and ClpP may also be 
involved in the activation of autolysin in S. pyogenes. The case of ClpP is more complicated 
as the clpP mutant cells appeared to be affected in cell division. The first hypothesis will be 
that due to an abnormal accumulation of misfolded proteins and aggregates, cells are not fit to 
divide. However, studies showed that Clp-mediated proteolysis is directly involved in the 
regulation of cell cycle. For example, in E. coli, the ClpXP complex is responsible for the 
degradation of the cytosqueletal protein FtsZ promoting the septum formation and in L. 
monocytogenes, ClpC and ClpE are required for the septum formation [104, 333]. A recent 
study performed in our lab revealed that in L. monocytogenes, the ClpCP complex degrades in 
vivo the chromosome segregating factor ParB (Spiess, 2010 in press). Moreover, clpX is 
expressed in an operon with YihA, a protein required for cell division [320]. Our results bring 
striking evidences that in S. pyogenes, ClpP-mediated proteolysis is required for the 
regulation of the cell cycle but the role of each ATPase in this process remains unclear. 
4. Clp proteolysis regulates cell to cell aggregation 
Our results show that the ClpXP complex inhibits the formation of biofilms and reduces 
cell to cell aggregation. On the other hand, the chaperone ClpE promotes biofilm formation 
and cell aggregation which is consistent with findings obtained in S. mutans and indicates a 
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conserved role for Clp proteins in aggregation and biofilm formation in Streptococci [91, 
105]. However, we believe that the variations in biofilm formation in the mutants are due to 
differences in cell to cell aggregation, therefore the role of ClpX, ClpP and ClpE on biofilm 
formation may only be indirect. The fact that the clpP- and clpX-deficient strains exhibit a 
defect in cell division and chain formation could partly explain the increase in bacterial 
aggregation, though other factors involved in adhesion could be assumed to participate in 
these phenotypes as well. Only recently, S. pyogenes was found to produce pili-like structures 
at its surface, involved in cell to cell aggregation, biofilm formation and adhesion to epithelial 
cells [154, 197]. Chaperone proteins such as GroEL participate in the pili assembly therefore 
the chaperone activity of ClpE may be involved in the pilus assembly in S. pyogenes [334]. 
On the other hand, ClpXP mediated degradation would inhibit pili formation. The second 
interesting factor is the hyaluronic acid capsule involved in cell to cell interaction and in the 
binding to epithelial cells. In S. pneumoniae, an increased expression in the capsule genes in 
the clpP mutant was observed [87]. In S. pyogenes, the expression of the has operon, 
responsible for the hyaluronic acid synthesis, is repressed at the transcriptional level by CovR, 
the effector of the two-component system CovR/CovS. In our clpP- and clpX-deficient 
strains, the expression of CovR is visibly reduced, suggesting an augmentation of hyaluronic 
acid production [181, 183-186]. A thickening of the capsule could explain the increase of cell 
aggregation, the increase in interaction with epithelial cells, the increased resistance to 
penicilin and the defect in transformation observed in the clpX and clpP mutants. 
Consequently, in S. pyogenes the ClpXP complex would activate the expression of CovRS 
leading to the repression of capsule expression (Fig. 29). 
5. Clp proteolysis and stress response 
Stress conditions lead to an increase of misfolded proteins and aggregates, which need to 
be proteolyzed in order for the bacteria to survive the encountered stresses. Therefore 
proteolysis is required for survival upon stresses. In Gram-positive bacteria, Clp-mediated 
protolysis was shown to be involved in the response to heat-shock, suboptimal temperature 
exposure, oxidative, osmotic and acidic stress (Cf. Introduction Table 3). Here, our data show 
that ClpP and ClpX are required to survive oxidative stress in S. pyogenes. The fact that the 
clpE-deficient strain showed no difference in survival upon H2O2 treatment compared to the 
wild-type emphasizes the observation that ClpX in association with ClpP are required to 
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survive oxidative stress in S. pyogenes. Interestingly, Spx, a transcriptional regulator of 
oxidative response genes, was found to be a substrate of the ClpXP machinery in B. subtilis 
and S. mutans [55, 71, 105]. Two homologues of Spx were identified in the genome of S. 
pyogenes, Spy_1249 and Spy_2115, indicating that they could be potential substrates of the 
ClpXP complex linking ClpXP with the response to oxidative stress. In S. aureus, the 
resistance to oxidative stress and osmotic stress is carried out by the ClpXP complex [83]. 
However, in the case of S. pyogenes, ClpP but not ClpX appears to be involved in the 
response to high salt concentration exposure. Therefore we can presume that in S. pyogenes, 
another ATPase than ClpX is associated with ClpP as previously observed in L. 
monocytogenes, where ClpC and ClpP are required for the response to osmotic stress [99, 
104, 111]. Our phenotypic analyses reveal that the clpP and clpX mutants are more resistant to 
lethal temperature than the wild-type strain. In the case of ClpX, this phenotype was already 
observed in S. aureus [83, 101]. As previously mentioned, ClpX is not part of the CtsR 
regulon and its expression is not regulated by heat therefore it is not surprising that ClpX is 
not involved in the heat-shock response in S. pyogenes. However, ClpP of Gram-positive 
bacteria is known to be regulated by CtsR and its expression is activated after heat stress. 
Moreover, in other Gram-positive organisms including L. monocytogenes, S. aureus, S. 
pneumoniae and S. mutans, ClpP was systematically shown to be involved in heat-shock 
response. Therefore, our result is not consistent with the previously reported requirement of 
ClpP during heat-shock in other Gram-positive bacteria. However, the reduced expression of 
the transcriptional regulator RopB in the clpP mutant could be an explanation. Indeed, the 
streptococcal ropB-deficient strain was associated with an increase in resistance to high 
temperature and an activation of clpE expression [272]. ClpE, which is tightly regulated by 
CtsR, is required for resistance to heat-shock in L. monocytogenes and S. pneumoniae. Our 
experiments show that ClpE is also required for S. pyogenes to resist to lethal temperature [88, 
104]. Therefore, the increased tolerance to heat of the clpP-deficient strain could be explained 
by a decreased expression of RopB leading to an overexpression of ClpE. Finally, we 
observed that clpX- and clpP-deficient strains are more resistant to penicillin than the wild-
type. As previously mentioned, the putative increase in capsule production in the mutants 
could explain the increased resistance to penicillin of the mutants. Furthermore, RopB 
contributes to the penicillin mediated killing in S. pyogenes, suggesting that a reduced 
expression of ropB observed in the mutants could confer an increased resistance to penicillin 
[275]. 
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6. Clp involved in regulation of virulence 
One of the aims of our study was to determine the impact of the Clp-mediated proteolysis 
on the virulence of S. pyogenes. The observation that clpX and clpP mutants display an 
increase in cell aggregation led us to hypothesize that ClpX and ClpP were involved in the 
regulation of adherence of S. pyogenes. Adhesion assays to laryngeal epithelial cells showed 
that the clpX and clpP mutants adhere better to epithelial cells compared to the wild-type. 
This could be explained by an increase in cell to cell aggregation observed in the mutants and 
the putative thickening of the capsule. However, we cannot exclude that an overexpression of 
other adhesins or fibronectin-binding proteins is responsible for the increased streptococcal 
adherence in the clp mutants. To determine the impact of ClpE, ClpX and ClpP on virulence 
factor expression, we compared the exoprotein expression profile of the three clp-deficient 
strains with the wild-type. Mass spectrometry analyses confirmed by Western blot revealed an 
overexpression of M protein, Ska, Sic and a repression of SpeB expression in the clpX- and 
clpP-deficient mutants compared to the wild-type (Fig. 18-19). In the case of M protein and 
Ska, we observed a constant increase of expression throughout the growth of the mutants. 
This indicates that ClpX and ClpP negatively regulate the expression of M protein and Ska. 
The expression of Sic in the mutants was slightly different as in late-exponential and 
stationary phase, Sic amounts faded away in the wild-type but remained equal in the mutants. 
At the RNA level, sic was overexpressed in both mutants during exponential phase but not at 
early-stationary phase indicating an enhanced protein stability of Sic in the mutants during 
stationary phase. Consequently, Sic could be a substrate for the ClpXP proteolytic complex 
explaining its increased stability in the mutants. The expression of SpeB in the clpX and clpP 
mutants was reduced indicating that ClpX and ClpP positively regulate SpeB expression. 
However we observed a discrepancy in phenotypes comparing the two mutant strains. In fact, 
in the clpP mutant the expression of SpeB was totally abolished whereas in the clpX-deficient 
strain, the expression of SpeB was delayed. In addition, while SpeB was cleaved into its 
mature form in the wild-type, the clpX mutant exhibited only the zymogen form of 40 kDa 
suggesting a defect in SpeB expression and maturation. The maturation of SpeB involves 
SpeB itself and the cell wall-associated protease HtrA [196, 223]. Therefore, ClpX and ClpP 
may be involved in the proper folding of SpeB and/or in the regulation of HtrA expression. 
The weaker phenotype observed in ∆clpX suggests that ClpP activates SpeB expression in 
association with ClpX but as well with another ATPase. The absence of phenotype 
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concerning SpeB production in the clpE deficient strain suggests that ClpC might be the other 
Clp ATPase that plays a role in this regulation.  
After concluding that ClpX and ClpP are involved in the regulation of major streptococcal 
virulence factors expression we were interested in determining the level of regulation. 
Northern blot analysis revealed that ClpX and ClpP act already at the transcriptional level as 
the RNA level is consistent with the protein level observed in Western blot (Fig. 20). We 
observed an increased expression of the M protein encoding gene, emm, sic and ska and a 
decreased expression of speB as well as the streptolysin encoding genes, sls and slo and the 
superantigen encoding gene speC. In the clpP mutant, the expression of speB was totally 
abolished revealing that ClpP-mediated proteolysis is required for speB expression. We can 
conclude that ClpX and ClpP are involved in the inhibition of emm, ska and sic expression 
and the activation of speB, sls, slo and spec expression. Similarly to the activation of 
streptolysin expression, ClpP was shown to participate in the activation of the listeriolysin O 
encoding gene, llo in L. monocytogenes suggesting that ClpP contributes to the escape of the 
host immune response in both pathogens [99]. Interestingly, M protein, Ska and Sic are 
virulence factors involved in the colonization of the host therefore expressed early during 
infection whereas SpeB, SpeC and Streptolysins S and O are required for the spreading into 
the organism expressed later during the infection [236]. This suggests a growth phase-
dependent regulation of virulence factor expression by the ClpXP proteolytic complex. In E. 
coli, the ClpXP complex is involved in the regulation of the sigma factor σs and in B. subtilis, 
ClpX degrades RsiW the negative regulator of the sigma factor σw
 
 [48, 50]. In S. aureus, the 
coordination of growth phase-dependent expression is mediated by the agr locus and the 
ClpXP complex was shown to activate agr expression [119]. In the absence of Sigma factors 
in S. pyogenes, the growth phase-dependent gene regulation is carried out by stand-alone 
transcriptional regulators such as Mga, RofA and RopB, which respond to environmental 
signals [236]. Therefore we can speculate that in S. pyogenes, the ClpXP proteolytic complex 
influences these regulators. In the absence of specific antibodies directed against Mga, RofA, 
Nra and RopB, we analyzed the RNA level of these regulators in the wild-type, clpX- and 
clpP-deficient strains. No differences were observed for mga, rofA and nra while the 
expression of ropB was decreased in the mutants. Consequently, ClpX and ClpP interfere with 
RopB expression known to be the regulator of the entry into stationary phase [236].  
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Fig. 29. Model of the impact of ClpXP-mediated proteolysis in S. pyogenes. 
 
RopB is the main activator of SpeB transcription, which would explain the reduction and 
absence of SpeB expression in the clpX and clpP mutants, respectively [265, 269]. In 
addition, RopB represses genes necessary for colonization by inhibiting the expression of mga 
and its regulon in the entry of stationary phase [239]. emm, sic, and ska are part of the mga 
regulon, thus their increased expression in the mutants could be explained by the decrease in 
ropB expression. However, no striking differences in mga expression were observed in the 
mutants. It is possible that the increased expression of mga was not visible in our Northern 
blot or that RopB acts at the translational level. To summarize, the clpP and clpX mutants 
exhibit an increased expression of colonization factors and a decreased expression of 
dissemination factors. Therefore, we could envisage that during infection, both mutants will 
colonize the host, faster and more efficiently than the wild-type however they may not 
managed to spread in the host which at the the end, will make them less virulent than the 
wild-type. In addition to stand-alone regulators, we examined the expression of other 
regulators such as PerR, MalR, CodY and two-component systems effectors and regulators. 
We observed a reduction of transcription of fasA and covR, both encoding effectors of the 
two-component systems FasBCA and CovRS, respectively and fasX a small regulatory RNA 
activating the expression of the FasBCA operon (Fig. 22). Notably, RopB activates the 
expression of CovR and the Fas operon. Therefore, most of the phenotypes we observed in the 
clpP and clpX mutants during our study can be associated with the decrease in ropB 
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expression. RopB regulates autolysin involved in cell segregation, capsule expression 
involved in aggregation and adherence, penicillin resitance and virulence factor expression by 
repressing mga and activating CovRS and FasBCA. In S. aureus, the growth phase-dependent 
gene regulation is mediated by the agr locus composed of RNAII and RNAIII, which are 
divergently transcribed. RNAII encodes a two-component system, which activates the 
expression of RNAIII, which is an activator of virulence factor expression [335]. The ClpXP 
complex was shown to activate transcription of the agr locus [119]. We can conclude that the 
main role of the ClpX and ClpP proteins in S. aureus as well as in S. pyogenes is to promote 
the entry into stationary phase via regulation of agr and ropB, respectively (Fig. 29). The 
simplest hypothesis would be that the ClpXP complex degrades in vivo an inhibitor of RopB 
expression, however, no factor involved in its expression has been identified so far. Finally, 
RopB is expressed from two distinct promoters located in the intergenic region between speB 
and ropB where speB is transcribed in the opposite direction of ropB (Fig. 21). In the wild-
type, at early stages of growth, ropB is expressed from P1 and in the late-exponential/early-
stationary phase, its expression switches to the second promoter. However, in the clpX and 
clpP mutants we observed an increased transcription from the promoter P1 but never from the 
second promoter P2. Previous studies of this region concluded that SpeB is expressed from 
two disctinct promoters Pa and Pb and that RopB binds in the region of the proximal promoter 
of SpeB corresponding to the promoter P1 of ropB. We could hypothesize that a factor is 
responsible for the switch of ropB promoter activity promoting the entry into stationary phase 
and that the ClpXP complex could interfere at this level. Thus, the link between the Clp-
mediated proteolysis and RopB remains unknown and deserves to be investigated in the 
future. 
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7. Conclusion 
 
Fig. 30. Summary of the functions of the ClpXP proteolytic complex in S. pyogenes. 
 
Our study shows that in S. pyogenes, similar to other Gram-positive pathogens, Clp-
mediated proteolysis is required for the survival under various stresses and adaptation to new 
environmental conditions encountered during infection. Moreover, we showed that Clp 
proteolysis is essential for cell separation during cell division. Furthermore, Clp proteins 
respress the expression of virulence factors required for colonization (emm, ska, sic among 
others) and activates the expression virulence factors necessary for the spreading and 
persistence (such as speB, slo, sls)  by activating the expression of their main transcriptional 
regulator, RopB (Fig. 30). The main challenge in the future will be to identify by which 
mechanisms the ClpXP complex activates RopB expression. In parallel, it will be necessary to 
study in more detail, the other Clp proteins associated with proteolysis, ClpC and ClpE, to 
determine their functions in S. pyogenes. Another aspect of research would be to elucidate the 
interactions and mutual modulations within the Clp network. The fact that ClpP is a direct 
target of ADEPs [137], a new class of antibiotics, stresses the importance of understanding 
how the Clp-mediated proteolysis interferes with virulence, to further develop new drugs 
directed especially against multi-resitant Gram-positive pathogens. 
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Appendix 
Table 1: Bacterial strains used in the Clp’s study 
Code Relevant characteristics Source 
 
EC904 
S. pyogenes 
SF370 M1 serotype wild-type ATCC 700294 
   
                 ClpX 
   
EC1463 EC904(pEC272)replicating Clone 3 This study 
EC1468 EC904::pEC272 integrated clone 3.I This study 
EC1469 EC904::pEC272 integrated clone 3.II This study 
EC1470 EC904::pEC272 integrated clone 3.III This study 
EC1488 EC904 ∆clpX clone 3.I.22 This study 
EC1489 EC904 clpX WT clone 3.I.23 This study 
EC1490 EC904 clpX WT clone 3.I.24 This study 
EC1491 EC904 clpX WT clone 3.I.25 This study 
EC1492 EC904 clpX WT clone 3.I.44 This study 
   
                 Spy_0886 
    
EC1464 EC904 (pEC271) replicating clone 3 This study 
EC1465 EC904::pEC271 integrated clone 3.I This study 
EC1466 EC904::pEC271 integrated clone 3.II This study 
EC1467 EC904::pEC271 integrated clone 3.III This study 
EC1493 EC904 Spy_0886  WT clone 3.II.17 This study 
EC1494 EC904 Spy_0886  WT clone 3.II.25 This study 
EC1495 EC904 Spy_0886  WT clone 3.II.30 This study 
EC1496 EC904 Spy_0886  WT clone 3.II.38 This study 
EC1497 EC904 Spy_0886  WT clone 3.II.1 This study 
EC1498 EC904 Spy_0886  WT clone 3.II.18 This study 
EC1499 
 
EC904 Spy_0886  WT clone 3.II.27 This study 
No Spy_0886 clones could be obtained.  
  
                  ClpP 
    
EC1379 EC904 (pEC217) replicating clone A This study 
EC1380 EC904 (pEC217) replicating clone B This study 
EC1381 EC904 (pEC217) replicating clone C This study 
EC1382 EC904::pEC217 integrated clone A.1 This study 
EC1383 EC904::pEC217 integrated clone A.2 This study 
EC1384 EC904::pEC217 integrated clone A.3 This study 
EC1520 EC904 ∆clpP clone A.1.12 This study 
EC1521 EC904 ∆clpP clone A.1.18 This study 
EC1522 EC904 ∆clpP clone A.1.19 This study 
EC1523 EC904 clpP WT clone A.1.1 This study 
EC1524 EC904 clpP WT clone A.1.2 This study 
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                  ClpE 
    
EC1427 EC904 (pEC266) replicating clone A This study 
EC1428 EC904 (pEC266) replicating clone B This study 
EC1429 EC904::pEC266 integrated clone B.1 This study 
EC1430 EC904::pEC266 integrated clone B.2 This study 
EC1431 EC904::pEC266 integrated clone B.3 This study 
EC1435 EC904 ∆clpE clone B.1.8 This study 
EC1445 EC904 ∆clpE clone B.1.2 This study 
EC1446 EC904 ∆clpE clone B.1.9 This study 
EC1447 EC904 clpE WT clone B.1.1 This study 
EC1450 EC1446 (pEC85)  This study 
EC1451 EC1446 (pEC259) This study 
    
                  ClpC 
    
EC1510 EC904 (pEC275) replicating clone B This study 
EC1511 EC904 (pEC275) replicating clone C This study 
EC1512 EC904 (pEC275) replicating clone D This study 
EC1513 EC904 (pEC275) replicating clone E This study 
EC1514 EC904::pEC275 integrated clone D.1 This study 
EC1515 EC904::pEC275 integrated clone D.2 This study 
EC1516 EC904::pEC275 integrated clone D.3 This study 
EC1535 EC904::pEC275 integrated clone C.1 This study 
EC1536 EC904::pEC275 integrated clone C.2 This study 
EC1537 EC904::pEC275 integrated clone C.3 This study 
EC1550 EC904 ∆clpC clone C.1.4 This study 
EC1551 EC904 ∆clpC clone C.1.5 This study 
EC1552 EC904 clpC WT clone C.1.10 This study 
EC1553 EC904 clpC WT clone C.1.6 This study 
 
 
E. coli 
RDN204 Top10 - Host for cloning Lab strains 
EC480 TOP10 (pEC84) Lab strains 
EC1037 TOP10 (pEC85) Lab strains 
EC1046 TOP10 (pMAD) Gift from Debarbouille 
EC1434 TOP10 (pEC214) This study 
    
                     ClpX 
    
EC1460 TOP10 (pEC272) clone 3 This study 
EC1461 TOP10 (pEC272) clone 4 This study 
EC1462 TOP10 (pEC272) clone 7 This study 
   
                 Spy_0886 
    
EC1457 TOP10 (pEC271) clone 3 This study 
EC1458 TOP10 (pEC271) clone 5 This study 
EC1459 TOP10 (pEC271) clone 9 This study 
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                 ClpP 
   
EC1147 TOP10 (pEC206) This study 
EC1157 TOP10 (pEC209) clone 5 This study 
EC1158 TOP10 (pEC209) clone 7 This study 
EC1363 TOP10 (pEC217) This study 
EC1509 TOP10 (pEC260)  
   
                  ClpE 
    
EC1366 TOP10 (pEC252) This study 
EC1367 TOP10 (pEC252) clone15 This study 
EC1368 TOP10 (pEC254) clone14 This study 
EC1422 TOP10 (pEC265) clone 2 This study 
EC1423 TOP10 (pEC265) clone e This study 
EC1424 TOP10 (pEC266) This study 
EC1444 TOP10 (pEC259) This study 
 
                  ClpC 
    
EC1365 TOP10 (pEC253) This study 
EC1432 TOP10 (pEC267) This study 
EC1508 
EC2021 
EC2022 
TOP10 (pEC275) 
TOP10 (pEC401) clone 3 
TOP10 (pEC401) clone 6 
This study 
This study 
This study 
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Table 2: Plasmids used in the Clp’s study 
Plasmid Relevant characteristics Source 
   
pEC81 repAts-pWV01, ermAM/B, ColE1 Lab construct 
pEC84 repAts-pWV01, pJH1-aphIII, ColE1  Lab construct 
pEC85 repDEG-pAMß1, pJH1-aphIII, ColE1  Lab construct 
pEC214 pEC84ΩPclpB-ß-gal This study 
   
                 ClpX 
   
pEC230 pEC214ΩclpXKOdw This study 
pEC231 pEC230ΩclpXKOup This study 
pEC261 pEC85ΩPclpXTT This study 
pEC272 pEC214ΩclpXKO2up-dw This study 
   
                Spy_0886 
   
pEC271 pEC214ΩSpy_0886KOup-dw This study 
   
                 ClpP 
   
pEC206 pEC84ΩclpPKOdw This study 
pEC209 pEC206ΩclpPKOup This study 
pEC217 pEC209Ωßgal This study 
pEC260 pEC85ΩPclpPTT This study 
   
                  ClpE 
   
pEC252 pEC254ΩclpEKOup This study 
pEC254 pUC19ΩclpEKOdw This study 
pEC259 pEC85ΩPclpETT This study 
pEC265 pEC84ΩclpEKOupdw This study 
pEC266 pEC265Ωβgal This study 
   
                 ClpC 
   
pEC253 pUC19ΩclpCKOdw This study 
pEC267 pUC19ΩclpCKOup-aphIII-clpCKOdw This study 
pEC275 
pEC401 
pEC214ΩclpCKO2up-dw 
pEC85ΩP2
This study 
clpCTT This study 
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Table 3: Oligonucleotides used in the Clp study 
 
Oligo  
 
*F/ R 
 
 
Sequence 5’ - 3’ 
 
Characteristics 
    
OLEC644 F ATGCACCTCGAG Bgal from pMad  
TTAGCATATTATGTTGCCAACTG 
OLEC645 R ATGCACCCGCGG
 
GTCTAGTTAATGTGTAACGTAAC 
   
                 ClpX 
    
OLEC1153 F ATGCAGCTGCAG ClpX up fragment 
TAGGACTAATTTCTTTGATATTAAA 
OLEC1154 R CTGTTCATTTTGTGGTAAAAGCCAGTAAGTCACAAAAGTGCGTATCACCAAGG 
OLEC1155 F CCTTGGTGATACGCACTTTTGTGACTTACTGGCTTTTACCACAAAATGAACAG ClpX dw fragment OLEC1156 R ATGCAGGAATTC
OLEC807 
CTATTACGATATCGAACACCAAAA 
F GTATTCACGCCTTCTATG 
PCR, Seq OLEC808 R 
GCCAAATTTTTGCGCCCC 
OLEC809 F CTCAAGAATTGCTAAAACG 
OLEC810 R CGTTCTTTACTACTCAAG 
OLEC847 F TGACTGAAGCAGGGTATG 
SB probe OLEC850 R 
GATCTCCTCGATGCCATC 
OLEC867 R GGAAGTCTTTTGCAATTC 
OLEC868 F TTAAGGAGATGAGTCATG 
OLEC963 F ACTGAGCTGCAG ClpX complementation  
TGAGGAGATGATAAGCGATGCAAC 
OLEC827 R ACTGAGGAATTC
 
GTATTTAAGACTTGTTCTTCAGCCA 
   
                Spy_0886 
    
OLEC1157 F ATGCAGCTGCAGGCAGATGCAACTTCTTTGACTGAAG Spy_0886 up fragment OLEC1158 R TAGATAAATCAACACCTATCGCTATGAACGTCCAGCGAGGGCAATTTC 
OLEC1159 F GAAATTGCCCTCGCTGGACGTTCATAGCGATAGGTGTTGATTTATCTA Spy_0886 dw fragment OLEC1160 R ATGCAGGAATTCGAAGGACAACTAGTGATTAGGCAAAACG 
OLEC1161 F TCAAAACCCGTTTTAGAG 
PCR, Seq OLEC1162 R 
CTGTGTCATGACTCATC 
OLEC1163 F TGTCTCGTTTACAGAAAG 
OLEC1164 R GACGCTAAAGCTCATTTG 
OLEC1270 F ATGTCCCTGGTTATGGC Spy_0886 complementation OLEC1271 R GCCACGAGGAATCTTATC 
    
                 ClpP 
    
OLEC562 F ATGCAGCTGCAG ClpP up fragment 
AAAGGTAGCTGATAAAAAATCAGG 
OLEC563 R ATGCAGGGATCC
OLEC564 
AATACATTCTCCAATCTACAAGGG 
F ATGCAGGGATCC ClpP dw fragment 
AGAGGATCTCTGCAAAAGTATTCTAG 
OLEC565 R ATGCAGGAATTC
OLEC863 
GTTGCTCTAAAACAGTCGTTTTCCCT 
F ATGATTTGACCTTTATTG 
PCR, Seq OLEC864 R 
AAAGGGATCTGAACTGAC 
OLEC865 F CTTTAAACCGACAGGCCG 
OLEC866 R TGTTTTAGGGTCCATAGC 
OLEC877 F GCTCTTATTCCTTGACGC 
SB probe OLEC878 R 
GATGTTCTGCTGCGATAG 
OLEC879 R AGCTAATTTTTTACCAGC 
OLEC880 F GGGTTAACAACCCCCTAG 
OLEC1018 F ATGCAGCGTCAG
ClpP complementation  
GTCTAGTTAATGTGTAACGTAACA 
OLEC1004 R CCACTAGGTCATCTCTTTTTTACTGCGATCCTTAATTATATTATAGTC 
OLEC1003 F GACTATAATATAATTAAGGATCGCAGTAAAAAAGAGATGACCTAGTGG 
OLEC965 R ACTGAGGAATCC
 
AGGGATCTGAACTGACGTTTTAAC 
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                 ClpE 
    
OLEC573 F ATGCAGTCTAGA ClpE up fragment 
GGAAGTAGTCTTGAAAAGTCCAAG 
OLEC574 R ATGCAGGGTACC
OLEC575 
AATATACCTCCGAGGGTTTATCTA 
F ATGCAGGGTACC ClpE up fragment 
CGTTAGCTAAGAGAGTTTCTATAAG 
OLEC576 R ATGCAGGAATTC
OLEC859 
TCTTTTAAGAAAATTGCTGGCTTC 
F AAAGCTAACGCTAAAGCG 
PCR, Seq OLEC860 R 
ATTTTATTTACCTTTCC 
OLEC861 F CATGGCATTTTGAGGACG 
OLEC862 R TAAGAAGACAACCATC 
OLEC873 F AGGCAAGCAAGTGATTCG 
SB probe OLEC874 R 
AACAGAAGGTTCATCAAC 
OLEC875 R ATCTTTATTGTAATGAAC 
OLEC876 F TTACCCAAGCACCAAAAC 
OLEC966 F ACTGAGGGATCC ClpE complementation  
CCGCCATCTGTCACCATCAACTCC 
OLEC967 R ATCGAGGAGCTC
 
TTCTTCATTATACTAAATTTTTGC 
   
                 ClpC 
    
OLEC1262 F ATGCACCGTCAG ClpC up fragment 
TTTATGAGTGCCTGCAAGGACAAAAC 
OLEC1263 R ATGCACGAATTC
OLEC1264 
TTAAGCGGTCCATGCTAGCAGATTCG 
F CTTTTTCTGCCAATGTAGTAATAATAGCTACCATAGCTAACAAAACATG ClpC dw fragment OLEC1265 R CATGTTTTGTTAGCTATGGTAGCTATTATTACTACATTGGCAGAAAAAG 
OLEC855 F CAATAAAAGAATCTTTAG 
PCR, Seq OLEC856 R 
TTTTCACGGACTCGATAC 
OLEC857 F CTTCAAGTTCTGTTTCC 
OLEC858 R ATATGCGTTAAAAGTTAG 
OLEC869 F GCTCTTATTCCTTGACGC 
SB probe OLEC870 R 
AAAATCAGCACCTGAGAC 
OLEC871 R TGGTTCTCCCTTAATTAC 
OLEC872 F CGTTGACCTTCTTCGACG 
OLEC968 F ACTGAGGGATCC ClpC complementation  
AAAGAATCTTTAGTAAAGTTAGCAC 
OLEC969 R ACTGAGGGATCC
 
AATTTAATGGCAACTATTGAAGAC 
italic, sequence annealing to the template; underlined, restriction site. 
 F, forward primer; R, reverse primer.  
 SB, probe for Southern blot; NB, probe for northern blot, Seq: sequencing 
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Table 4: Oligonuclotides for Northern blot probes 
 
Probes for Northern blot 
 
clp genes 
clpC OLEC969 
GCTCTTATTCCTTGACGC F NB probe 
OLEC970 AAAATCAGCACCTGAGAC R NB probe 
clpE OLEC973 
AGGCAAGCAAGTGATTCG F NB probe 
OLEC974 AACAGAAGGTTCATCAAC R NB probe 
clpX OLEC847 
TGACTGAAGCAGGGTATG F NB probe 
OLEC850 GATCTCCTCGATGCCATC R NB probe 
clpP OLEC877 
GCTCTTATTCCTTGACGC F NB probe 
OLEC878 GATGTTCTGCTGCGATAG R NB probe 
     
Virulence genes     
emm oliRN133 
TATTCGCTTAGAAAATGAA F NB probe 
oliRN134 GCAAGTTCTTCAGCTTGTTT R NB probe 
ska oliRN264 
TTGTTGTAGAGTAGTTTAGC F NB probe 
OLEC636 CGTGACTCCTCAATCGTCAC R NB probe 
speC OLIRN47 
CATAATTACAGTCACTGATT F NB probe 
OLIRN48 ATCGAAATGACTAAAGTTCTTCAT R NB probe 
sic OLEC1534 
GAAGAATGGCCTGAAG F NB probe 
OLEC1535 CCCTGTACCTAATGCTCC R NB probe 
speB OLIRN45 
GATAACCATACGATTCAGCT F NB probe 
OLIRN46 TCTGTGTCTGATGGATAGC R NB probe 
slo OLIRN49 
TGCCACTAGAATCTGCAGAAAA F NB probe 
OLIRN50 CCCAAAGGATTTCATATTGAGC R NB probe 
sagA OLIRN137 
TTATTTACCTGGCGTATAAC F NB probe 
OLIRN138 ATTAGATAAGGAGGTAAACC R NB probe 
speI OLEC1151 
GGAAAAATAAATGAAGGTCC F NB probe 
OLEC1552 CAAAGCCAGATTGAAATC R NB probe 
     
Regulator genes     
rgg OLEC278 
TAGACAACTTGAATGTCAAT F NB probe 
OLEC279 AAGCTTTATCATACTCTTGT R NB probe 
covR OLEC1541 ACTGCTTTGGAAAAAGAGTTTG F NB probe 
OLEC1542 CATGACACGATTCATATTAGTC R NB probe 
fasA OLEC184 AGAGACTAGAATACCATG F NB probe 
OLEC185 TTTGACTCACGACTAGAC R NB probe 
fasX OLEC182 GAGCAATAACATTTTAGG F NB probe 
OLEC183 TTACAATCAGCTGATGTG R NB probe 
mga OLIRN135 AGCTCAGTTAACTTGATTCG F NB probe 
OLIRN136 AAAGGCGTAGACAATTGG R NB probe 
perR OLEC1549 GAATTACAGAGACACGTAAAG F NB probe 
OLEC1550 CCTGTTTGCTCATGGGCTTC R NB probe 
codY OLEC274 ATAGCCTAGAAACAGAATTA F NB probe 
OLEC275 TTCTGAATAAGAAAGCGTAT R NB probe 
rofA OLEC1547 GCATTGATTCCTTTATTAA F NB probe 
OLEC1548 CTGCTGAAAAGTTTAGTTGG R NB probe 
srv OLEC276 ACATTTTGCAACGGTATATT F NB probe 
OLEC277 AATAGGGTCATTAAGTCATA R NB probe 
rivR OLEC1545 CGGAGATGAACTTAAAATACG F NB probe 
OLEC1546 CTGAAGACGATGGATTAG R NB probe 
malR OLEC1543 GTCGACTATTACTAACGAAG F NB probe 
OLEC1544 CCATCAATATTTCTACGC R NB probe 
sigX OLEC1532 GTCGATAGAGACAAGAGC F NB probe 
OLEC1533 TCTTCATATGCTAACTTATGG R NB probe 
 
88 
 
Verification of plasmid constructs by PCR, Southern blot or sequencing analysis 
ColE1 OLEC1560 GAAGTACATCCGCAACTGTC F PCR, SB, SEQ OLEC1562 GTGATGCTCGTCAGGGGG R PCR, SB, SEQ 
repAts oliRN228 GGAACGAAAACTCACGTTAA F PCR, SB, SEQ oliRN229 AGGTTCTTGATGCTGAAACG R PCR, SB, SEQ 
 
 italic, sequence annealing to the template; underlined, restriction site. 
 F, forward primer; R, reverse primer.  
 SB, probe for Southern blot; NB, probe for northern blot, SEQ: sequencing 
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Fig. S1: Alignment of amino acids sequence of ClpC from Gram-positive pathogens. The important amino acids 
from the zinc finger binding domain (purple), the Walker A (yellow) and Walker B (blue) motifs, the pore 
forming loop (green) and the P-loop (red) are highlighted. 
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Fig. S2: Alignment of amin -acids sequence of ClpC from Gram-positive pathogens. The amino acids involved 
in the catalytic site are marked in green. 
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Fig. S3: Alignment of amino acids sequence of ClpE from Gram-positive pathogens. The important amino acids 
from the zinc finger binding domain (purple), the Walker A (yellow) and Walker B (blue) motifs, the pore 
forming loop (green) and the P-loop (red) are highlighted. 
S.pyogenes           MLCQNCNLNESTIHLYTSVNGKQRQVDLCQNCYQIMKSDPANSILNGLTPGYRAQDRSTS 60 
S.pneumoniae         MLCQNCKINDSTIHLYTNLNGKQKQIDLCQNCYKIIKTDPNNSLFKGMTD---LNNRDFD 57 
B.subtilis           MRCQHCHQNEATIRLNMQINSVHKQMVLCETCYNELTRKPSMSMG----------PQSFG 50 
L.monocytogenes      MNCEKCNQNPATIQLYMNINGKRVEMPLCASCYAEVRNQANFGSNE--------FPGASG 52 
                      
S.pyogenes           PFFDDFFGDLNNFRAFGNLPNTPPTQAGQNGNGGGRYGGNYNGQRPAQPQTPNQQAKGLL 120 
S.pneumoniae         P-FGDFFNDLNNFRPSSNTPPIPPTQSGGGYGGNGGYGSQNRG--SAQTPPPSQ-EKGLL 113 
B.subtilis           FPFEQAFQPKEQSAAKQSEKK------------------------------------GLL 74 
L.monocytogenes      SPFDDIFRQLSGAANQANREQRSQANAQVQTQTAGGG-------------------NGIL 93 
 
S.pyogenes           EEFGINVTDIARNGNIDPVIGRDEEITRVIEILNRRTKNNPVLIGEPGVGKTAVVEGLAQ 180 
S.pneumoniae         EEFGINVTEIARRGDIDPVIGRDDEIIRVIEILNRRTKNNPVLIGEPGVGKTAVVEGLAQ 173 
B.subtilis           DELAQNITNGAKAGLIDPVIGRDDEVARVIEILNRRNKNNPVLIGEPGVGKTAIAEGLAL 134 
L.monocytogenes      DEFGTNLTDMAKNEQLDPVIGRDKEIKRVIEILNRRNKNNPVLIGEPGVGKTAVVEGLAN 153                  
 
S.pyogenes           KIIDGTVPQKLQGKQVIRLDVVSLVQGTGIRGQFEERMQKLMEEIRNRKDVILFIDEIHE 240 
S.pneumoniae         KIVDGDVPHKLQGKQVIRLDVVSLVQGTGIRGQFEERMQKLMEEIRKREDIILFIDEIHE 233 
B.subtilis           KIAEGDVPNKLKNKELYLLDVASLVANTGIRGQFEERMKQLITELKERKNVILFIDEIHL 194 
L.monocytogenes      AIVAGDVPSKLMNKEVILLDVASLVSGTGIRGQFEERMKQLIKELQERKNTILFIDEVHT 213 
                       
S.pyogenes           IVGAGSAGDGNMDAGNILKPALARGELQLVGATTLNEYRIIEKDAALERRMQPVKVDEPS 300 
S.pneumoniae         IVGAGSASDGNMDAGNILKPALARGELQLVGATTLNEYRIIEKDAALERRMQPVKVDEPT 293 
B.subtilis           LVGAGSA-EGSMDAGNILKPALARGELQVIGATTLKEYRQIEKDAALERRFQPVMVQEPS 253 
L.monocytogenes      IVGAGSA-EGSMDAGNILKPALARGDLQMIGATTLKEYRTIEKDAALERRFQPVTVSEPS 272 
                      
S.pyogenes           VEETITILKGIQPKYEDYHHVKYSPAAIEAAAHLSNRYIQDRFLPDKAIDLLDEAGSKMN 360 
S.pneumoniae         VDETITILKGIQKKYEDYHHVQYTDAAIEAAATLSNRYIQDRFLPDKAIDLLDEAGSKMN 353 
B.subtilis           IEQAILILQGIKDKYEAYHGVTFSDEAIKACVTLSSRYIQDRHLPDKAIDLLDEAGSKAN 313 
L.monocytogenes      TKETLTILNGLKPKYEDFHEVVYSPEALTAAVELSARYIQDRHLPDKAIDLMDEVGSKYN 332 
                       
S.pyogenes           LTLNFVDPKEIDKRLIEAENLKAQATRDEDYERAAYFRDQITKYKEMQAQKVDEQDIPII 420 
S.pneumoniae         LTLNFVDPKVIDQRLIEAENLKSQATREEDFEKAAYFRDQIAKYKEMQKKKITDQDTPSI 413 
B.subtilis           LLIDELNDEDAAERLTAIEAEKTKALEEENYELAAKLRDEELALEKKL-NSSSAHTAVTV 372 
L.monocytogenes      LSIEKLDENTVSERVARLEDEKNQALQMEDYEKAAKVRDEITRLEENK-TSNSFSERPVI 391 
                      
S.pyogenes           TEKTIEAIVEQKTNIPVGDLKEKEQSQLVNLANDLKAHVIGQDDAVDKIAKAIRRNRVGL 480 
S.pneumoniae         SEKTIEHIIEQKTNIPVGDLKEKEQSQLIHLAEDLKSHVIGQDDAVDKIAKAIRRNRVGL 473 
B.subtilis           EAEHIQEIVEQKTGIPVGKLQADEQTKMKELEAKLHERVIGQEAAVQKVAKAVRRSRAGL 432 
L.monocytogenes      QASDIQAIIEEKTGIPVGRLQEDEQSKMKNLERNLTGKVIGQEDAVKKVAKAIRRSRVGL 451 
 
S.pyogenes           GTPNRPIGSFLFVGPTGVGKTELSKQLAIELFGSTNNMIRFDMSEYMEKHAVAKLVGAPP 540 
S.pneumoniae         GTPNRPIGSFLFVGPTGVGKTELSKQLAIELFGSADSMIRFDMSEYMEKHSVAKLVGAPP 533 
B.subtilis           KSKNRPVGSFLFVGPTGVGKTELSKTLADELFGTKDAIIRLDMSEYMEKHAVSKIIGSPP 492 
L.monocytogenes      KSKNRPIGSFLFVGPTGVGKTELGRTLARELFGTSEAMIRLDMSEFMEKHSISKLIGSPP 511 
 
S.pyogenes           GYIGYEEAGQLTEQVRRNPYSLILLDEVEKAHPDVMHMFLQVLDDGRLTDGQGRTVSFKD 600 
S.pneumoniae         GYVGYDEAGQLTEKVRHNPYSLILLDEVEKAHPDVMHMFLQVLDDGRLTDGQGRTVSFKD 593 
B.subtilis           GYVGHEEAGQLTEKVRRNPYSIVLLDEIEKAHPDVQHMFLQIMEDGRLTDSQGRTVSFKD 552 
L.monocytogenes      GYVGHEEAGQLTEKVRRNPYSIILLDEIEKAHPDVQHMFLQILEDGRLTDSQGRTVSFKD 571 
 
S.pyogenes           TIIIMTSNAGTGKSEASVGFGAAREGRT---SSVLGELSNFFSPEFMNRFDGIIEFKALS 657 
S.pneumoniae         AIIIMTSNAGTGKTEASVGFGAAREGRT---NSVLGELGNFFSPEFMNRFDGIIEFKALS 650 
B.subtilis           TVIIMTSNAGAGEKQTKVGFQSD-DSVIEEQT-LIDSLSMFFKPEFLNRFDSIIEFRSLE 610 
L.monocytogenes      TVIIMTSNAGATDTEASVGFNTTTETKLEKGSDILAKLGAYFKPEFLNRLDSVIEFKSLE 631 
 
S.pyogenes           KEHLLHIVDLMLEDVNERLGYNGIHLDVTQKVKEKLVDLGYDPKMGARPLRRTIQDYIED 717 
S.pneumoniae         KDNLLQIVELMLADVNKRLSSNNIRLDVTDKVKEKLVDLGYDPKMGARPLRRTIQDYIED 710 
B.subtilis           KEHLVKIVSLLLGELEETLAERGISLNVTDEAKEKIAELGYHPSFGARPLRRTIQEWVED 670 
L.monocytogenes      KDDLVQIIDLMLVDLNEMLAQEGVTIDVSKEVKEHLIDLGYDPKFGARPLRRTIQEHLED 691 
                      
S.pyogenes           AITDYYLEHPTEKQLRALMTNSENITIKAVKEGDSFLNEESLD 760 
S.pneumoniae         TITDYYLENPSEKDLKAVMTSKGNIQIKSAKKAEVKSSEKEK- 752 
B.subtilis           EMTDLLLDNGEITSFHVILEDDK-IKVRAK------------- 699 
L.monocytogenes      TIADSLIDQPEAKNLVATLNDNKEITITEQVTA---------- 724 
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Fig. S4: Alignment of amino acids sequence of ClpC from Gram-positive pathogens. The important amino acids 
from the Walker A (yellow) and Walker B (blue) motifs, the pore forming loop (green) and the P-loop (red) are 
highlighted. 
B.subtilis           MMFGRFTERAQKVLALAQEEALRLGHNNIGTEHILLGLVREGEGIAAKALQALGLGSEKI 60 
L.monocytogenes      MMFGRFTQRAQKVLALSQEEAMRLNHSNLGTEHILLGLVREGEGIAAKALYELGISSEKV 60 
S.pyogenes           MIM--YSTKMQDIFRQAQFQAARFDSHCLETWHVLLAMVAVDNSLANMILSEYDAQVAIE 58 
S.pneumoniae         -MN--YSKALNECIESAYMVAGHFGARYLESWHLLIAMSNHSYSVAGATLNDYPYEMDRL 57 
S.aureus             ------------------MNNGFFNSDFDSIFRRMMKDMQGSNQVGNKKYYINGKEVS-- 40 
 
B.subtilis           QKEVESLIGRGQ---EMSQTIHY---TPRAKKVIELSMDEARKLGHSYVGTEHILLGLIR 114 
L.monocytogenes      QQEVEGLIGHGE---KAVTTIQY---TPRAKKVIELSMDEARKLGHTYVGTEHILLGLIR 114 
S.pyogenes           EYEAAAILAMGKTPKEQLSRVDFRPQSKTLTNLLAFAQAISQITRDQEVGSEHVLFAILL 118 
S.pneumoniae         EEVALELTETDYSQDETFTELPF---SRRLQVLFDEAEYVASVVHAKVLGTEHVLYAILH 114 
S.aureus             PEELAQLTQQGG------------------------------------------------ 52 
 
B.subtilis           EGEGVAARVLNNLGVSLN---------------------------KARQQVLQLLGSNET 147 
L.monocytogenes      EGEGVAARVLSNLGISLN---------------------------KARQQVLQLLGGGDA 147 
S.pyogenes           NPDIMASRLLEIAGYQIKDNGNGQPRLADLRKAIERHAGYSKEMIKAIHELRKPKKTKTQ 178 
S.pneumoniae         DSNALATRILERAGFSYEDK-KDQVKIAALRRNLEERAGWTREDLKALRQRHRTVADKQN 173 
S.aureus             -----------------------------------------------NHSAEQSAQAFQQ 65 
 
B.subtilis           GSSAAGTNSNANTPTLDSLARDLTAIAKEDSLDPVIGRSKEIQRVIEVLSRRTKNNPVLI 207 
L.monocytogenes      TGAGRQTNTQA-TPTLDSLARDLTVIAREDNLDPVIGRSKEIQRVIEVLSRRTKNNPVLI 206 
S.pyogenes           GTFSDMMKPPSTAGELSDFTRDLTEMARQGLLESVIGRDQEVSRMIQVLSRKTKNNPVLV 238 
S.pneumoniae         SMANMMGMPQTPSGGLEDYTHDLTEQARSGKLEPVIGRDKEISRMIQILSRKTKNNPVLV 233 
S.aureus             AAQRQQGQQGGNGNYLEQIGRNLTQEARDGLLDPVIGRDKEIQETAEVLSRRTKNNPILV 125 
 
B.subtilis           GEPGVGKTAIAEGLAQQIINNEVPEILRDKRVMTLDMGTVVAGTKYRGEFEDRLKKVMDE 267 
L.monocytogenes      GEPGVGKTAIAEGLAQQIVRNEVPETLRGKRVMTLDMGTVVAGTKYRGEFEDRLKKVMDE 266 
S.pyogenes           GDAGVGKTALAYGLAQRIANGAIPYELKEMRVLELDMMSVVAGTRFRGDFEERMNQIIDD 298 
S.pneumoniae         GDAGVGKTALALGLAQRIASGDVPAEMAKMRVLELDLMNVVAGTRFRGDFEERMNNIIKD 293 
S.aureus             GEAGVGKTAIVEGLAQAIVEGNVPAAIKDKEIISVDISSLEAGTQYRGAFEENIQKLIEG 185 
 
B.subtilis           IRQAGNIILFIDELHTLIGAG---GAEGAIDASNILKPSLARGELQCIGATTLDEYRKYI 324 
L.monocytogenes      IRQAGNVILFIDELHTLIGAG---GAEGAIDASNILKPPLARGELQCIGATTLDEYRKYI 323 
S.pyogenes           IEADGQIILFVDELHTIMGSGS--GIDSTLDAANILKPALSRGTLHMVGATTQEEYQKHI 356 
S.pneumoniae         IEEDGQVILFIDELHTIMGSGS--GIDSTLDAANILKPALARGTLRTVGATTQEEYQKHI 351 
S.aureus             VKSSQNAVLFFDEIHQIIGSGATGSDSGSKGLSDILKPALSRGEISIIGATTQDEYRNNI 245 
 
B.subtilis           EKDAALERRFQPIQVDQPSVDESIQILQGLRDRYEAHHRVSITDDAIEAAVKLSDRYISD 384 
L.monocytogenes      EKDAALERRFQPIKVDEPTVEESIQILHGLRDRYEAHHRVAITDEALEAAVRLSDRYISD 383 
S.pyogenes           EKDAALSRRFAKILIEEPNTEDAYQILMGLKLSYETYHNVSISNEAVKTAVKMAHRYLTS 416 
S.pneumoniae         EKDAALSRRFAKVTIEEPSVADSMTILQGLKATYEKHHRVQITDEAVETAVKMAHRYLTS 411 
S.aureus             LKDAALTRRFNEVLVNEPSAKDTVEILKGIREKFEEHHQVKLPDDVLKACVDLSIQYIPQ 305 
 
B.subtilis           RFLPDKAIDLIDEAGSKVRLRSFTTPPNLKELEQKLDEVRKEKDAAVQSQEFEKAASLRD 444 
L.monocytogenes      RFLPDKAIDVIDESGSKVRLKSFTTPKNVKEMENNLSDLKKEKDAAVQGQEFEKAASLRD 443 
S.pyogenes           KNLPDSAIDLLDEASAAVQN----MVK--KSAPETLTPI----DQALINGDMKKVSRLLA 466 
S.pneumoniae         RHLPDSAIDLLDEAAATVQN----KAKHVKADDSDLSPA----DKALMDGKWKQAAQLIA 463 
S.aureus             RLLPDKAIDVLDITAAHLSAQS--PAVDKVETEKRISELENDKRKAVSAEEYKKADDIQN 363 
 
B.subtilis           TEQRLREQVEDTKKSWKEKQGQENSEVTVDDIAMVVSSWTGVPVSKIAQTETDKLLNMEN 504 
L.monocytogenes      KEQKLKKSLEETKANWQEKQGLDHSEVTEDIVAEVVASWTGIPVAKLAETETNKLLNMEK 503 
S.pyogenes           KEA--------------KGQMRKPTPVTEDDILATLSKLSGIPLEKLTQADSKKYLNLEK 512 
S.pneumoniae         KEE--------------EVPVYK-DLVTESDILTTLSRLSGIPVQKLTQTDAKKYLNLEA 508 
S.aureus             EIKSLQDKLE-------NSNGEHTAVATVHDISDTIQRLTGIPVSQMDDNDIERLKNISN 416 
 
B.subtilis           ILHSRVIGQDEAVVAVAKAVRRARAGLKDPKRPIGSFIFLGPTGVGKTELARALAESIFG 564 
L.monocytogenes      LLHERVIGQDAAVKAVSLAVRRARAGLKDPKRPIGSFIFLGPTGVGKTELARALAESMFG 563 
S.pyogenes           ELHKRVIGQDAAVTAISRAIRRNQSGIRTGKRPIGSFMFLGPTGVGKTELAKALAEVLFD 572 
S.pneumoniae         ELHKRVIGQDQAVSSISRAIRRNQSGIRSHKRPIGSFMFLGPTGVGKTELAKALAEVLFD 568 
S.aureus             RLRSKIIGQDQAVEMVSRAIRRNRAGFDDGNRPIGSFLFVGPTGVGKTELAKQLAIDLFG 476 
 
B.subtilis           DEESMIRIDMSEYMEKHSTSRLVGSPPGYVGYDEGG-QLTEKVRRKPYSVVLLDEIEKAH 623 
L.monocytogenes      DEDSMIRIDMSEYMEKFSTARLVGAPPGYVGYEEGG-QLTEKVRQKPYSVVLLDEIEKAH 622 
S.pyogenes           DEAALIRFDMSEYMEKFAASRLNGAPPGYVGYDEGG-ELTQKVRNKPYSVLLFDEVEKAH 631 
S.pneumoniae         DESALIRFDMSEYMEKFAASRLNGAPPGYVGYEEGG-ELTEKVRNKPYSVLLFDEVEKAH 627 
S.aureus             NKDALIRLDMSEYSDTTAVSKMIGTTAGYVGYDDNSNTLTEKVRRNPYSVILFDEIEKAN 536 
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B.subtilis           PDVFNILLQVLEDGRLTDSKGRTVDFRNTILIMTSNVGASELKRNKYVGFNVQDETQNHK 683 
L.monocytogenes      PDVFNMLLQVLDDGRLTDSKGRVVDFRNTVIIMTSNIGAQEMKQDKSMGFNVTDPLKDHK 682 
S.pyogenes           PDIFNVLLQVLDDGILTDSRGRKVDFSNTIIIMTSNLGATALRDDKTVGFGVKDIHQDHQ 691 
S.pneumoniae         PDIFNVLLQVLDDGVLTDSKGRKVDFSNTIIIMTSNLGATALRDDKTVGFGAKDIRFDQE 687 
S.aureus             PQILTLLLQVMDDGNLTDGQGNVINFKNTIIICTSNAGFGNGNDAE-------------- 582 
 
B.subtilis           DMKDKVMGELKRAFRPEFINRIDEIIVFHSLEKKHLTEIVSLMSDQLTKRLKEQDLSIEL 743 
L.monocytogenes      AMEHRVLQDLKQAFRPEFINRIDETIVFHSLQEKELKQIVTLLTAQLTKRLAERDIHVKL 742 
S.pyogenes           AMEKRILEELRKTYRPEFINRIDEKVVFHSLTQDNMRDVVKIMVQPLITTLAEKGITLKI 751 
S.pneumoniae         NMEKRMFEELKKAYRPEFINRIDEKVVFHSLSSDHMQEVVKIMVKPLVASLTEKGIDLKL 747 
S.aureus             --EKDIMHEMKKFFRPEFLNRFNGIVEFLHLDKDALQDIVNLLLDDVQVTLDKKGITMDV 640 
 
B.subtilis           TDAAKAKVAEEGVDLEYGARPLRRAIQKHVEDRLSEELLRGNIHKGQHIVLDVEDGEFVV 803 
L.monocytogenes      TEGAKSKIAKDGYDPEYGARPLKRAIQKEVEDMLSEELLRGNIKVGDYVEIGVKDGKLEV 802 
S.pyogenes           QPLALKHLSEVGYDEHMGARPLRRTLQTEIEDKLSELILSRELTSGHTLKIGLSHGKLTF 811 
S.pneumoniae         QASALKLLANQGYDPEMGARPLRRTLQTEVEDKLAELLLKGDLVAGSTLKIGVKAGQLKF 807 
S.aureus             SQDAKDWLIEEGYDEELGARPLRRIVEQQVRDKITDYYLDHTDVK--HVDIDVEDNELVV 698 
 
B.subtilis           K--------TTAKTN--- 810 
L.monocytogenes      RKKDAPKKKTTSKKVKAK 820 
S.pyogenes           HIA--------------- 814 
S.pneumoniae         DIA--------------- 810 
S.aureus             KGK--------------- 701 
 
 
  
 
94 
 
 References 
1. Goldberg, A.L. and A.C. St John, Intracellular protein degradation in mammalian and bacterial 
cells: Part 2. Annu Rev Biochem, 1976. 45: p. 747-803. 
2. Jenal, U. and R. Hengge-Aronis, Regulation by proteolysis in bacterial cells. Curr Opin Microbiol, 
2003. 6(2): p. 163-72. 
3. Baker, T.A. and R.T. Sauer, ATP-dependent proteases of bacteria: recognition logic and operating 
principles. Trends Biochem Sci, 2006. 31(12): p. 647-53. 
4. Martin, A., T.A. Baker, and R.T. Sauer, Protein unfolding by a AAA+ protease is dependent on 
ATP-hydrolysis rates and substrate energy landscapes. Nat Struct Mol Biol, 2008. 15(2): p. 139-
45. 
5. Baumeister, W., et al., The proteasome: paradigm of a self-compartmentalizing protease. Cell, 
1998. 92(3): p. 367-80. 
6. Tomoyasu, T., et al., Escherichia coli FtsH is a membrane-bound, ATP-dependent protease which 
degrades the heat-shock transcription factor sigma 32. EMBO J, 1995. 14(11): p. 2551-60. 
7. Schmidt, R., B. Bukau, and A. Mogk, Principles of general and regulatory proteolysis by AAA+ 
proteases in Escherichia coli. Res Microbiol, 2009. 160(9): p. 629-36. 
8. Reid, B.G., et al., ClpA mediates directional translocation of substrate proteins into the ClpP 
protease. Proc Natl Acad Sci U S A, 2001. 98(7): p. 3768-72. 
9. Weber-Ban, E.U., et al., Global unfolding of a substrate protein by the Hsp100 chaperone ClpA. 
Nature, 1999. 401(6748): p. 90-3. 
10. Tucker, P.A. and L. Sallai, The AAA+ superfamily--a myriad of motions. Curr Opin Struct Biol, 
2007. 17(6): p. 641-52. 
11. Weibezahn, J., et al., Characterization of a trap mutant of the AAA+ chaperone ClpB. J Biol Chem, 
2003. 278(35): p. 32608-17. 
12. Hattendorf, D.A. and S.L. Lindquist, Cooperative kinetics of both Hsp104 ATPase domains and 
interdomain communication revealed by AAA sensor-1 mutants. EMBO J, 2002. 21(1-2): p. 12-21. 
13. Steel, G.J., et al., A screen for dominant negative mutants of SEC18 reveals a role for the AAA 
protein consensus sequence in ATP hydrolysis. Mol Biol Cell, 2000. 11(4): p. 1345-56. 
14. Ogura, T., S.W. Whiteheart, and A.J. Wilkinson, Conserved arginine residues implicated in ATP 
hydrolysis, nucleotide-sensing, and inter-subunit interactions in AAA and AAA+ ATPases. J Struct 
Biol, 2004. 146(1-2): p. 106-12. 
15. Hanson, P.I. and S.W. Whiteheart, AAA+ proteins: have engine, will work. Nat Rev Mol Cell Biol, 
2005. 6(7): p. 519-29. 
16. Banecki, B., et al., Structure-function analysis of the zinc-binding region of the Clpx molecular 
chaperone. J Biol Chem, 2001. 276(22): p. 18843-8. 
17. Ishikawa, T., M.R. Maurizi, and A.C. Steven, The N-terminal substrate-binding domain of ClpA 
unfoldase is highly mobile and extends axially from the distal surface of ClpAP protease. J Struct 
Biol, 2004. 146(1-2): p. 180-8. 
18. Kirstein, J., et al., Adaptor protein controlled oligomerization activates the AAA+ protein ClpC. 
EMBO J, 2006. 25(7): p. 1481-91. 
19. Kim, Y.I., et al., Molecular determinants of complex formation between Clp/Hsp100 ATPases and 
the ClpP peptidase. Nat Struct Biol, 2001. 8(3): p. 230-3. 
20. Weibezahn, J., et al., Thermotolerance requires refolding of aggregated proteins by substrate 
translocation through the central pore of ClpB. Cell, 2004. 119(5): p. 653-65. 
21. Singh, S.K., et al., Functional domains of the ClpA and ClpX molecular chaperones identified by 
limited proteolysis and deletion analysis. J Biol Chem, 2001. 276(31): p. 29420-9. 
22. Kress, W., H. Mutschler, and E. Weber-Ban, Assembly pathway of an AAA+ protein: tracking ClpA 
and ClpAP complex formation in real time. Biochemistry, 2007. 46(21): p. 6183-93. 
 
95 
 
23. Maurizi, M.R., et al., Molecular properties of ClpAP protease of Escherichia coli: ATP-dependent 
association of ClpA and clpP. Biochemistry, 1998. 37(21): p. 7778-86. 
24. Bochtler, M., et al., The structures of HsIU and the ATP-dependent protease HsIU-HsIV. Nature, 
2000. 403(6771): p. 800-5. 
25. Sousa, M.C., et al., Crystal and solution structures of an HslUV protease-chaperone complex. Cell, 
2000. 103(4): p. 633-43. 
26. Burton, B.M., T.L. Williams, and T.A. Baker, ClpX-mediated remodeling of mu transpososomes: 
selective unfolding of subunits destabilizes the entire complex. Mol Cell, 2001. 8(2): p. 449-54. 
27. Pak, M. and S. Wickner, Mechanism of protein remodeling by ClpA chaperone. Proc Natl Acad Sci 
U S A, 1997. 94(10): p. 4901-6. 
28. Wang, J., J.A. Hartling, and J.M. Flanagan, The structure of ClpP at 2.3 A resolution suggests a 
model for ATP-dependent proteolysis. Cell, 1997. 91(4): p. 447-56. 
29. Ortega, J., et al., ClpA and ClpX ATPases bind simultaneously to opposite ends of ClpP peptidase 
to form active hybrid complexes. J Struct Biol, 2004. 146(1-2): p. 217-26. 
30. Gribun, A., et al., The ClpP double ring tetradecameric protease exhibits plastic ring-ring 
interactions, and the N termini of its subunits form flexible loops that are essential for ClpXP and 
ClpAP complex formation. J Biol Chem, 2005. 280(16): p. 16185-96. 
31. Kang, S.G., et al., Crystallography and mutagenesis point to an essential role for the N-terminus 
of human mitochondrial ClpP. J Struct Biol, 2004. 148(3): p. 338-52. 
32. Jennings, L.D., et al., The ClpP N-terminus coordinates substrate access with protease active site 
reactivity. Biochemistry, 2008. 47(42): p. 11031-40. 
33. Kirstein, J., et al., Localization of general and regulatory proteolysis in Bacillus subtilis cells. Mol 
Microbiol, 2008. 70(3): p. 682-94. 
34. Simmons, L.A., A.D. Grossman, and G.C. Walker, Clp and Lon proteases occupy distinct 
subcellular positions in Bacillus subtilis. J Bacteriol, 2008. 190(20): p. 6758-68. 
35. Kain, J., G.G. He, and R. Losick, Polar localization and compartmentalization of ClpP proteases 
during growth and sporulation in Bacillus subtilis. J Bacteriol, 2008. 190(20): p. 6749-57. 
36. Lewis, P.J., S.D. Thaker, and J. Errington, Compartmentalization of transcription and translation 
in Bacillus subtilis. EMBO J, 2000. 19(4): p. 710-8. 
37. Mascarenhas, J., M.H. Weber, and P.L. Graumann, Specific polar localization of ribosomes in 
Bacillus subtilis depends on active transcription. EMBO Rep, 2001. 2(8): p. 685-9. 
38. Burton, B.M. and T.A. Baker, Remodeling protein complexes: insights from the AAA+ unfoldase 
ClpX and Mu transposase. Protein Sci, 2005. 14(8): p. 1945-54. 
39. Ortega, J., et al., Visualization of substrate binding and translocation by the ATP-dependent 
protease, ClpXP. Mol Cell, 2000. 6(6): p. 1515-21. 
40. Dougan, D.A., et al., AAA+ proteins and substrate recognition, it all depends on their partner in 
crime. FEBS Lett, 2002. 529(1): p. 6-10. 
41. Keiler, K.C., P.R. Waller, and R.T. Sauer, Role of a peptide tagging system in degradation of 
proteins synthesized from damaged messenger RNA. Science, 1996. 271(5251): p. 990-3. 
42. Gottesman, S., et al., The ClpXP and ClpAP proteases degrade proteins with carboxy-terminal 
peptide tails added by the SsrA-tagging system. Genes Dev, 1998. 12(9): p. 1338-47. 
43. Levchenko, I., et al., Structure of a delivery protein for an AAA+ protease in complex with a 
peptide degradation tag. Mol Cell, 2003. 12(2): p. 365-72. 
44. Song, H.K. and M.J. Eck, Structural basis of degradation signal recognition by SspB, a specificity-
enhancing factor for the ClpXP proteolytic machine. Mol Cell, 2003. 12(1): p. 75-86. 
45. Flynn, J.M., et al., Modulating substrate choice: the SspB adaptor delivers a regulator of the 
extracytoplasmic-stress response to the AAA+ protease ClpXP for degradation. Genes Dev, 2004. 
18(18): p. 2292-301. 
46. Dougan, D.A., et al., ClpS, a substrate modulator of the ClpAP machine. Mol Cell, 2002. 9(3): p. 
673-83. 
 
96 
 
47. Erbse, A., et al., ClpS is an essential component of the N-end rule pathway in Escherichia coli. 
Nature, 2006. 439(7077): p. 753-6. 
48. Zhou, Y., et al., The RssB response regulator directly targets sigma(S) for degradation by ClpXP. 
Genes Dev, 2001. 15(5): p. 627-37. 
49. Neher, S.B., R.T. Sauer, and T.A. Baker, Distinct peptide signals in the UmuD and UmuD' subunits 
of UmuD/D' mediate tethering and substrate processing by the ClpXP protease. Proc Natl Acad 
Sci U S A, 2003. 100(23): p. 13219-24. 
50. Zellmeier, S., W. Schumann, and T. Wiegert, Involvement of Clp protease activity in modulating 
the Bacillus subtilissigmaw stress response. Mol Microbiol, 2006. 61(6): p. 1569-82. 
51. Neher, S.B., et al., Latent ClpX-recognition signals ensure LexA destruction after DNA damage. 
Genes Dev, 2003. 17(9): p. 1084-9. 
52. Flynn, J.M., et al., Proteomic discovery of cellular substrates of the ClpXP protease reveals five 
classes of ClpX-recognition signals. Mol Cell, 2003. 11(3): p. 671-83. 
53. Stephani, K., D. Weichart, and R. Hengge, Dynamic control of Dps protein levels by ClpXP and 
ClpAP proteases in Escherichia coli. Mol Microbiol, 2003. 49(6): p. 1605-14. 
54. Ruvolo, M.V., K.E. Mach, and W.F. Burkholder, Proteolysis of the replication checkpoint protein 
Sda is necessary for the efficient initiation of sporulation after transient replication stress in 
Bacillus subtilis. Mol Microbiol, 2006. 60(6): p. 1490-508. 
55. Garg, S.K., et al., The YjbH protein of Bacillus subtilis enhances ClpXP-catalyzed proteolysis of Spx. 
J Bacteriol, 2009. 191(4): p. 1268-77. 
56. Larsson, J.T., A. Rogstam, and C. von Wachenfeldt, YjbH is a novel negative effector of the 
disulphide stress regulator, Spx, in Bacillus subtilis. Mol Microbiol, 2007. 66(3): p. 669-84. 
57. Turgay, K., et al., Competence in Bacillus subtilis is controlled by regulated proteolysis of a 
transcription factor. EMBO J, 1998. 17(22): p. 6730-8. 
58. Prepiak, P. and D. Dubnau, A peptide signal for adapter protein-mediated degradation by the 
AAA+ protease ClpCP. Mol Cell, 2007. 26(5): p. 639-47. 
59. Ogura, M. and K. Tsukahara, Autoregulation of the Bacillus subtilis response regulator gene degU 
is coupled with the proteolysis of DegU-P by ClpCP. Mol Microbiol, 2010. 75(5): p. 1244-59. 
60. Nakano, M.M., S. Nakano, and P. Zuber, Spx (YjbD), a negative effector of competence in Bacillus 
subtilis, enhances ClpC-MecA-ComK interaction. Mol Microbiol, 2002. 44(5): p. 1341-9. 
61. Schlothauer, T., et al., MecA, an adaptor protein necessary for ClpC chaperone activity. Proc Natl 
Acad Sci U S A, 2003. 100(5): p. 2306-11. 
62. Pan, Q., D.A. Garsin, and R. Losick, Self-reinforcing activation of a cell-specific transcription factor 
by proteolysis of an anti-sigma factor in B. subtilis. Mol Cell, 2001. 8(4): p. 873-83. 
63. Kock, H., U. Gerth, and M. Hecker, The ClpP peptidase is the major determinant of bulk protein 
turnover in Bacillus subtilis. J Bacteriol, 2004. 186(17): p. 5856-64. 
64. Hengge-Aronis, R., Recent insights into the general stress response regulatory network in 
Escherichia coli. J Mol Microbiol Biotechnol, 2002. 4(3): p. 341-6. 
65. Schweder, T., et al., Regulation of Escherichia coli starvation sigma factor (sigma s) by ClpXP 
protease. J Bacteriol, 1996. 178(2): p. 470-6. 
66. Mika, F. and R. Hengge, A two-component phosphotransfer network involving ArcB, ArcA, and 
RssB coordinates synthesis and proteolysis of sigmaS (RpoS) in E. coli. Genes Dev, 2005. 19(22): 
p. 2770-81. 
67. Bougdour, A., S. Wickner, and S. Gottesman, Modulating RssB activity: IraP, a novel regulator of 
sigma(S) stability in Escherichia coli. Genes Dev, 2006. 20(7): p. 884-97. 
68. Bougdour, A., et al., Multiple pathways for regulation of sigmaS (RpoS) stability in Escherichia 
coli via the action of multiple anti-adaptors. Mol Microbiol, 2008. 68(2): p. 298-313. 
69. Merrikh, H., et al., A DNA damage response in Escherichia coli involving the alternative sigma 
factor, RpoS. Proc Natl Acad Sci U S A, 2009. 106(2): p. 611-6. 
 
97 
 
70. Nakano, M.M., et al., Loss-of-function mutations in yjbD result in ClpX- and ClpP-independent 
competence development of Bacillus subtilis. Mol Microbiol, 2001. 42(2): p. 383-94. 
71. Nakano, S., et al., Spx-dependent global transcriptional control is induced by thiol-specific 
oxidative stress in Bacillus subtilis. Proc Natl Acad Sci U S A, 2003. 100(23): p. 13603-8. 
72. Choi, S.Y., et al., The global regulator Spx functions in the control of organosulfur metabolism in 
Bacillus subtilis. J Bacteriol, 2006. 188(16): p. 5741-51. 
73. Newberry, K.J., et al., Crystal structure of the Bacillus subtilis anti-alpha, global transcriptional 
regulator, Spx, in complex with the alpha C-terminal domain of RNA polymerase. Proc Natl Acad 
Sci U S A, 2005. 102(44): p. 15839-44. 
74. Nakano, S., et al., Redox-sensitive transcriptional control by a thiol/disulphide switch in the 
global regulator, Spx. Mol Microbiol, 2005. 55(2): p. 498-510. 
75. Zhang, Y. and P. Zuber, Requirement of the zinc-binding domain of ClpX for Spx proteolysis in 
Bacillus subtilis and effects of disulfide stress on ClpXP activity. J Bacteriol, 2007. 189(21): p. 
7669-80. 
76. Dubnau D, T.K., Regulation of competence in Bacillus subtilis and its relation to stress. Bacterial 
stress response, edited by Storz G and Hengge-Aronis. ASM press, 2000: p. 249-260. 
77. Chen, I., P.J. Christie, and D. Dubnau, The ins and outs of DNA transfer in bacteria. Science, 2005. 
310(5753): p. 1456-60. 
78. Hamoen, L.W., et al., A small gene, designated comS, located within the coding region of the 
fourth amino acid-activation domain of srfA, is required for competence development in Bacillus 
subtilis. Mol Microbiol, 1995. 15(1): p. 55-63. 
79. Nakano, M.M., et al., Mutations conferring amino acid residue substitutions in the carboxy-
terminal domain of RNA polymerase alpha can suppress clpX and clpP with respect to 
developmentally regulated transcription in Bacillus subtilis. Mol Microbiol, 2000. 37(4): p. 869-
84. 
80. Derre, I., G. Rapoport, and T. Msadek, CtsR, a novel regulator of stress and heat shock response, 
controls clp and molecular chaperone gene expression in gram-positive bacteria. Mol Microbiol, 
1999. 31(1): p. 117-31. 
81. Hecker, M., W. Schumann, and U. Volker, Heat-shock and general stress response in Bacillus 
subtilis. Mol Microbiol, 1996. 19(3): p. 417-28. 
82. Derre, I., et al., ClpE, a novel type of HSP100 ATPase, is part of the CtsR heat shock regulon of 
Bacillus subtilis. Mol Microbiol, 1999. 32(3): p. 581-93. 
83. Frees, D., et al., Clp ATPases are required for stress tolerance, intracellular replication and biofilm 
formation in Staphylococcus aureus. Mol Microbiol, 2004. 54(5): p. 1445-62. 
84. Kruger, E. and M. Hecker, The first gene of the Bacillus subtilis clpC operon, ctsR, encodes a 
negative regulator of its own operon and other class III heat shock genes. J Bacteriol, 1998. 
180(24): p. 6681-8. 
85. Nair, S., et al., CtsR controls class III heat shock gene expression in the human pathogen Listeria 
monocytogenes. Mol Microbiol, 2000. 35(4): p. 800-11. 
86. Derre, I., G. Rapoport, and T. Msadek, The CtsR regulator of stress response is active as a dimer 
and specifically degraded in vivo at 37 degrees C. Mol Microbiol, 2000. 38(2): p. 335-47. 
87. Kwon, H.Y., et al., Effect of heat shock and mutations in ClpL and ClpP on virulence gene 
expression in Streptococcus pneumoniae. Infect Immun, 2003. 71(7): p. 3757-65. 
88. Chastanet, A., et al., Regulation of Streptococcus pneumoniae clp genes and their role in 
competence development and stress survival. J Bacteriol, 2001. 183(24): p. 7295-307. 
89. Chastanet, A., J. Fert, and T. Msadek, Comparative genomics reveal novel heat shock regulatory 
mechanisms in Staphylococcus aureus and other Gram-positive bacteria. Mol Microbiol, 2003. 
47(4): p. 1061-73. 
90. Chastanet, A., et al., clpB, a novel member of the Listeria monocytogenes CtsR regulon, is 
involved in virulence but not in general stress tolerance. J Bacteriol, 2004. 186(4): p. 1165-74. 
 
98 
 
91. Lemos, J.A. and R.A. Burne, Regulation and Physiological Significance of ClpC and ClpP in 
Streptococcus mutans. J Bacteriol, 2002. 184(22): p. 6357-66. 
92. Gerth, U., et al., Fine-tuning in regulation of Clp protein content in Bacillus subtilis. J Bacteriol, 
2004. 186(1): p. 179-91. 
93. Kruger, E., et al., Clp-mediated proteolysis in Gram-positive bacteria is autoregulated by the 
stability of a repressor. EMBO J, 2001. 20(4): p. 852-63. 
94. Kirstein, J., et al., A tyrosine kinase and its activator control the activity of the CtsR heat shock 
repressor in B. subtilis. EMBO J, 2005. 24(19): p. 3435-45. 
95. Fuhrmann, J., et al., McsB is a protein arginine kinase that phosphorylates and inhibits the heat-
shock regulator CtsR. Science, 2009. 324(5932): p. 1323-7. 
96. Kirstein, J., et al., The tyrosine kinase McsB is a regulated adaptor protein for ClpCP. EMBO J, 
2007. 26(8): p. 2061-70. 
97. Msadek, T., et al., ClpP of Bacillus subtilis is required for competence development, motility, 
degradative enzyme synthesis, growth at high temperature and sporulation. Mol Microbiol, 
1998. 27(5): p. 899-914. 
98. Frees, D. and H. Ingmer, ClpP participates in the degradation of misfolded protein in Lactococcus 
lactis. Mol Microbiol, 1999. 31(1): p. 79-87. 
99. Gaillot, O., et al., The ClpP serine protease is essential for the intracellular parasitism and 
virulence of Listeria monocytogenes. Mol Microbiol, 2000. 35(6): p. 1286-94. 
100. Nair, S., et al., Role of the Streptococcus agalactiae ClpP serine protease in heat-induced stress 
defence and growth arrest. Microbiology, 2003. 149(Pt 2): p. 407-17. 
101. Frees, D., et al., Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and 
virulence. Mol Microbiol, 2003. 48(6): p. 1565-78. 
102. Wang, C., et al., Role of ClpP in biofilm formation and virulence of Staphylococcus epidermidis. 
Microbes Infect, 2007. 9(11): p. 1376-83. 
103. Charpentier, E., R. Novak, and E. Tuomanen, Regulation of growth inhibition at high 
temperature, autolysis, transformation and adherence in Streptococcus pneumoniae by clpC. 
Mol Microbiol, 2000. 37(4): p. 717-26. 
104. Nair, S., et al., ClpE, a novel member of the HSP100 family, is involved in cell division and 
virulence of Listeria monocytogenes. Mol Microbiol, 1999. 31(1): p. 185-96. 
105. Kajfasz, J.K., et al., Role of Clp proteins in expression of virulence properties of Streptococcus 
mutans. J Bacteriol, 2009. 191(7): p. 2060-8. 
106. Robertson, G.T., et al., Essentiality of clpX, but not clpP, clpL, clpC, or clpE, in Streptococcus 
pneumoniae R6. J Bacteriol, 2003. 185(9): p. 2961-6. 
107. Borezee, E., et al., Identification in Listeria monocytogenes of MecA, a homologue of the Bacillus 
subtilis competence regulatory protein. J Bacteriol, 2000. 182(20): p. 5931-4. 
108. Borezee, E., et al., SvpA, a novel surface virulence-associated protein required for intracellular 
survival of Listeria monocytogenes. Microbiology, 2001. 147(Pt 11): p. 2913-23. 
109. Gaillot, O., et al., Stress-induced ClpP serine protease of Listeria monocytogenes is essential for 
induction of listeriolysin O-dependent protective immunity. Infect Immun, 2001. 69(8): p. 4938-
43. 
110. Raynaud, C. and A. Charbit, Regulation of expression of type I signal peptidases in Listeria 
monocytogenes. Microbiology, 2005. 151(Pt 11): p. 3769-76. 
111. Rouquette, C., et al., The ClpC ATPase of Listeria monocytogenes is a general stress protein 
required for virulence and promoting early bacterial escape from the phagosome of 
macrophages. Mol Microbiol, 1998. 27(6): p. 1235-45. 
112. Liu, S., et al., Identification of Listeria monocytogenes genes expressed in response to growth at 
low temperature. Appl Environ Microbiol, 2002. 68(4): p. 1697-705. 
113. Donegan, N.P., et al., Proteolytic regulation of toxin-antitoxin systems by ClpPC in Staphylococcus 
aureus. J Bacteriol, 2010. 192(5): p. 1416-22. 
 
99 
 
114. Frees, D., K. Sorensen, and H. Ingmer, Global virulence regulation in Staphylococcus aureus: 
pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network. Infect Immun, 2005. 
73(12): p. 8100-8. 
115. Michel, A., et al., Global regulatory impact of ClpP protease of Staphylococcus aureus on 
regulons involved in virulence, oxidative stress response, autolysis, and DNA repair. J Bacteriol, 
2006. 188(16): p. 5783-96. 
116. Chatterjee, I., et al., Staphylococcus aureus ClpC is required for stress resistance, aconitase 
activity, growth recovery, and death. J Bacteriol, 2005. 187(13): p. 4488-96. 
117. Jelsbak, L., et al., The chaperone ClpX stimulates expression of Staphylococcus aureus protein A 
by Rot dependent and independent pathways. PLoS One, 2010. 5(9): p. e12752. 
118. Mei, J.M., et al., Identification of Staphylococcus aureus virulence genes in a murine model of 
bacteraemia using signature-tagged mutagenesis. Mol Microbiol, 1997. 26(2): p. 399-407. 
119. Frees, D., L.E. Thomsen, and H. Ingmer, Staphylococcus aureus ClpYQ plays a minor role in stress 
survival. Arch Microbiol, 2005. 183(4): p. 286-91. 
120. Cao, J., et al., Enhanced protection against pneumococcal infection elicited by immunization with 
the combination of PspA, PspC, and ClpP. Vaccine, 2007. 25(27): p. 4996-5005. 
121. Ibrahim, Y.M., et al., Contribution of the ATP-dependent protease ClpCP to the autolysis and 
virulence of Streptococcus pneumoniae. Infect Immun, 2005. 73(2): p. 730-40. 
122. Kwon, H.Y., et al., The ClpP protease of Streptococcus pneumoniae modulates virulence gene 
expression and protects against fatal pneumococcal challenge. Infect Immun, 2004. 72(10): p. 
5646-53. 
123. Robertson, G.T., et al., Global transcriptional analysis of clpP mutations of type 2 Streptococcus 
pneumoniae and their effects on physiology and virulence. J Bacteriol, 2002. 184(13): p. 3508-20. 
124. Sung, C.K. and D.A. Morrison, Two distinct functions of ComW in stabilization and activation of 
the alternative sigma factor ComX in Streptococcus pneumoniae. J Bacteriol, 2005. 187(9): p. 
3052-61. 
125. Wu, K., et al., Immunization with a combination of three pneumococcal proteins confers additive 
and broad protection against Streptococcus pneumoniae Infections in Mice. Infect Immun, 2010. 
78(3): p. 1276-83. 
126. Park, C.Y., et al., Virulence attenuation of Streptococcus pneumoniae clpP mutant by sensitivity 
to oxidative stress in macrophages via an NO-mediated pathway. J Microbiol, 2010. 48(2): p. 
229-35. 
127. Polissi, A., et al., Large-scale identification of virulence genes from Streptococcus pneumoniae. 
Infect Immun, 1998. 66(12): p. 5620-9. 
128. Zhang, Q., et al., Contribution of ClpE to virulence of Streptococcus pneumoniae. Can J Microbiol, 
2009. 55(10): p. 1187-94. 
129. Choi, I.H., et al., Limited stress response in Streptococcus pneumoniae. Microbiol Immunol, 1999. 
43(8): p. 807-12. 
130. Tu le, N., et al., Modulation of adherence, invasion, and tumor necrosis factor alpha secretion 
during the early stages of infection by Streptococcus pneumoniae ClpL. Infect Immun, 2007. 
75(6): p. 2996-3005. 
131. Deng, D.M., J.M. ten Cate, and W. Crielaard, The adaptive response of Streptococcus mutans 
towards oral care products: involvement of the ClpP serine protease. Eur J Oral Sci, 2007. 115(5): 
p. 363-70. 
132. Niu, G., et al., The Streptococcus mutans IrvR repressor is a CI-like regulator that functions 
through autocleavage and Clp-dependent proteolysis. J Bacteriol, 2010. 192(6): p. 1586-95. 
133. Len, A.C., D.W. Harty, and N.A. Jacques, Stress-responsive proteins are upregulated in 
Streptococcus mutans during acid tolerance. Microbiology, 2004. 150(Pt 5): p. 1339-51. 
 
100 
 
134. Ripio, M.T., et al., Evidence for expressional crosstalk between the central virulence regulator 
PrfA and the stress response mediator ClpC in Listeria monocytogenes. FEMS Microbiol Lett, 
1998. 158(1): p. 45-50. 
135. Novick, R.P., Mobile genetic elements and bacterial toxinoses: the superantigen-encoding 
pathogenicity islands of Staphylococcus aureus. Plasmid, 2003. 49(2): p. 93-105. 
136. Oscarsson, J., C. Harlos, and S. Arvidson, Regulatory role of proteins binding to the spa (protein 
A) and sarS (staphylococcal accessory regulator) promoter regions in Staphylococcus aureus 
NTCC 8325-4. Int J Med Microbiol, 2005. 295(4): p. 253-66. 
137. Brotz-Oesterhelt, H., et al., Dysregulation of bacterial proteolytic machinery by a new class of 
antibiotics. Nat Med, 2005. 11(10): p. 1082-7. 
138. Kirstein, J., et al., The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an 
uncontrolled protease. EMBO Mol Med, 2009. 1(1): p. 37-49. 
139. Beall, B., R. Facklam, and T. Thompson, Sequencing emm-specific PCR products for routine and 
accurate typing of group A streptococci. J Clin Microbiol, 1996. 34(4): p. 953-8. 
140. Jones, K.F., et al., Genetic diversity among the T-protein genes of group A streptococci. Mol 
Microbiol, 1991. 5(12): p. 2947-52. 
141. Martin, J.M. and M. Green, Group A streptococcus. Semin Pediatr Infect Dis, 2006. 17(3): p. 140-
8. 
142. Cunningham, M.W., Pathogenesis of group A streptococcal infections. Clin Microbiol Rev, 2000. 
13(3): p. 470-511. 
143. Bessen, D.E., et al., Genetic correlates of throat and skin isolates of group A streptococci. J Infect 
Dis, 1996. 173(4): p. 896-900. 
144. Ferretti, J.J., et al., Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc 
Natl Acad Sci U S A, 2001. 98(8): p. 4658-63. 
145. Musser, J.M. and F.R. DeLeo, Toward a genome-wide systems biology analysis of host-pathogen 
interactions in group A Streptococcus. Am J Pathol, 2005. 167(6): p. 1461-72. 
146. Akesson, P., A.G. Sjoholm, and L. Bjorck, Protein SIC, a novel extracellular protein of 
Streptococcus pyogenes interfering with complement function. J Biol Chem, 1996. 271(2): p. 
1081-8. 
147. Chatellier, S., et al., Genetic relatedness and superantigen expression in group A streptococcus 
serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun, 
2000. 68(6): p. 3523-34. 
148. Kotb, M., et al., An immunogenetic and molecular basis for differences in outcomes of invasive 
group A streptococcal infections. Nat Med, 2002. 8(12): p. 1398-404. 
149. Hu, M.C., et al., Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun, 
2002. 70(4): p. 2171-7. 
150. Dale, J.B., Multivalant group A streptococcal vaccine. In: StevensDL, Kaplan EL, eds. Streptococcal 
infections: clinical aspects, microbiology, and molecular phatogenesis. New York: Oxford 
universiy press, 2000: p. 390-401. 
151. Fischetti, Vaccine approaches to protect against group A streptococcal pharyngitis. In: Fischetti 
VA, et al, eds. Gram positive pathogens. American society for microbiology, 2000: p. 96-104. 
152. Hasty, D.L., et al., Multiple adhesins of streptococci. Infect Immun, 1992. 60(6): p. 2147-52. 
153. Caparon, M.G., et al., Role of M protein in adherence of group A streptococci. Infect Immun, 
1991. 59(5): p. 1811-7. 
154. Manetti, A.G., et al., Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm 
formation. Mol Microbiol, 2007. 64(4): p. 968-83. 
155. Ashbaugh, C.D., et al., Bacterial determinants of persistent throat colonization and the 
associated immune response in a primate model of human group A streptococcal pharyngeal 
infection. Cell Microbiol, 2000. 2(4): p. 283-92. 
 
101 
 
156. LaPenta, D., et al., Group A streptococci efficiently invade human respiratory epithelial cells. Proc 
Natl Acad Sci U S A, 1994. 91(25): p. 12115-9. 
157. Greco, R., et al., Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol, 
1995. 146(7): p. 551-60. 
158. Osterlund, A., et al., Intracellular reservoir of Streptococcus pyogenes in vivo: a possible 
explanation for recurrent pharyngotonsillitis. Laryngoscope, 1997. 107(5): p. 640-7. 
159. Scott, J.R., et al., Relationship of M protein genes in group A streptococci. Proc Natl Acad Sci U S 
A, 1985. 82(6): p. 1822-6. 
160. Horstmann, R.D., et al., Antiphagocytic activity of streptococcal M protein: selective binding of 
complement control protein factor H. Proc Natl Acad Sci U S A, 1988. 85(5): p. 1657-61. 
161. Whitnack, E. and E.H. Beachey, Biochemical and biological properties of the binding of human 
fibrinogen to M protein in group A streptococci. J Bacteriol, 1985. 164(1): p. 350-8. 
162. Okada, N., et al., Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein 
of the group A streptococcus. Proc Natl Acad Sci U S A, 1995. 92(7): p. 2489-93. 
163. Caparon, M.G. and J.R. Scott, Identification of a gene that regulates expression of M protein, the 
major virulence determinant of group A streptococci. Proc Natl Acad Sci U S A, 1987. 84(23): p. 
8677-81. 
164. McIver, K.S., A.S. Thurman, and J.R. Scott, Regulation of mga transcription in the group A 
streptococcus: specific binding of mga within its own promoter and evidence for a negative 
regulator. J Bacteriol, 1999. 181(17): p. 5373-83. 
165. Bisno, A.L., M.O. Brito, and C.M. Collins, Molecular basis of group A streptococcal virulence. 
Lancet Infect Dis, 2003. 3(4): p. 191-200. 
166. Heath, D.G. and P.P. Cleary, Fc-receptor and M-protein genes of group A streptococci are 
products of gene duplication. Proc Natl Acad Sci U S A, 1989. 86(12): p. 4741-5. 
167. Jeppson, H., E. Frithz, and L.O. Heden, Duplication of a DNA sequence homologous to genes for 
immunoglobulin receptors and M proteins in Streptococcus pyogenes. FEMS Microbiol Lett, 
1992. 71(2): p. 139-45. 
168. Cleary, P. and D. Retnoningrum, Group A streptococcal immunoglobulin-binding proteins: 
adhesins, molecular mimicry or sensory proteins? Trends Microbiol, 1994. 2(4): p. 131-6. 
169. Hollingshead, S.K., et al., Structural heterogeneity of the emm gene cluster in group A 
streptococci. Mol Microbiol, 1993. 8(4): p. 707-17. 
170. Bessen, D.E. and V.A. Fischetti, Nucleotide sequences of two adjacent M or M-like protein genes 
of group A streptococci: different RNA transcript levels and identification of a unique 
immunoglobulin A-binding protein. Infect Immun, 1992. 60(1): p. 124-35. 
171. Visai, L., et al., Isolation and characterization of a novel collagen-binding protein from 
Streptococcus pyogenes strain 6414. J Biol Chem, 1995. 270(1): p. 347-53. 
172. McLandsborough, L.A. and P.P. Cleary, Insertional inactivation of virR in Streptococcus pyogenes 
M49 demonstrates that VirR functions as a positive regulator of ScpA, FcRA, OF, and M protein. 
FEMS Microbiol Lett, 1995. 128(1): p. 45-51. 
173. Cleary, P.P., et al., Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun, 
1992. 60(12): p. 5219-23. 
174. Purushothaman, S.S., H.S. Park, and P.P. Cleary, Promotion of fibronectin independent invasion 
by C5a peptidase into epithelial cells in group A Streptococcus. Indian J Med Res, 2004. 119 
Suppl: p. 44-7. 
175. Koroleva, I.V., A. Efstratiou, and A.N. Suvorov, Structural heterogeneity of the streptococcal C5a 
peptidase gene in Streptococcus pyogenes. J Bacteriol, 2002. 184(22): p. 6384-6. 
176. Wessels, M.R. and M.S. Bronze, Critical role of the group A streptococcal capsule in pharyngeal 
colonization and infection in mice. Proc Natl Acad Sci U S A, 1994. 91(25): p. 12238-42. 
 
102 
 
177. Schrager, H.M., et al., Hyaluronic acid capsule modulates M protein-mediated adherence and 
acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin 
Invest, 1998. 101(8): p. 1708-16. 
178. Cywes, C. and M.R. Wessels, Group A Streptococcus tissue invasion by CD44-mediated cell 
signalling. Nature, 2001. 414(6864): p. 648-52. 
179. Whitnack, E., A.L. Bisno, and E.H. Beachey, Hyaluronate capsule prevents attachment of group A 
streptococci to mouse peritoneal macrophages. Infect Immun, 1981. 31(3): p. 985-91. 
180. Stoolmiller, A.C. and A. Dorfman, The biosynthesis of hyaluronic acid by Streptococcus. J Biol 
Chem, 1969. 244(2): p. 236-46. 
181. Dougherty, B.A. and I. van de Rijn, Molecular characterization of a locus required for hyaluronic 
acid capsule production in group A streptococci. J Exp Med, 1992. 175(5): p. 1291-9. 
182. Ashbaugh, C.D., S. Alberti, and M.R. Wessels, Molecular analysis of the capsule gene region of 
group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol, 1998. 
180(18): p. 4955-9. 
183. Crater, D.L., B.A. Dougherty, and I. van de Rijn, Molecular characterization of hasC from an 
operon required for hyaluronic acid synthesis in group A streptococci. Demonstration of UDP-
glucose pyrophosphorylase activity. J Biol Chem, 1995. 270(48): p. 28676-80. 
184. Levin, J.C. and M.R. Wessels, Identification of csrR/csrS, a genetic locus that regulates hyaluronic 
acid capsule synthesis in group A Streptococcus. Mol Microbiol, 1998. 30(1): p. 209-19. 
185. Federle, M.J., K.S. McIver, and J.R. Scott, A response regulator that represses transcription of 
several virulence operons in the group A streptococcus. J Bacteriol, 1999. 181(12): p. 3649-57. 
186. Graham, M.R., et al., Virulence control in group A Streptococcus by a two-component gene 
regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci 
U S A, 2002. 99(21): p. 13855-60. 
187. Courtney, H.S., D.L. Hasty, and J.B. Dale, Molecular mechanisms of adhesion, colonization, and 
invasion of group A streptococci. Ann Med, 2002. 34(2): p. 77-87. 
188. Courtney, H.S., et al., Lipoteichoic acid and M protein: dual adhesins of group A streptococci. 
Microb Pathog, 1992. 12(3): p. 199-208. 
189. Hanski, E., P.A. Horwitz, and M.G. Caparon, Expression of protein F, the fibronectin-binding 
protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains 
promotes their adherence to respiratory epithelial cells. Infect Immun, 1992. 60(12): p. 5119-25. 
190. Kreikemeyer, B., S.R. Talay, and G.S. Chhatwal, Characterization of a novel fibronectin-binding 
surface protein in group A streptococci. Mol Microbiol, 1995. 17(1): p. 137-45. 
191. Courtney, H.S., J.B. Dale, and D.I. Hasty, Differential effects of the streptococcal fibronectin-
binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and HEp-2 
tissue culture cells. Infect Immun, 1996. 64(7): p. 2415-9. 
192. Jaffe, J., et al., Protein F2, a novel fibronectin-binding protein from Streptococcus pyogenes, 
possesses two binding domains. Mol Microbiol, 1996. 21(2): p. 373-84. 
193. Rocha, C.L. and V.A. Fischetti, Identification and characterization of a novel fibronectin-binding 
protein on the surface of group A streptococci. Infect Immun, 1999. 67(6): p. 2720-8. 
194. Strauch, K.L. and J. Beckwith, An Escherichia coli mutation preventing degradation of abnormal 
periplasmic proteins. Proc Natl Acad Sci U S A, 1988. 85(5): p. 1576-80. 
195. Strauch, K.L., K. Johnson, and J. Beckwith, Characterization of degP, a gene required for 
proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature. J 
Bacteriol, 1989. 171(5): p. 2689-96. 
196. Lyon, W.R. and M.G. Caparon, Role for serine protease HtrA (DegP) of Streptococcus pyogenes in 
the biogenesis of virulence factors SpeB and the hemolysin streptolysin S. Infect Immun, 2004. 
72(3): p. 1618-25. 
197. Mora, M., et al., Group A Streptococcus produce pilus-like structures containing protective 
antigens and Lancefield T antigens. Proc Natl Acad Sci U S A, 2005. 102(43): p. 15641-6. 
 
103 
 
198. Lottenberg, R., D. Minning-Wenz, and M.D. Boyle, Capturing host plasmin(ogen): a common 
mechanism for invasive pathogens? Trends Microbiol, 1994. 2(1): p. 20-4. 
199. Sun, H., et al., Plasminogen is a critical host pathogenicity factor for group A streptococcal 
infection. Science, 2004. 305(5688): p. 1283-6. 
200. McCarty, The occurrence of nucleases in culture filtrates of group A hemolytic streptococci. J Exp 
Med, 1948. 88(2): p. 181-8. 
201. Ferreira, B.T., et al., Extracellular deoxyribonucleases of streptococci: a comparison of their 
occurrence and levels of production among beta-hemolytic strains of various serological groups. 
Zentralbl Bakteriol, 1992. 277(4): p. 493-503. 
202. Aziz, R.K., et al., Post-proteomic identification of a novel phage-encoded streptodornase, Sda1, in 
invasive M1T1 Streptococcus pyogenes. Mol Microbiol, 2004. 54(1): p. 184-97. 
203. Broudy, T.B., V. Pancholi, and V.A. Fischetti, The in vitro interaction of Streptococcus pyogenes 
with human pharyngeal cells induces a phage-encoded extracellular DNase. Infect Immun, 2002. 
70(6): p. 2805-11. 
204. Voyich, J.M., et al., Genome-wide protective response used by group A Streptococcus to evade 
destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A, 2003. 100(4): p. 
1996-2001. 
205. Brinkmann, V., et al., Neutrophil extracellular traps kill bacteria. Science, 2004. 303(5663): p. 
1532-5. 
206. Sumby, P., et al., Extracellular deoxyribonuclease made by group A Streptococcus assists 
pathogenesis by enhancing evasion of the innate immune response. Proc Natl Acad Sci U S A, 
2005. 102(5): p. 1679-84. 
207. Buchanan, J.T., et al., DNase expression allows the pathogen group A Streptococcus to escape 
killing in neutrophil extracellular traps. Curr Biol, 2006. 16(4): p. 396-400. 
208. Fernie-King, B.A., et al., Streptococcal inhibitor of complement (SIC) inhibits the membrane 
attack complex by preventing uptake of C567 onto cell membranes. Immunology, 2001. 103(3): 
p. 390-8. 
209. Frick, I.M., et al., SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial 
peptides. J Biol Chem, 2003. 278(19): p. 16561-6. 
210. Fernie-King, B.A., et al., Streptococcal inhibitor of complement inhibits two additional 
components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and 
lysozyme. Infect Immun, 2002. 70(9): p. 4908-16. 
211. Hoe, N.P., et al., Insight into the molecular basis of pathogen abundance: group A Streptococcus 
inhibitor of complement inhibits bacterial adherence and internalization into human cells. Proc 
Natl Acad Sci U S A, 2002. 99(11): p. 7646-51. 
212. Yu, C.E. and J.J. Ferretti, Frequency of the erythrogenic toxin B and C genes (speB and speC) 
among clinical isolates of group A streptococci. Infect Immun, 1991. 59(1): p. 211-5. 
213. Kapur, V., et al., A conserved Streptococcus pyogenes extracellular cysteine protease cleaves 
human fibronectin and degrades vitronectin. Microb Pathog, 1993. 15(5): p. 327-46. 
214. Collin, M. and A. Olsen, Effect of SpeB and EndoS from Streptococcus pyogenes on human 
immunoglobulins. Infect Immun, 2001. 69(11): p. 7187-9. 
215. Kuo, C.F., et al., Degradation of complement 3 by streptococcal pyrogenic exotoxin B inhibits 
complement activation and neutrophil opsonophagocytosis. Infect Immun, 2008. 76(3): p. 1163-
9. 
216. Kapur, V., et al., Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta 
by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci 
U S A, 1993. 90(16): p. 7676-80. 
217. Herwald, H., et al., Streptococcal cysteine proteinase releases kinins: a virulence mechanism. J 
Exp Med, 1996. 184(2): p. 665-73. 
 
104 
 
218. Schmidtchen, A., I.M. Frick, and L. Bjorck, Dermatan sulphate is released by proteinases of 
common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol, 2001. 
39(3): p. 708-13. 
219. Berge, A. and L. Bjorck, Streptococcal cysteine proteinase releases biologically active fragments 
of streptococcal surface proteins. J Biol Chem, 1995. 270(17): p. 9862-7. 
220. Raeder, R., et al., A secreted streptococcal cysteine protease can cleave a surface-expressed M1 
protein and alter the immunoglobulin binding properties. Res Microbiol, 1998. 149(8): p. 539-48. 
221. Svensson, M.D., et al., Roles of the plasminogen activator streptokinase and the plasminogen-
associated M protein in an experimental model for streptococcal impetigo. Microbiology, 2002. 
148(Pt 12): p. 3933-45. 
222. Walker, M.J., et al., DNase Sda1 provides selection pressure for a switch to invasive group A 
streptococcal infection. Nat Med, 2007. 13(8): p. 981-5. 
223. Rosch, J.W. and M.G. Caparon, The ExPortal: an organelle dedicated to the biogenesis of 
secreted proteins in Streptococcus pyogenes. Mol Microbiol, 2005. 58(4): p. 959-68. 
224. Collin, M. and A. Olsen, Generation of a mature streptococcal cysteine proteinase is dependent 
on cell wall-anchored M1 protein. Mol Microbiol, 2000. 36(6): p. 1306-18. 
225. von Pawel-Rammingen, U., B.P. Johansson, and L. Bjorck, IdeS, a novel streptococcal cysteine 
proteinase with unique specificity for immunoglobulin G. EMBO J, 2002. 21(7): p. 1607-15. 
226. Lei, B., et al., Evasion of human innate and acquired immunity by a bacterial homolog of CD11b 
that inhibits opsonophagocytosis. Nat Med, 2001. 7(12): p. 1298-305. 
227. Soderberg, J.J. and U. von Pawel-Rammingen, The streptococcal protease IdeS modulates 
bacterial IgGFc binding and generates 1/2Fc fragments with the ability to prime 
polymorphonuclear leucocytes. Mol Immunol, 2008. 45(12): p. 3347-53. 
228. Shatursky, O., et al., The mechanism of membrane insertion for a cholesterol-dependent 
cytolysin: a novel paradigm for pore-forming toxins. Cell, 1999. 99(3): p. 293-9. 
229. Carr, A., et al., Similarities between complement-mediated and streptolysin S-mediated 
hemolysis. J Biol Chem, 2001. 276(45): p. 41790-6. 
230. Sierig, G., et al., Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of 
poorly encapsulated group a streptococci. Infect Immun, 2003. 71(1): p. 446-55. 
231. Betschel, S.D., et al., Reduced virulence of group A streptococcal Tn916 mutants that do not 
produce streptolysin S. Infect Immun, 1998. 66(4): p. 1671-9. 
232. Nizet, V., et al., Genetic locus for streptolysin S production by group A streptococcus. Infect 
Immun, 2000. 68(7): p. 4245-54. 
233. Mangold, M., et al., Synthesis of group A streptococcal virulence factors is controlled by a 
regulatory RNA molecule. Mol Microbiol, 2004. 53(5): p. 1515-27. 
234. Papageorgiou, A.C. and K.R. Acharya, Microbial superantigens: from structure to function. Trends 
Microbiol, 2000. 8(8): p. 369-75. 
235. Opdyke, J.A., J.R. Scott, and C.P. Moran, Jr., A secondary RNA polymerase sigma factor from 
Streptococcus pyogenes. Mol Microbiol, 2001. 42(2): p. 495-502. 
236. Kreikemeyer, B., K.S. McIver, and A. Podbielski, Virulence factor regulation and regulatory 
networks in Streptococcus pyogenes and their impact on pathogen-host interactions. Trends 
Microbiol, 2003. 11(5): p. 224-32. 
237. McIver, K.S. and J.R. Scott, Role of mga in growth phase regulation of virulence genes of the 
group A streptococcus. J Bacteriol, 1997. 179(16): p. 5178-87. 
238. Beckert, S., B. Kreikemeyer, and A. Podbielski, Group A streptococcal rofA gene is involved in the 
control of several virulence genes and eukaryotic cell attachment and internalization. Infect 
Immun, 2001. 69(1): p. 534-7. 
239. Chaussee, M.S., et al., Rgg influences the expression of multiple regulatory loci to coregulate 
virulence factor expression in Streptococcus pyogenes. Infect Immun, 2002. 70(2): p. 762-70. 
 
105 
 
240. Robbins, J.C., et al., Streptococcus pyogenes type 12 M protein gene regulation by upstream 
sequences. J Bacteriol, 1987. 169(12): p. 5633-40. 
241. Bessen, D.E., et al., Evolution of transcription regulatory genes is linked to niche specialization in 
the bacterial pathogen Streptococcus pyogenes. J Bacteriol, 2005. 187(12): p. 4163-72. 
242. Caparon, M.G., et al., Environmental regulation of virulence in group A streptococci: transcription 
of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol, 1992. 174(17): p. 
5693-701. 
243. Simpson, W.J., et al., Coregulation of type 12 M protein and streptococcal C5a peptidase genes in 
group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol, 
1990. 172(2): p. 696-700. 
244. Kihlberg, B.M., et al., Biological properties of a Streptococcus pyogenes mutant generated by 
Tn916 insertion in mga. Microb Pathog, 1995. 19(5): p. 299-315. 
245. Hytonen, J., et al., Identification of a novel glycoprotein-binding activity in Streptococcus 
pyogenes regulated by the mga gene. Microbiology, 2000. 146 ( Pt 1): p. 31-9. 
246. Rasmussen, M., A. Eden, and L. Bjorck, SclA, a novel collagen-like surface protein of 
Streptococcus pyogenes. Infect Immun, 2000. 68(11): p. 6370-7. 
247. Ribardo, D.A. and K.S. McIver, Defining the Mga regulon: Comparative transcriptome analysis 
reveals both direct and indirect regulation by Mga in the group A streptococcus. Mol Microbiol, 
2006. 62(2): p. 491-508. 
248. Podbielski, A., et al., Molecular characterization of group A streptococcal (GAS) oligopeptide 
permease (opp) and its effect on cysteine protease production. Mol Microbiol, 1996. 21(5): p. 
1087-99. 
249. Podbielski, A. and B.A. Leonard, The group A streptococcal dipeptide permease (Dpp) is involved 
in the uptake of essential amino acids and affects the expression of cysteine protease. Mol 
Microbiol, 1998. 28(6): p. 1323-34. 
250. McIver, K.S., et al., Specific binding of the activator Mga to promoter sequences of the emm and 
scpA genes in the group A streptococcus. J Bacteriol, 1995. 177(22): p. 6619-24. 
251. Almengor, A.C. and K.S. McIver, Transcriptional activation of sclA by Mga requires a distal 
binding site in Streptococcus pyogenes. J Bacteriol, 2004. 186(23): p. 7847-57. 
252. Almengor, A.C., et al., The catabolite control protein CcpA binds to Pmga and influences 
expression of the virulence regulator Mga in the Group A streptococcus. J Bacteriol, 2007. 
189(23): p. 8405-16. 
253. Ribardo, D.A. and K.S. McIver, amrA encodes a putative membrane protein necessary for 
maximal exponential phase expression of the Mga virulence regulon in Streptococcus pyogenes. 
Mol Microbiol, 2003. 50(2): p. 673-85. 
254. Fogg, G.C. and M.G. Caparon, Constitutive expression of fibronectin binding in Streptococcus 
pyogenes as a result of anaerobic activation of rofA. J Bacteriol, 1997. 179(19): p. 6172-80. 
255. Kreikemeyer, B., et al., Group A streptococcal RofA-type global regulators exhibit a strain-specific 
genomic presence and regulation pattern. Microbiology, 2002. 148(Pt 5): p. 1501-11. 
256. Granok, A.B., et al., The RofA binding site in Streptococcus pyogenes is utilized in multiple 
transcriptional pathways. J Bacteriol, 2000. 182(6): p. 1529-40. 
257. VanHeyningen, T., et al., Adherence and fibronectin binding are environmentally regulated in the 
group A streptococci. Mol Microbiol, 1993. 9(6): p. 1213-22. 
258. Podbielski, A., et al., Characterization of nra, a global negative regulator gene in group A 
streptococci. Mol Microbiol, 1999. 31(4): p. 1051-64. 
259. Molinari, G., et al., The role played by the group A streptococcal negative regulator Nra on 
bacterial interactions with epithelial cells. Mol Microbiol, 2001. 40(1): p. 99-114. 
260. Kreikemeyer, B., et al., The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional 
regulatory network and its control of virulence factor expression from the novel eno ralp3 epf 
sagA pathogenicity region. Infect Immun, 2007. 75(12): p. 5698-710. 
 
106 
 
261. Kwinn, L.A., et al., Genetic characterization and virulence role of the RALP3/LSA locus upstream 
of the streptolysin s operon in invasive M1T1 Group A Streptococcus. J Bacteriol, 2007. 189(4): p. 
1322-9. 
262. Roberts, S.A., G.G. Churchward, and J.R. Scott, Unraveling the regulatory network in 
Streptococcus pyogenes: the global response regulator CovR represses rivR directly. J Bacteriol, 
2007. 189(4): p. 1459-63. 
263. Roberts, S.A. and J.R. Scott, RivR and the small RNA RivX: the missing links between the CovR 
regulatory cascade and the Mga regulon. Mol Microbiol, 2007. 66(6): p. 1506-22. 
264. Lyon, W.R., C.M. Gibson, and M.G. Caparon, A role for trigger factor and an rgg-like regulator in 
the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes. 
EMBO J, 1998. 17(21): p. 6263-75. 
265. Chaussee, M.S., D. Ajdic, and J.J. Ferretti, The rgg gene of Streptococcus pyogenes NZ131 
positively influences extracellular SPE B production. Infect Immun, 1999. 67(4): p. 1715-22. 
266. Sulavik, M.C., G. Tardif, and D.B. Clewell, Identification of a gene, rgg, which regulates expression 
of glucosyltransferase and influences the Spp phenotype of Streptococcus gordonii Challis. J 
Bacteriol, 1992. 174(11): p. 3577-86. 
267. Vickerman, M.M., P.E. Minick, and N.M. Mather, Characterization of the Streptococcus gordonii 
chromosomal region immediately downstream of the glucosyltransferase gene. Microbiology, 
2001. 147(Pt 11): p. 3061-70. 
268. Rawlinson, E.L., I.F. Nes, and M. Skaugen, Identification of the DNA-binding site of the Rgg-like 
regulator LasX within the lactocin S promoter region. Microbiology, 2005. 151(Pt 3): p. 813-23. 
269. Neely, M.N., et al., Role of RopB in growth phase expression of the SpeB cysteine protease of 
Streptococcus pyogenes. J Bacteriol, 2003. 185(17): p. 5166-74. 
270. Dmitriev, A.V., E.J. McDowell, and M.S. Chaussee, Inter- and intraserotypic variation in the 
Streptococcus pyogenes Rgg regulon. FEMS Microbiol Lett, 2008. 284(1): p. 43-51. 
271. Dmitriev, A.V., et al., The Rgg regulator of Streptococcus pyogenes influences utilization of 
nonglucose carbohydrates, prophage induction, and expression of the NAD-glycohydrolase 
virulence operon. J Bacteriol, 2006. 188(20): p. 7230-41. 
272. Chaussee, M.A., E.A. Callegari, and M.S. Chaussee, Rgg regulates growth phase-dependent 
expression of proteins associated with secondary metabolism and stress in Streptococcus 
pyogenes. J Bacteriol, 2004. 186(21): p. 7091-9. 
273. Chaussee, M.S., et al., Identification of Rgg-regulated exoproteins of Streptococcus pyogenes. 
Infect Immun, 2001. 69(2): p. 822-31. 
274. Chaussee, M.S., et al., Rgg coordinates virulence factor synthesis and metabolism in 
Streptococcus pyogenes. J Bacteriol, 2003. 185(20): p. 6016-24. 
275. Chaussee, M.A., et al., Proteomic analysis of a penicillin-tolerant rgg mutant strain of 
Streptococcus pyogenes. J Antimicrob Chemother, 2006. 58(4): p. 752-9. 
276. Reid, S.D., et al., Multilocus analysis of extracellular putative virulence proteins made by group A 
Streptococcus: population genetics, human serologic response, and gene transcription. Proc Natl 
Acad Sci U S A, 2001. 98(13): p. 7552-7. 
277. Doern, C.D., et al., Biofilm formation by group A Streptococcus: a role for the streptococcal 
regulator of virulence (Srv) and streptococcal cysteine protease (SpeB). Microbiology, 2009. 
155(Pt 1): p. 46-52. 
278. Reid, S.D., A.G. Montgomery, and J.M. Musser, Identification of srv, a PrfA-like regulator of 
group A streptococcus that influences virulence. Infect Immun, 2004. 72(3): p. 1799-803. 
279. Reid, S.D., et al., Inactivation of the group A Streptococcus regulator srv results in chromosome 
wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB. FEMS 
Immunol Med Microbiol, 2006. 48(2): p. 283-92. 
280. Malke, H. and J.J. Ferretti, CodY-affected transcriptional gene expression of Streptococcus 
pyogenes during growth in human blood. J Med Microbiol, 2007. 56(Pt 6): p. 707-14. 
 
107 
 
281. Malke, H., et al., Linking the nutritional status of Streptococcus pyogenes to alteration of 
transcriptional gene expression: the action of CodY and RelA. Int J Med Microbiol, 2006. 296(4-
5): p. 259-75. 
282. Loughman, J.A. and M.G. Caparon, A novel adaptation of aldolase regulates virulence in 
Streptococcus pyogenes. EMBO J, 2006. 25(22): p. 5414-22. 
283. Shelburne, S.A., 3rd, et al., MalE of group A Streptococcus participates in the rapid transport of 
maltotriose and longer maltodextrins. J Bacteriol, 2007. 189(7): p. 2610-7. 
284. Deutscher, J., et al., P-Ser-HPr--a link between carbon metabolism and the virulence of some 
pathogenic bacteria. Biochim Biophys Acta, 2005. 1754(1-2): p. 118-25. 
285. Hondorp, E.R. and K.S. McIver, The Mga virulence regulon: infection where the grass is greener. 
Mol Microbiol, 2007. 66(5): p. 1056-65. 
286. Nakata, M., A. Podbielski, and B. Kreikemeyer, MsmR, a specific positive regulator of the 
Streptococcus pyogenes FCT pathogenicity region and cytolysin-mediated translocation system 
genes. Mol Microbiol, 2005. 57(3): p. 786-803. 
287. Lizano, S., et al., Impact of orthologous gene replacement on the circuitry governing pilus gene 
transcription in streptococci. PLoS One, 2008. 3(10): p. e3450. 
288. Bates, C.S., et al., Characterization of MtsR, a new metal regulator in group A streptococcus, 
involved in iron acquisition and virulence. Infect Immun, 2005. 73(9): p. 5743-53. 
289. Hanks, T.S., et al., Differential regulation of iron- and manganese-specific MtsABC and heme-
specific HtsABC transporters by the metalloregulator MtsR of group A Streptococcus. Infect 
Immun, 2006. 74(9): p. 5132-9. 
290. Toukoki, C., et al., MtsR is a dual regulator that controls virulence genes and metabolic functions 
in addition to metal homeostasis in the group A streptococcus. Mol Microbiol, 2010. 76(4): p. 
971-89. 
291. Olsen, R.J., et al., Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation 
that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A, 2010. 107(2): p. 888-93. 
292. Cox, K.H., et al., Inactivation of DltA modulates virulence factor expression in Streptococcus 
pyogenes. PLoS One, 2009. 4(4): p. e5366. 
293. Pulliainen, A.T., et al., Deficiency of the Rgg regulator promotes H2O2 resistance, AhpCF-
mediated H2O2 decomposition, and virulence in Streptococcus pyogenes. J Bacteriol, 2008. 
190(9): p. 3225-35. 
294. Brenot, A., K.Y. King, and M.G. Caparon, The PerR regulon in peroxide resistance and virulence of 
Streptococcus pyogenes. Mol Microbiol, 2005. 55(1): p. 221-34. 
295. Brenot, A., B.F. Weston, and M.G. Caparon, A PerR-regulated metal transporter (PmtA) is an 
interface between oxidative stress and metal homeostasis in Streptococcus pyogenes. Mol 
Microbiol, 2007. 63(4): p. 1185-96. 
296. Tsou, C.C., et al., Oxidative stress and metal ions regulate a ferritin-like gene, dpr, in 
Streptococcus pyogenes. Int J Med Microbiol, 2010. 300(4): p. 259-64. 
297. Gao, J., et al., Binding of the global response regulator protein CovR to the sag promoter of 
Streptococcus pyogenes reveals a new mode of CovR-DNA interaction. J Biol Chem, 2005. 
280(47): p. 38948-56. 
298. Gusa, A.A. and J.R. Scott, The CovR response regulator of group A streptococcus (GAS) acts 
directly to repress its own promoter. Mol Microbiol, 2005. 56(5): p. 1195-207. 
299. Heath, A., et al., A two-component regulatory system, CsrR-CsrS, represses expression of three 
Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic 
exotoxin B. Infect Immun, 1999. 67(10): p. 5298-305. 
300. Leday, T.V., et al., TrxR, a new CovR-repressed response regulator that activates the Mga 
virulence regulon in group A Streptococcus. Infect Immun, 2008. 76(10): p. 4659-68. 
301. Shelburne, S.A., et al., A combination of independent transcriptional regulators shapes bacterial 
virulence gene expression during infection. PLoS Pathog, 2010. 6(3): p. e1000817. 
 
108 
 
302. Kreikemeyer, B., et al., Group A streptococcal growth phase-associated virulence factor 
regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a 
small RNA molecule. Mol Microbiol, 2001. 39(2): p. 392-406. 
303. Voyich, J.M., et al., Engagement of the pathogen survival response used by group A 
Streptococcus to avert destruction by innate host defense. J Immunol, 2004. 173(2): p. 1194-201. 
304. Hidalgo-Grass, C., et al., A locus of group A Streptococcus involved in invasive disease and DNA 
transfer. Mol Microbiol, 2002. 46(1): p. 87-99. 
305. Eran, Y., et al., Transcriptional regulation of the sil locus by the SilCR signalling peptide and its 
implications on group A streptococcus virulence. Mol Microbiol, 2007. 63(4): p. 1209-22. 
306. Shelburne, S.A., 3rd, et al., Central role of a bacterial two-component gene regulatory system of 
previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A, 
2005. 102(44): p. 16037-42. 
307. Liu, M., et al., Defects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A 
Streptococcus caused by interruption of response regulator gene vicR. Microbiology, 2006. 
152(Pt 4): p. 967-78. 
308. Sonenshein, A.L., CodY, a global regulator of stationary phase and virulence in Gram-positive 
bacteria. Curr Opin Microbiol, 2005. 8(2): p. 203-7. 
309. Bernish, B. and I. van de Rijn, Characterization of a two-component system in Streptococcus 
pyogenes which is involved in regulation of hyaluronic acid production. J Biol Chem, 1999. 
274(8): p. 4786-93. 
310. Miller, A.A., N.C. Engleberg, and V.J. DiRita, Repression of virulence genes by phosphorylation-
dependent oligomerization of CsrR at target promoters in S. pyogenes. Mol Microbiol, 2001. 
40(4): p. 976-90. 
311. Federle, M.J. and J.R. Scott, Identification of binding sites for the group A streptococcal global 
regulator CovR. Mol Microbiol, 2002. 43(5): p. 1161-72. 
312. Gryllos, I., J.C. Levin, and M.R. Wessels, The CsrR/CsrS two-component system of group A 
Streptococcus responds to environmental Mg2+. Proc Natl Acad Sci U S A, 2003. 100(7): p. 4227-
32. 
313. Argaman, L., et al., Novel small RNA-encoding genes in the intergenic regions of Escherichia coli. 
Curr. Biol., 2001. 11(12): p. 941-950. 
314. Kreikemeyer, B., et al., Group A streptococcal growth phase-associated virulence factor 
regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a 
small RNA molecule. Mol. Microbiol., 2001. 39(2): p. 392-406. 
315. Roberts, S.A. and J.R. Scott, RivR and the small RNA RivX: the missing links between the CovR 
regulatory cascade and the Mga regulon. Mol. Microbiol., 2007. 66(6): p. 1506-1522. 
316. Ringdahl, U., et al., Molecular co-operation between protein PAM and streptokinase for plasmin 
acquisition by Streptococcus pyogenes. J Biol Chem, 1998. 273(11): p. 6424-30. 
317. Opdyke, J.A., J.R. Scott, and C.P. Moran, Jr., Expression of the secondary sigma factor sigmaX in 
Streptococcus pyogenes is restricted at two levels. J Bacteriol, 2003. 185(15): p. 4291-7. 
318. Woodbury, R.L., X. Wang, and C.P. Moran, Jr., Sigma X induces competence gene expression in 
Streptococcus pyogenes. Res Microbiol, 2006. 157(9): p. 851-6. 
319. Steiner, K. and H. Malke, relA-Independent amino acid starvation response network of 
Streptococcus pyogenes. J Bacteriol, 2001. 183(24): p. 7354-64. 
320. Cooper, E.L., J. Garcia-Lara, and S.J. Foster, YsxC, an essential protein in Staphylococcus aureus 
crucial for ribosome assembly/stability. BMC Microbiol, 2009. 9: p. 266. 
321. Wicker-Planquart, C., et al., Interactions of an essential Bacillus subtilis GTPase, YsxC, with 
ribosomes. J Bacteriol, 2008. 190(2): p. 681-90. 
322. Martinussen, J., et al., Two genes encoding uracil phosphoribosyltransferase are present in 
Bacillus subtilis. J Bacteriol, 1995. 177(1): p. 271-4. 
 
109 
 
323. Bessman, M.J., D.N. Frick, and S.F. O'Handley, The MutT proteins or "Nudix" hydrolases, a family 
of versatile, widely distributed, "housecleaning" enzymes. J Biol Chem, 1996. 271(41): p. 25059-
62. 
324. Zhang, J., A. Banerjee, and I. Biswas, Transcription of clpP is enhanced by a unique tandem 
repeat sequence in Streptococcus mutans. J Bacteriol, 2009. 191(3): p. 1056-65. 
325. Cho, K.H. and M.G. Caparon, Patterns of virulence gene expression differ between biofilm and 
tissue communities of Streptococcus pyogenes. Mol Microbiol, 2005. 57(6): p. 1545-56. 
326. Swanson, J. and M. McCarty, Electron microscopic studies on opaque colony variants of group A 
streptococci. J Bacteriol, 1969. 100(1): p. 505-11. 
327. Schaefer, L., et al., Multiple GTPases participate in the assembly of the large ribosomal subunit in 
Bacillus subtilis. J Bacteriol, 2006. 188(23): p. 8252-8. 
328. Dassain, M., et al., A new essential gene of the 'minimal genome' affecting cell division. 
Biochimie, 1999. 81(8-9): p. 889-95. 
329. Pragai, Z. and C.R. Harwood, YsxC, a putative GTP-binding protein essential for growth of Bacillus 
subtilis 168. J Bacteriol, 2000. 182(23): p. 6819-23. 
330. Riethdorf, S., et al., Cloning, nucleotide sequence, and expression of the Bacillus subtilis lon gene. 
J Bacteriol, 1994. 176(21): p. 6518-27. 
331. Rosen, R., et al., Protein aggregation in Escherichia coli: role of proteases. FEMS Microbiol Lett, 
2002. 207(1): p. 9-12. 
332. Thomsen, L.E., et al., ClpP is involved in the stress response and degradation of misfolded 
proteins in Salmonella enterica serovar Typhimurium. Microbiology, 2002. 148(Pt 9): p. 2727-33. 
333. Camberg, J.L., J.R. Hoskins, and S. Wickner, ClpXP protease degrades the cytoskeletal protein, 
FtsZ, and modulates FtsZ polymer dynamics. Proc Natl Acad Sci U S A, 2009. 106(26): p. 10614-9. 
334. Saibil, H., Molecular chaperones: containers and surfaces for folding, stabilising or unfolding 
proteins. Curr Opin Struct Biol, 2000. 10(2): p. 251-8. 
335. George, E.A. and T.W. Muir, Molecular mechanisms of agr quorum sensing in virulent 
staphylococci. Chembiochem, 2007. 8(8): p. 847-55. 
 
 
  
 
110 
 
Curriculum Vitae 
 
  
  
 
 
Education 
 
 
Jun 2000  Baccalaureat
Sep.2000-Jun.2001  First year Medicine study at the University of Paris VI 
 (A-level): Biology, Physics, Chemistry, and Mathematics 
 
Sep.2001-Jun.2004 Bachelor 
 
of Genetics (third year degree) at the University Paris VII (France) 
Jun.2004-Sep.2004 Training period at the University of Leicester (England), Dept of Microbiology, 
in Prof. J. Ketley group 
Subject: Complementation of a chuA mutant, an iron carrier in 
Campylobacter jejuni. 
 
Sep.2004-Jun.2006  Master study in Genetics at the University of Paris VII (France) 
 
Mar.2005-Sep.2005 Training period the SCRIPPS institute (La Jolla, California), Dept. of Oncology, 
in Prof. D.E. Zhang group 
Subject: Modification of HSPC150 by ISG15, an ubiquitin family member 
 
Dec.2005-Jun.2006  Master thesis at Necker Medical School (Paris, France) in Dr JM. Reyrat group 
 Title: Species specificity of a glycopeptidoprotein carrier (Gap) in 
Mycobacterium 
Jun.2006  Master Degree
 
 in Genetics at the University of Paris VII (France) 
Oct.2006-Oct.2009 PhD Thesis at the Max F. Perutz Laboratories (Vienna, Austria), Institute 
 of Microbiology and Immunobiology, in Dr. E. Charpentier group 
 Title: Role of Clp-mediated proteolysis in the gram positive pathogen 
Streptococcus pyogenens 
Nov.2009-Jul.2010 Relocation of research at the University of Umea (Sweden), Dept. of 
 Molecular Biology, MIMS, in Dr E. Charpentier group 
 
  
Surname   Beneyt  
Firstname   Fanny L.M.   
Date of Birth  14th October 1982 (28 years old) 
Place of Birth  Paris, France  
Nationality  French 
Family status  Single 
 
111 
 
 
Scientific experience 
 
♦ S2 Lab, Sterile hood 
♦ Writing Reports, Presentations 
 
♦ DNA: Cloning, Southern blot 
Molecular Biology: 
♦ RNA: Northern blot, Reverse transcription 
♦ Protein: Purification, Overexpression, Western blot 
♦ Cell Culture : Culture, Transfection, Infection 
 
♦ S. pyogenes, S. aureus, M. smegmatis, C. jejuni, E. coli 
Microbiology:  
♦ Knock out strains construction in S. pyogenes and S. aureus 
♦ Biofilm assay, Autolysis assay, Motility, Survival to stress, Infection 
♦ Light and Scanning Electron Microscopy 
 
 
Teaching 
 
♦ Tutor for “UE in Molekularer Mikrobiologie” University of Vienna (2008) 
♦ Tutor for the supervision of exams of Molecular Biology study (2007-2009) 
♦ Supervision of 2 praktikum students and 1 diploma student 
 
Business 
 
♦ Selling at C&A Haussmann (Paris, France), Men’s department (2001-2002) 
♦ Cashier at C&A Haussmann (Paris, France) (2003) 
 
Languages 
 
♦ French: Native speaker 
♦ English: Fluent 
♦ German: Advanced (B2) 
♦ Spanish: Conversational  
 
Further informations 
 
♦ Computer skills: PC and Mac, Office (Word, Excel, Powerpoint), Photoshop, VectorNTI, DNA 
Star 
♦ Driving licence B 
♦ Golf, Swimming, Ball room dancing, Badminton 
♦ Cinema, Live music, French and American literature 
  
 
112 
 
 
Oral presentation 
 
♦ 18.11.2008: VBC symposium II, Intercell, Vienna, Austria. 
Fanny Beneyt:
 
 Role of Clp mediated proteolysis in Streptococcus pyogenes pathogenicity 
 
Poster presentation 
 
♦ 18.10.2007: VBC Symposium, Intercell, Vienna, Austria 
Fanny Beneyt
Role of Clp protein in Gram positive pathogens 
, Silvia Spiess, Tim Clausen, Emmanuelle Charpentier  
 
♦ 6-7.03.2008: 3rd Symposium of the DFG Priority program. Proteolysis in prokaryotes: Protein 
quality control and regulatory principles. Berlin, Germany 
Fanny Beneyt
Role of Clp-mediated proteolysis in Gram positive human pathogens 
, Silvia Spiess, Kürsad Turgay, Tim Clausen, Emmanuelle Charpentier  
 
  
 
113 
 
Acknowledgements 
 
First of all, I would like to thank my supervisor Emmanuelle Charpentier for giving 
me the opportunity to work on this project as well as her support and input throughout my 
Ph.D. 
I also would like to thank the members of my Ph.D commitee, Angela Witte, Manuela 
Baccarini and Eszter Nagy for their advice and guidance. Then I would like to thank Pavel 
Kovarik and Kürsad Turgay for reviewing this thesis. 
 
My special thanks go to my collegues Steffi, Karine, Maria E., Eli, Kris, Doris, 
Barbara, Markus M., Maria S., Agniezka and Christine for all the fun and great moments we 
shared throughout the years. It was great to work with you guys! I will miss the lunches, 
coffee breaks, mad plans and announcement times. Fortunately, we still have many dinners to 
come. And a special mention to Silvia which I thank for all the above and as well for the time 
we shared in Sweden. It made the North Pole not so bad after all. 
I would also like to mention Lena, Anais, Sophie, Michaela, Hannah, David and 
Barbara for their warm welcome into the cold far North. I promess to visit soon. 
 
Puis j’aimerais remercier mes amies qui ont été un formidable soutien de l’autre coté 
des Alpes: Caroline, Virginie, Audrey et Evelyne. J’ai beaucoup de chance d’avoir des amies 
comme vous. Je suis heureuse que la distance ne change rien, c’est du solide et garantie à vie. 
Et je n’oublie pas les plus importants, mes parents M.A et J.D. J’en suis là grâce à 
votre amour et soutien tout au long de ses années. Merci pour tout vos precieux conseils: 
même si je ne les suis pas toujours, je les cheris. 
 
Last but not least, I would like to thank Andi for his love, patience and support. I 
would never have made it without you. 
 
